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1 EXECUTIVE SUMMARY 
The Royal National Institute of Blind People (RNIB) commissioned the Welsh Institute for Health and 
Social Care (WIHSC), University of South Wales working in partnership with the Swansea Centre for 
Health Economics (SCHE), Swansea University, to evaluate the impact that patient information and 
support services in UK NHS ophthalmology departments makes for patients, the clinic and on services 
more generally.  
RNIB were interested to understand the difference that those that provide patient information or 
support services (most typically called eye clinic liaison officers – ECLOs, or vision support officers) 
make where they are present in clinics – whether defined in health-related quality of life outcomes 
(HRQoL) for people with sight loss, capturing  or quantifying other benefits that they bring to the 
running of the clinic. 
1.1 TERMS OF REFERENCE AND METHOD 
The study was required to answer several key questions, structured around three areas of impact: 
Impact on patients 
 How does the ECLO ‘value add’ for the patient? 
 How does contact with the ECLO impact on the HRQoL for patients? 
 Are ECLOs targeting the right people? 
Impact on clinics 
 How do ECLOs operate within the clinic setting? 
 What is the impact of an ECLO on clinic activity? 
Impact on services 
 What are the service benefits for having an ECLO present in clinic? 
 Are there cost-savings to the NHS when an ECLO is part of the care team? 
 What would happen if ECLO services were expanded? 
The study was undertaken through an analysis of existing RNIB/Action for Blind People data on ECLO 
activity, complemented by 30 site visits to UK NHS ophthalmology outpatients. Our original ‘typology’ 
of sites based on presence or absence of an ECLO proved too simplistic. Instead, we used the 
experience described by patients divided into four categories: a) patients who said that they had 
support needs that were a) not met as no support was offered or requested; b) met by an ECLO; c) met 
by another person (whether nurse, doctor, volunteer etc. but not by an ECLO); or d) patients who said 
that they had no support needs. It is important to recognise that all four categories of patient could be 
present in each of the sites. The complex nature of ophthalmology departments meant that no two 
sites or ECLO services in the study were the same as organisations arranged their services to reflect 
local priorities.  
The visits to outpatient departments were designed to gather: 
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 HRQoL data from patients using National Institute of Health and Care Excellence (NICE) preferred 
measures, which were then followed-up after three months;  
 Patient experience data;  
 Staff data on the time spent on tasks that they undertake similar to ECLOs; and 
 Interviews with a range of individuals including ECLOs, consultant ophthalmologists, clinic/ 
directorate managers, optometrist, commissioners, rehabilitation officers for visual impairment; 
orthoptists, registrars and medical secretaries. 
1.2 RESULTS OF QUALITATIVE ANALYSES 
There were four main categories in our coding framework (Figure 1.1) which evolved throughout the 
research project, namely: Capacity, Patient-centred, Skills and Knowledge, and Relationships.  
FIGURE 1.1 · Coding framework - summary 
 
1.2.1 CAPACITY 
‘They’re like a little cog that makes all the others spin. They’re a central link that the patient can go to 
and the ECLO can start all the other cogs spinning for them’ [Operations manager] 
The themes that became apparent under this category include the ways in which ECLOs affect the 
capacity of each service: that they add to the capacity in clinics and services and work in the most 
efficient, patient-centred manner possible. ECLOs also have positive effects on fundamental issues 
such as applying for a CVI, or impact on the various pathways that have to be negotiated by patients. 
ECLOs often have both networked power and networking power, the former being the means to 
enact, interact and facilitate core aspects of the ‘care’ system for those losing their sight, such as 
completing the CVI process. The latter, networking power, would be the use of tools such as referral 
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and signposting to activate other relationships across the various networks in which ECLOs operate, 
and in which they are important nodes.  
The CVI process 
 ECLOs have made CVI processes more efficient compared to previous systems that were in place. 
Many of our interviewees, professionals working alongside ECLOs, reiterated that ECLOs seem to 
have 'sorted out' the CVI pathway, in a comprehensive manner, in many of the sites visited.  
 ECLOs ensure that all eligible patients are supported through the CVI process in a timely manner 
so that they access preventative support from their local council. 
 ECLOs have more time to explain the significance of the Certificate clearly – it is an opportunity to 
offer support in what can be an emotional process for the patient. Crucially, ECLOs are able to 
follow up the process, including setting up any further support from that point onwards. 
Time saving, streamlining processes and pathways to care 
 Many of our interviewees were convinced that having an ECLO in post saves a lot of clinical time. 
We heard this from clinical managers, matrons, nurses, consultants and others. This assertion is 
no less valid as a finding for having been established qualitatively. However the quantitative study 
found that staff in non-ECLO clinics do not spend much time per patient performing as ‘ECLO-like’ 
staff. The ECLOs provide extra time and support for patients, rather than delivering support that 
other staff give. 
 Interviewees from ophthalmology clinics acknowledged that ECLOs save them time primarily by 
taking pressure off them. The medical staff are required to move people through the system quite 
quickly, more so with ever tightening budgets: ‘it releases some of the time for the trained staff to 
do what they trained for’. 
 Overwhelmingly, interviewees believe that ECLOs contribute to the smooth running of eye clinics.  
They would seem to enhance efficiency within clinics and streamline processes to release 
capacity, not only through the CVI process as outlined, but by referring and signposting 
appropriately and according to the needs of patients, in a timely way:  ‘…[referring to an ECLO...is] 
about putting the patient in the right place for the right reasons at the right time – that’s how it 
works’ [Orthoptist]; ‘[I]t definitely does have an impact on the smooth running of the clinic and 
that’s how it saves money’ [Clinical Lead] 
 Many interviewees are of the opinion that time is also saved for other staff through ECLOs taking 
ownership of the CVI process. Inappropriate referrals are avoided. In more than one account it 
was stated that if there is early engagement with patients (e.g. pre-CVI), people will impact less, 
further down the line. Part of an ECLO job is early intervention and prevention, not waiting until 
the patient is registered. 
 Giving patients time to talk and get used to their diagnosis is a key function of ECLO practice. Most 
interviewees recognize this, and this was a comment made by many across the nations and 
regions. By giving this time to talk, an ECLO allows other clinical staff to carry on with their tasks. 
1.2.2 PATIENT–CENTRED 
‘We fill the gap where patients used to fall, and give them the help to remain independent’ [ECLO] 
Another major category developed in our data was that of ‘patient-centred’ practice. By being 
‘patient-centred’, there is slight shift in emphasis in ECLO practice, where the focus is on the need of 
the patient rather than the needs of the service.  
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Bridge between clinical and non-clinical services 
 ECLOs are clearly the bridge between services both within the clinical environment and services 
outside of the hospital, and this is a key practice – linking the health service and the wider world – 
whether that is to social services, social care, local sight loss charities or other voluntary sector 
groups. By linking services together, this benefits patients, their families and carers. It also enables 
care to continue once medical options have been exhausted.  
 As we have seen, there are clear examples of when the ECLO takes over in the clinic for ‘non-
clinical’ work e.g. certification, but also raising patient awareness in other ways. 
Emotional support 
 Providing a wide range of emotional support is obviously a key practice for ECLOs. They provide 
support for patients who are anxious about their condition including those whose symptoms are 
mild and are anxious about their future, and are able to manage expectations. 
 ECLOs fill a gap in services. In clinics without ECLOs, and before existing ECLOs were in post, the 
capacity to provide emotional support was limited: ‘The really tough patients, the patients that 
really need a lot of emotional support, there’s no way we would be able to provide it without [the 
ECLO], no way at all’ [Optometrist] 
 In many clinics people who are anxious about their condition are referred to an ECLO immediately. 
Both clinicians and ECLOs perceive this saves time in the clinic and gives the clinicians ‘permission’ 
to move to the next patient. 
Developing emotional resilience and enabling  
 ECLOs are enabling in the sense that they help patients to get on with their lives outside of the 
clinic, and help them develop the necessary coping mechanisms, what is now commonly called 
emotional resilience. The clinician is able to refer the patient with confidence – their needs will be 
seen to as fully as possible by the ECLO, beyond the starkness of the diagnosis and details of the 
treatment: ‘It’s the quality you can bring to a patient’s life I think, the quality service, a way of life, 
a coping strategy.  It is just a good experience, an all-round experience, and it is part of our patient 
care, and it enhances the patient experiences and enhances their lives I would say’ [ECLO] 
Preventative work - early intervention 
 Many ECLOs are proactive, not reactive, often working to fill gaps and provide the patient with 
tools to take things further. In this sense, ECLOs add value because if they spot a patient earlier 
(not at the point of CVI), more work can be done to help. We heard several times during our 
interviews how delays in the system can have knock on consequences for the patient and that 
early intervention by the ECLO can avoid some of this: ‘Getting things in place so that they cope 
with the visual impairment before they fall and become an inpatient...We felt it was important to 
say to the doctors we’ve made contact with every new person should they need it’ [ECLO] 
 Several Rehabilitation Officers for Visually Impaired people (ROVIs) interviewed were of the 
opinion that ECLOs are a real help to engagement, and they prefer it when the ECLO refers to 
them, because they can explain fully what ROVIs do: 'when they find out that you’re not a social 
worker, you’re a rehab worker and you’re there to teach them to stay independent, you find that 
they will take the service up' [ROVI] 
 By linking to the outside world, ECLOs often facilitate early intervention and rehabilitation, and 
the 'work' starts before they see the ROVI, for instance.  
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 10 
Maintaining engagement and continuity of care 
 Engagement with patients can be an opportunistic process; ECLOs have to be able to improvise 
and be flexible with the time it takes. An ECLO needs to be there at the precise point when the 
patient asks for help, which might be immediately, or because of circumstances or attitudes 
towards support, later on. Either way, this can be a commitment that lasts for many months.  
 Another aspect to this is the follow-up, to maintain that engagement, and many interviewees 
indicated that it is often the ECLO who does a lot of the follow up work to make sure that care 
continues beyond the medical care of the clinic. By supporting the patient early on in their 
journey, we heard how it then helps other professionals in the local eye health network to 
maintain their engagement: ‘You’ve not left the patient to go home wondering if they’re safe, but 
you pass over to a person who is more specialised to follow it up. Whereas the doctors and nurses 
they don’t have the time and they don’t have the skills just for that purpose because there are so 
many other things clinically to do.  If I have a patient, I do encourage them to speak with [the 
ECLO].  It makes a difference and you feel safer’ [Clinic manager] 
Quality of service 
 ECLOs have made a major improvement to services across the nations and regions of the UK. The 
feedback from many clinicians was clear about the benefit to patients: ‘Given the very positive 
feedback we’ve had about their support, there is a direct service quality and patient benefit 
argument for having one in any clinic’ [Consultant Ophthalmologist].  
 Many interviewees stated that an ECLO adds to the quality of care offered: ‘Our service would be 
very incomplete without the ECLO component: people need to know how to live their lives after 
walking through the door – this is what an ECLO brings’ [Consultant Ophthalmologist]. 
1.2.3 SKILLS AND KNOWLEDGE 
This is a very wide category and encompasses descriptions of a range of practices, from the 
awareness raising or administrative roles to advocacy and communication with external stakeholders.  
Admin and paperwork  
 Apart from the CVI process, which seems central to everyday practice, we heard how ECLOs also 
have a fair amount of administration and other paperwork to complete, both for internal audit 
and tracking functions but also, more importantly, on behalf of the patient. 
 We detected that there were differences of emphasis in the systems used across the nations, 
regions and local authority areas, depending on local need e.g. some adapted the way that ECLOs 
had to record contacts because many of the ECLOs are partially sighted. 
Advocacy 
 ECLOs advocate for patients on a regular basis. We heard how this could be both within the 
clinical system and other external pathways. Because their practice is patient-centred, they often 
reduce stigma, and ensure people aren’t ignored as they try to navigate complex systems and 
frameworks of rights and entitlements, whilst at the same time experiencing profound changes in 
their eye health status. 
 By helping people to deal with their worries and concerns, we found evidence through our 
interviewees that they often demystify challenging situations, and encourage people to benefit 
from the offer of support that exists: ‘We have a lot of patients who don’t want to have social 
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services involved, especially the very elderly, because they think it’s an intrusion and [the ECLO] 
will have more time to explain to them that they’re there to help and it’s, they don’t have to come 
to your house and intrude, you know, it’s just the help that’s there’ [Clinic Manager] 
Communication 
 The ECLO role is very much about communication between patient and community as they get 
used to the diagnosis: ‘Patients at least need to be much clearer about what they can do, and how 
to live their life after they walk through the door, and that’s the big difference that the ECLO can 
bring’ [Consultant Ophthalmologist] 
 Good internal communication is also part of ECLO role – they often make sure that parts of the 
eye care team, and the eye care system as a whole, work together. The continual arrival of new 
staff in clinics means that there is always a need for ECLOs to educate staff about what they do. 
 The evidence suggests that there is a very ‘embodied’ nature to the role of ECLO; it became 
evident from many of the accounts heard that the ECLO role is a very physical presence in the 
clinic. We heard how much easier it is if they're physically there in the clinic, not only to help 
immediately with those who are upset, but to connect the various part of the team.  
Awareness raising role 
 Fundamentally, ECLOs help people by providing a lot of information. We heard how they are often 
able to explain the eye condition in terms that are understood by patients, and how they have an 
important role in the internal workings of teams and training for medical professionals. 
 Their awareness raising role can be quite varied. For example in some places, the ECLO is part of 
the induction process for medical staff – in at least one place, this included taking part in the 
mandatory training on falls prevention for all doctors.  
 We heard also that some ECLOs are very involved in patient awareness initiatives such as how to 
administer drops, which in some places, meant saving a certain amount of clinical time for others.  
Experience and background 
 ECLOs come from a wide variety of backgrounds.  There is a whole range of background in our 
interviews, from those with nursing experience, to those who have the lived experience of sight 
loss, to others who have spent years in the voluntary sector. 
 Most ECLOs have a degree of clinical knowledge but the vast majority aren’t formally trained as 
clinicians. As mentioned, for a minority, having a background in nursing is seen as an important 
component in the team 'makeup', and gives another way of experiencing the gaps in the system.  
 Many of those interviewed have completed a lot of training to become ECLOs in the first place, 
with some able to add value by being able run things such as low vision clinics, for example. 
Knowledge of local services/ local knowledge 
 Having good local knowledge of services available in several sectors, and being able to maintain 
that knowledge through networks, would seem to be a key skill for ECLOs. As we’ve explored 
previously, ECLOs act as a bi-directional node, with knowledge about local services coming into 
clinical teams also through the role.  
Referral and signposting 
‘It would be a disaster in clinic without the ECLO – patients would not be directed to the proper 
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places’ [Senior Doctor] 
 Referrals seem to be the most common way that patients come to ECLOs, and for many, a key 
point of contact, enabling support to begin.  
 In general, ECLOs are trained to signpost after helping the patient gain some understanding of 
their condition and they signpost for a diverse group of patients, from older people with macular 
degeneration, to young diabetics.  What we heard from several ECLOs was that because it's 
constantly changing, one of the main challenges for ECLOs is to keep up with what’s happening 
locally through their networks, and having strong relationships within those networks is key. 
1.2.4 RELATIONSHIPS 
Building and maintaining a strong network of relationships with other services both within the clinical 
environment and outside the clinic with other sectors would seem to be a key ECLO role: ‘The ECLO 
isn’t just about lending an ear –it’s about efficiently liaising with services’ [Outpatients Sister] 
Connections with the community 
 Having good relationships with local eye health networks is a fundamental part of ECLO practice.  
This means constantly having to update information about what's going on in the local community 
or voluntary sector, for a wide range of patient ages and interests, and maintaining those 
relationships over time.  
 Many clinicians admitted in our interviews that ECLOs make the connections that are very difficult 
for them to make, and therefore they complete the care needed for their patients. Patients are 
referred to the ECLO because clinicians recognise they provide holistic rather than medical care 
and so add value to the service. 
Connections with social services 
 ECLOs save waiting time for patients in making connections with social services. In some places, 
this relationship is quite formalised and meetings will take place on a regular basis. We heard how 
ECLOs help with the important background work that’s needed so people are more open to 
getting their rights and entitlements as patients/citizens.  
Connections with the voluntary sector 
 ECLOs signpost to a very wide range of voluntary sector organisations, from the small local groups 
to services offered by large charities.  Again, this is an important part of their practice and they 
have to keep up with what’s going on locally, often through the relationships built up in their own 
networks. 
Trust and value 
 As a trusted link between clinical services and other sectors, ECLOs do the necessary support 
work, beyond the clinical work. Many clinicians noted that without the ECLO it would be really 
difficult to offer the emotional support to people who are having a tough time with their 
diagnosis. 
 ECLOs thrive on relationships of trust, and some believe that being identified as part of the NHS 
means that they are seen more as a ‘trusted’ member of the clinic staff: 'When my badge said I 
worked for a charity, people didn’t want to see you. The minute that badge changed my numbers 
trebled, because they know you’re trained, they know you are a trained professional, they know 
that you’ll be telling them the proper stuff. The NHS see you as a professional' [ECLO]. 
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1.3 RESULTS OF QUANTITATIVE ANALYSES 
1.3.1 ECLO ACTIVITY 
The ECLO activity data included the outcomes of the meeting with the patient in three categories: 
‘Informed about’ relates to providing information related to patients’ main concerns, such as giving 
leaflets to patients; ‘Signposted to’ relates to providing specific source of support or services that 
patients can seek help from; and ‘Referred to’ relates to making referrals for patients with the 
purpose of getting further specific support.  
 During the 12 months of the study period (April, 2015 – March, 2016) a total of 16,887, 2,934, 
2,341 and 4,126 meetings with ECLOs were recorded in England, Wales, Scotland and Northern 
Ireland respectively. 
 Overall, Welsh patients tended to re-visit the ECLOs more than the other three UK countries, and 
in each country, women and people between the ages of 60 and 89 years are the main age groups 
seen by the ECLOs. 
 While living with family members was the most frequently recorded living arrangement for 
patients in all four countries, over half of patients of age 80 years and above reported living alone. 
 Age-related macular degeneration (AMD) was the most commonly seen eye condition among the 
patients ECLOs see. 
 Various interaction types between the ECLOs and patients were used, including face-to-face 
meetings and phone calls (most frequent type of interaction) and email, letters, and texts.  
 In most cases, ECLOs spent 16-30 minutes either face to face or telephone with patients and also 
another half an hour undertaking activities on behalf of patient if it was necessary.  
 Of patients aged 60 years and above who reported to the ECLO they had a fall, 60% reported a 
previous fall.   
 Overall rates for patients aged 60 years and above in terms of fear of falling shows that they have 
higher rates than the general population, with the highest prevalence in Wales (60%). 
 Following patient contact, the data indicate that up to 70% of patients receive information about 
eye related services, with referrals to services provided less often.  
 The main concerns patients express at ECLO meetings relate to their independence and reading 
ability. Up to 90% of patients received emotional support from the ECLOs. 
1.3.2 PATIENT SURVEY  
Data collected from the patient survey includes HRQoL outcomes (using the EQ-5D 5L instrument) 
from a number of perspectives revealing differences in HRQoL between different eye conditions, 
types of support required, received and not received, and time since diagnosis, scores of the different 
dimensions of HRQoL, and differences between the groups of the people that responded to the 
patient survey.   
 The “robustness” (i.e. how confident we can be of the results) of these differences in HRQoL 
between these patient conditions and support categories were then tested via statistical tests (i.e. 
Student t-tests).  
 The p-values of the t-tests indicate the probability that the samples do not differ; however trends 
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are seen that suggest differences.  
 Trends can be observed in the data however, the patient numbers at follow up are smaller than 
those who contributed at baseline, further data collection could strengthen the data and confirm 
the observed trends. 
 HRQoL (mean EQ-5D scores – utility scores) were lowest for Diabetic Retinopathy patients (mean 
0.751, Standard Deviation (SD) 0.322), and these patients were recorded as receiving the lowest 
level of support from either and ECLO or other staff.  For other eye conditions (Dry and Wet AMD, 
and Glaucoma) those receiving ECLO support had slightly lower HRQoL than those seen by other 
staff. 
 Patients supported by ECLOs or non-ECLOs showed a decline in HRQoL captured in the utility 
scores at follow-up (0.011 and 0.07 respectively for the utility scores). However, the VAS scores 
showed a small increase at follow-up for those seeing an ECLO, with differences not being 
statistically robust and thus warranting further study with larger patient samples sizes. 
 The patient survey revealed a significant proportion of patients at ECLO supported clinics who 
stated they needed support but did not receive it.  This may be a signal that there may be a case 
for provision of more ECLO support in some centres. 
 While there was a trend suggesting a small overall decline in HRQoL scores at follow-up for 
patients supported by an ECLO or other staff, the decline was less for those patients attending an 
ECLO site in comparison to non-ECLO sites, possibility indicating that having an ECLO on-site may 
reduce the size or rate of the decline in patients’ HRQoL.  The staff survey data suggest that it may 
be that having an ECLO on-site may influence an improvement in the environment of support in 
general within eye clinics. 
 When changes to HRQoL after diagnosis were examined, a small improvement in HRQoL over the 
first 6 months post-diagnosis, followed by a small decline in the following 6 months was shown. 
This may suggest that the effect of diagnosis and initial treatment helps to improve HRQoL, but a 
later decline may be due to a decline in the eye condition itself, or that patient care has a lesser 
impact over time. 
 The differences of scores for the 5 domains of the EQ-5D between the whole study participant 
population and those who have received ECLO support indicates there is a proportion of all study 
patients that have moderate to severe problems with mobility, self-care, their usual activities, 
pain and discomfort, and depression and anxiety. In addition, data shows that the ECLO service is 
providing support to patients with these needs. 
 Of all study patients recording moderate and severe problems with anxiety/depression (n = 29 
and 11 respectively); over half had support from an ECLO, and of those reporting extreme 
problems (n=2), all received ECLO support, suggesting that the ECLOs are targeting the patients 
with self-reported anxiety/depression who need support and potentially those needing support 
are engaging with ECLOs. 
 For the four other domains of the EQ-5D (mobility, self-care, usual activities, and pain and 
discomfort) ECLOs see less than half of the study population that report moderate to severe levels 
of these impairments, suggesting that there may not be enough ECLOs to meet demand and to 
actively find and engage with patients who want support need for more ECLO or ECLO-type 
support. 
1.3.3 THE COST OF AN ECLO IN THE NHS SETTING 
We looked at whether the ECLO might release cash or capacity in the NHS clinic setting by 
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understanding what the staff in the absence of an ECLO might cost the NHS.  
We also looked at the data from the staff survey, to assess how much of staff time is spent providing 
the kinds of support to patients that ECLOs provide, so that this could be compared between sites and 
crucially act as inputs to the economic model which explored the potential of the ECLO to release 
staff capacity. 
 From the ECLO activity data it is conservatively estimated that an ECLO spends 76 minutes per 
client, overall, of which a little under half (35 minutes) is spent on behalf of the client.  Given a 35 
hour working week, 4,877 ECLOs would be required to deliver this level of service.  At NHS staff 
rates (see Table 5.19) an ECLO operating in band 5 unit costs (£36 per hour) a UK wide  ECLO 
service costs the NHS total £7.8m per year. 
 An estimate of £17.94 per patient per ECLO contact was reported in the literature; furthermore, 
approximately £247.76 for ECLO intervention over a person’s lifetime was estimated for 
proportions of people registered as severely sight impaired at each age group, assuming an ECLO 
is seen once per year.  However these figures do not give the whole picture The opportunity cost 
to the NHS of not having an ECLO is the staff member who would otherwise be employed and/the 
equivalent NHS pay band. 
In total 30 study sites were visited through the course of the study, from which 20 contributed to the 
staff survey. Analyses were conducted on time spent by staff in providing emotional support, 
advocacy and certification and registration.  
For the category Emotional Support (“I have spent time listening to patients/carers, talking through 
their worries or concerns”):  
 Consultant ophthalmologists at ECLO sites reported provided marginally more patients per week 
with emotional support than non ECLO sites; clinical nurse specialists and ophthalmic nurses at 
ECLO sites reported providing more patients per week with emotional support than non ECLO 
sites.  
 Staff nurses and sisters at ECLO sites reported seeing fewer patients per week for emotional 
support than non ECLO sites but spent more time providing emotional support in those contacts 
than non ECLO sites. 
For Advocacy (“I have helped people to have their voices heard; to secure their rights and to obtain 
the support they need”): 
 Consultant ophthalmologists at both ECLO and non ECLO sites reported low or no levels of 
advocacy; both clinical nurse specialists and ophthalmic nurses and staff nurses and sisters at 
ECLO sites reported low levels of advocacy support per week for patients with on average less 
than 1 patient receiving support of this nature, while non ECLO sites did not report advocacy 
support. 
On Certification and Registration (“I have informed and advised patients about Certification and 
Registration and its benefits. I have helped patients in a practical way by helping to fill in forms, for 
example”): 
 Consultant ophthalmologists and staff nurses and sisters at both ECLO and non ECLO sites saw a 
similar number of patients per week, supporting certification and registration but ECLO sites 
reported more time spent supporting patients with practical help such as form filling; clinical 
nurse specialists and ophthalmic nurses at ECLO sites reported marginally more support for 
patients per week supporting certification and registration than non ECLO sites. 
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1.3.4 BURDEN OF FALLS AND DEPRESSION 
While a number of studies have attempted to investigate the impact of the ECLO on falls reduction, 
our study attempts to pursue exploration of this further in order to better estimate the impact of the 
ECLO on NHS costs overall. We used data from our study and from the literature to estimate the 
potential impact of the ECLO service on both falls and depression which, aside from the personal 
impact on individuals, are both costly to the healthcare system. 
The literature indicates that the rate of falls and risk of falls and depression in people with sight loss is 
unequivocally linked. Thus the role of the ECLO, alert to the impact of a fall on a person with sight 
loss, is vital in making the connection between these risks, the patient and services available in the 
region.  
 The literature indicates that the rate of falls and risk of falls and the rate of depression in people is 
unequivocally linked with sight loss. The role of the ECLO, who is alert to the impact of a fall on a 
person with sight loss, is vital in making the connection between these risks, the patient and 
services available in the region. Using the quantitative data collected in our study, combined with 
costs and prevalence data on falls and depression from the literature, deterministic modelling was 
conducted to estimate the potential impact of the ECLO service on both falls and depression. 
 We estimated that the presence of ECLOs could lead to a 13.3% reduction in falls, overall in the 
prevalent cohort; equivalent to approximately 28,000 fewer falls, based on the 2013 UK 
population of people with sight loss: a reduction in the total fall rate from 25% to 21.7%.  
 Cost implications of ECLO provision for fall reduction was estimated at an incremental cost per fall 
avoided of £2,813 when an ECLO is supporting patients at risk of falls. Should the percentage of 
patients able to see an ECLO increase, a proportional saving increase should also ensue. 
 The DEPVIT study reported that 43% of those presenting to low vision rehabilitation clinics have 
significant depressive symptoms.  
 Our estimates suggest that the ECLO could prevent approximately 43,000 interventions from NHS 
services for depression, a reduction of 11.9% compared to a situation where no ECLO action was 
taken. At an average costs of £2,509 per depression episode per person, an estimated saving of 
£107.6m in avoided referrals to depression services is estimated.  
 After accounting for the total cost of the estimated 112 full-time ECLOs required, a total saving of 
£101m is estimated, equivalent to 11.2% saving compared with care without an ECLO. This 
represents an incremental cost per referral avoided of £2,361. Increasing the percentage of 
patients able to see an ECLO would result in a proportional saving increase. 
1.3.5 COST-UTILITY ANALYSIS 
Cost-effectiveness analysis (CEA) is a form of economic evaluation that utilises a single, specific, one- 
dimensional, health or clinical outcome to evaluate competing health interventions. In CEA, the 
ultimate measure of interest is the incremental cost-effectiveness ratio (ICER), which is the ratio of 
the difference in costs and the difference in outcomes for one intervention compared with another. 
Cost-utility analysis (CUA) is a special type of CEA in which multidimensional health outcomes (e.g. 
depression and mobility) are reduced to a single dimension (score) reflecting individuals’ preferences 
for health outcomes. The outcome in cost-utility analysis is the quality adjusted life year (QALY).  
Valuation of a healthcare intervention is made by measuring the additional cost per additional 
outcome ratio (e.g. an incremental cost/QALY ratio). This ratio is then compared with that to an 
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external threshold to evaluate the value of the new intervention with ratios for other interventions. 
 A simple cost-effectiveness of the impact of ECLOs compared with no ECLO was evaluated using 
CUA.  The analysis spanned a time period of 12 months, and was from the perspective of the NHS.  
 Inputs to the analysis included the EQ-5D utility scores from the patient survey and the costs to 
the NHS of an ECLO employed at the equivalent of NHS salary Band 4 and Band 5 - the most usual 
bandings for a NHS employed ECLO.  
 The incremental cost- per ‘QALY sustained’ showed that the patients seen at an ECLO site 
generated an incremental cost per ‘QALY sustained’ of £2,883 for an ECLO paid at Band 4 
compared with patients attending the non – ECLO site. When the cost of the ECLO increased 
based on Band 5, the incremental cost- effectiveness ratio (ICER) increased to £3,517 per ‘QALY 
sustained’ compared with patients attending a non ECLO site. 
 For patients who received support at an ECLO site compared with patients who needed support 
but did not receive support, at an ECLO site, the cost per ‘QALY sustained ‘was £3,348 for an ECLO 
with a Band 4 salary compared with patients not getting support at an ECLO site.  This increased 
to £4,102 per ‘QALY sustained’ compared with patients who did not get support, when the Band 5 
was used. 
 While the CUA was limited by the small patient numbers at follow up, a similar picture of small 
QALY losses across time was seen for unsupported patients, but the magnitude of differences is 
small and showed weak statistical significance.  
 ECLO support for patients could potentially be regarded as cost-effective when compared to a 
‘world without ECLO support’ by commonly accepted norms. These trends show promise but 
additional data collection would strengthen the statistical analysis. 
1.4 KEY MESSAGES FROM FINDINGS 
1.4.1 IMPACT ON PATIENTS 
ECLOs help those patients experiencing sight loss with the greatest needs. Evidence suggests that 
they may contribute to maintaining patient HRQoL over time. They provide a wide range of well-
targeted, well-appreciated services. In particular: 
 The ECLO ‘adds value’ for the patient by recognising the critical issues for them and providing the 
appropriate support and signposting/referring. 
 Contact with the ECLO may impact positively on health-related quality of life for patients in a 
number of ways. 
 ECLOs target the right people but some people may be ‘missing out’, either due to lack of an 
available ECLO, or because they do not access an ECLO where one is present. 
 ECLOs integrate services, securing immediate clinical needs for patients and also long-lasting 
rights and entitlements; the needs of people are well served by ECLOs integrating health, social 
services and others. 
 ECLOs are proactive patient-centred advocates, reducing stigma, and ensuring people aren’t 
ignored as they move through a complex system; in part through developing relationships, 
networks and trust, and standing up for patients, as constants at a time of change. 
 ECLOs help people to deal with their worries and concerns, demystifying challenging situations, 
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and reducing stigma and anxiety and allowing people to benefit from the offer of support that 
exists. 
 ECLOs develop relationships, networks and trust, instigating and inculcating local eye heath 
networks, bringing together professionals in two-way information flows. 
 ECLOs thrive on relationships of trust, becoming key members of the clinic ‘staff’ which is crucial 
to them being able to work effectively, whether or not they have a clinical background. 
1.4.2 IMPACT ON CLINICS 
Across the UK, we can describe seven broad types of valued service and support provided by ECLOs, 
working in ways which reflect the individual circumstances of different clinics and hospitals (see 
Figure 1.2). 
FIGURE 1.2 · Seven domains of ECLO practice 
 
 
ECLOs are effective in doing this as follows: 
 ECLOs improve and streamline the processes which operate within clinics, helping others provide 
quality services by aiding the smooth running of the clinic, and making administrative processes 
more efficient. 
 ECLOs develop quality services, catalysing and expediting change; they are experts in joining the 
dots and raising the profile of patients’ needs and their ‘soft power’ effects are significant; they 
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work with staff to make clinics better places for patients through raising awareness of what they 
need with staff and what represents good practice. 
 ECLOs enhance the profile of services through their added-value; by turning the routine into the 
efficient, and the regular into the effective; they stimulate change that improves the offer of 
clinics bringing up the overall quality of the clinic by looking beyond the vision and the visual. 
 ECLOs are proactive catalysers of change through developing effective relationships both within 
and without the clinic. 
 Whilst many ECLOs are working in the earlier stages of the patient journey to good effect, they 
also provide safe and meaningful ‘departure points’, taking the pressure off the system by offering 
a positive place for patients to reside towards the end of the treatment and clinical care pathway; 
they are an alternative to the binary choices of clinicians (continue treatment or stop treatment). 
 ECLOs provide continuous specialist expertise in how to emotionally support people during 
medical treatment and once that treatment ends, ensuring that people make meaningful contact 
between different services, within and without the hospital. 
 Training and continuing professional development for ECLOs could take account of these domains 
of practice. 
1.4.3 IMPACT ON SERVICES 
ECLOs enhance and broaden the care which clinical services provide, thereby potentially reducing 
patients’ longer-term care needs, and release NHS staff to perform their role. They add capacity and 
contribute to the increasing quality of the service offered in clinics; and they make a contribution to 
various other NHS objectives relevant to all four nations:  
 The principal benefit for having an ECLO present in clinic is in providing support that others do 
not/cannot provide.  ECLOs have a specific role; they provide a valued added service and they do 
not substitute for other clinic staff.  
 Hence there are no evident cost-savings within the clinic when an ECLO is part of the care team 
but there may be to the wider NHS in terms of reduced burden of falls, depression and anxiety.  
 If ECLO services were expanded, expressed needs may be met for more patients and through the 
ECLO referrals, negative impacts on health and social functioning may be addressed. 
This study confirmed that from a commissioner’s perspective it is ‘all about the evidence’ and that 
evidence should relate to the local health economy, patient health outcomes, well-being and 
experience rather than a more general reduction in costs to the NHS.   
The ECLO activity data is a valuable resource and has been fundamental as a source of evidence for 
this research.  It has power to provide evidence to commissioners on how the ECLO impacts the 
services and outcomes.  Enriching the data collection without overburdening ECLOs and ensuring it is 
gathered consistently across the UK is worthy of consideration. 
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2 INTRODUCTION AND METHODOLOGY 
The RNIB commissioned the Welsh Institute for Health and Social Care (WIHSC), University of South 
Wales working in partnership with the Swansea Centre for Health Economics (SCHE), Swansea 
University, to evaluate the impact that patient information and support services in UK NHS 
ophthalmology departments makes for patients, the clinic and on services more generally.  
RNIB were interested to understand the difference that those that provide patient information or 
support services (most typically called eye clinic liaison officers – ECLOs, or vision support officers) make 
where they are present in clinics – whether defined in health-related quality of life outcomes for people 
with sight loss, or a quantification of other benefits that they bring to the running of the clinic. 
2.1 INFORMATION ABOUT ECLOs 
The ECLO role was established to provide person-centred emotional advice and support tailored to the 
need of the patient, and to act as a bridge between health and social care services. The ECLO (who may 
also be known as a sight loss adviser or vision support officer, or indeed by other similar titles) works 
directly with people with sight loss to provide information and advice, emotional support and assistance 
in achieving an appropriate referral to community based services. The first ECLO began their work in 
February 1995. 
ECLOs are key in helping patients understand the impact of their diagnosis and providing them with 
emotional and practical support for their next steps. They provide those with an eye condition with the 
practical and emotional support which they need to understand their diagnosis, deal with their sight loss 
and maintain their independence. Most importantly, ECLOs have the time to dedicate to patients 
following consultation, so that they can discuss the impact the condition may have on their life. 
Role of RNIB in training non-RNIB ECLOs 
RNIB offers training and provides ongoing support to all those in ECLO or similar roles across the UK, 
from any organisation. The Accredited Eye Clinic Support Studies course is open to anyone performing 
an ECLO role (or very similar) in an ophthalmology department. RNIB offers resources to support ECLOs 
in post including an Induction pack for managers, a range of Good Practice Guides are available, as well 
as information about integrating into an eye department, and a set of referral guidelines aimed at 
clinical staff to help them in making appropriate patient referrals to the ECLO. RNIB provides networks 
specifically for ECLOs including the Early Intervention Support Network, an email based forum for ECLOs 
to ask questions and share expertise.  
There is Continuing Professional Development for ECLOs three times a year at seminars, and RNIB has 
developed a Quality Framework and Practice Guidelines, which can be used as a quality assessment tool 
for ECLO services. All these resources are available to RNIB and non-RNIB trained ECLOs alike. 
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Current number of ECLOs 
Tables 2.1 and 2.2 below provide the latest information RNIB holds on the current headcount and full-
time equivalent number of ECLOs across the UK. It gives information on both RNIB provided accredited  
ECLOs and other provider accredited ECLOs.1 
TABLE 2.1 · RNIB provided accredited ECLOs – UK (as at September 2016) 
Country FTE Headcount Funder 
UK 44.7 54 - 
England 28 32 RNIB / NHS trusts / local authorities / local societies2 
Northern Ireland 7.7 9 RNIB / Lottery 
Scotland 4.8 8 Health boards 
Wales 4.2 5 RNIB / Health boards / Novartis 
TABLE 2.2 · Other provider RNIB accredited ECLOs – UK (as at September 2016) 
Country FTE Headcount Funder 
UK 28.9 37 - 
England 24 29 NHS trusts / local authorities / local societies 
Northern Ireland - - - 
Scotland 3.9 7 RNIB partnership / local charities / health boards 
Wales 1 1 Health board / Sight Cymru 
2.2 TERMS OF REFERENCE 
The Terms of Reference for the study were originally outlined in the project specification and covered 
the following key research questions: 
 Does an ECLO release staff capacity to perform activities requiring their level of skill 
(substitution)? 
 Does the reallocation of resources save money and/or offset wastage in the clinic? Is there a cost 
saving or simply a reallocation of resources? 
 What is the impact of an ECLO on the delivery of care against quality standards and guidance? 
                                                     
1
 It should be noted that the funding situation for many ECLO posts is not simple, as there may be many different 
organisations funding a single post and the funding ratios can change each year. 
2
 Local societies include, for example, Kent Association for the Blind, Sight for Surrey, and VISTA. 
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 What is the impact of an ECLO on the health and social care cost of conditions associated with 
sight loss (e.g. risk of falling; increased isolation)? 
 What are the patient reported benefits of an ECLO? 
At the outset of the study, it was posited that there would be a marked difference between what might 
be defined as ‘ECLO sites’ where ECLOs were present and ‘non-ECLO sites’ where they were not. This 
initially led to an over-simplistic way of thinking about the complexities of service delivery, but in the 
early stages of the study, the project was comprised of a combination of intervention sites (i.e. with an 
ECLO present in the hospital) and comparison sites (i.e. an ECLO not present). This thinking evolved over 
time (as described in section 2.3 below) and after several iterations, a data ‘long-list’ was identified 
which captured all of the key metrics that the study would analyse (see Table 2.3).3 Emanating from this 
work, and building on the original specification, the following questions became central to the study, 
organised against three headings: 
Impact on patients  How does the ECLO ‘value add’ for the patient? 
 How does contact with the ECLO impact on the quality of life for 
patients? 
 Are ECLOs targeting the right people? 
Impact on clinics  How do ECLOs operate within the clinic setting? 
 What is the impact of an ECLO on clinic activity? 
Impact on services  What are the service benefits for having an ECLO present in clinic? 
 Are there cost-savings to the NHS when an ECLO is part of the care 
team? 
 What would happen if ECLO services were expanded? 
2.3 SITE VISITS AND CATEGORISATION 
In order to gather the data needed to answer the questions above, the study team undertook 30 site 
visits (across all four countries of the UK), to hospital-based ophthalmology outpatient clinics. The visits 
to each site had a number of activities designed to meet the project objectives, details of which are 
provided in section 2.4 below.  
2.3.1 PILOT 
In order to inform the substantive phase of the study, a pilot was undertaken. This included three site 
visits – one to a site with an ECLO employed by RNIB/Action, one to a site with an ECLO employed by the 
health organisation, and one to a site with no ECLO. In these visits, it was possible to test the study 
methodologies, interview schedules and much was learned to improve the substantive phase of the  
                                                     
3
 This list was derived after the pilot phase of the study. 
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study. 45 participants were engaged in completing patient outcome questionnaires, and 11 staff took 
part in interviews. The pilots were undertaken in both England and Wales. 
TABLE 2.3 · Key data and sources 
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Figure 2.1 provides a ‘schematic’ detailing the key components of each of the initial site visits – in effect 
we were trying to understand the relationship between the care provided within the clinic setting 
(whether with or without an ECLO) and a series of patient reported experience measures (PREMs), 
patient reported outcome measures (PROMs), outputs, and potential substitution activities. The figure 
also provides a source for each of these different data.4  
FIGURE 2.1 · Diagrammatic representation of site visits 
Case Study Sites Incl. both ‘ECLO’ and ‘Non-ECLO’ pts
PROCESS 
MAPPING
Fieldwork
Site visits
PREMs
RNIB, Action, Fieldwork
OUTCOMES
Literature
PROMs
RNIB
Fieldwork
1. Falls and other 
harms  
(prevention 
thereof?)
2. Quality of Life
3. Mental Health
OUTPUTS
Third party
RNIB
Fieldwork
Signposting
Referrals 
Reg./Cert.
Welfare benefits
Emotional/practic
al support (e.g. 
Adaptations)
SUBSTITUTION ACTIVITIES
Fieldwork
NHS, Social services, Housing, other?
 
This led to the team developing an initial ‘typology’ for ECLO provision across the UK, which formed the 
basis of the pilot for the study (see Table 2.4). This typology was developed following initial discussions 
with RNIB, and tried to build on the division between sites that had ECLOs (Types 1-3) and those sites 
that did not have ECLOs (Types 4-5). 
This typology was tested and refined during the pilot period. Importantly for the study as a whole, one 
of the key lessons from the pilot was that the binary distinction between ‘ECLO sites’ and ‘non-ECLO 
sites’ did not reflect the complexity of patient pathways into and out of the ophthalmology department. 
As such, the team developed a more nuanced approach to categorising patient pathways which was 
crucial to the analysis of data.  
                                                     
4
 It should be noted that this represented the approach at the outset of the study, and that the analysis of the data in the 
subsequent chapters has to extent superseded this diagram, although the core components remained. 
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TABLE 2.4 · Initial typology of sight loss support provision across the UK 
 Type 1 Type 2 Type 3 Type 4 Type 5 
Employer 
RNIB 
Action for Blind 
People 
Local 
arrangements 
Local 
arrangements 
‘Formal’ 
volunteer-led 
‘Informal’ 
volunteer-led 
No formal 
ECLO/vision 
support 
functions 
provided 
Name(s) 
ECLO 
Vision support 
worker 
Sight loss advisor 
ECLO 
Vision support 
worker 
Sight loss advisor 
ECLO 
Vision support 
worker 
Sight loss advisor 
May not have a 
title 
Trained as 
an ECLO by 
RNIB? 
Yes Maybe No No 
2.3.2 PATIENT CATEGORISATION 
The team recognised that there were in effect four possible categories of patient experience, based on 
whether they felt that they had support needs on arrival at the clinic, and whether those needs had 
been met (by an ECLO or someone else) or not.5 These four categories are as follows, and are 
represented in Figure 2.2: 
 Patients who said that they had support needs, but that no support to them was offered or 
provided (A); 
 Patients who said that they had support needs, and that those support needs were met by an 
ECLO (B, only applicable to ‘ECLO sites’); 
 Patients who said that they had support needs, and that those support needs were met by 
another person (C, whether nurse, doctor, volunteer etc. but not by an ECLO); and 
 Patients who said that they had no support needs (D). 
These categories are used in the chapters below as a unit of analysis for comparing between different 
groups of patients. 
Linked to this was the need to review and revise the original ‘typology’ of sites given that the simplistic 
distinctions between sites that had or did not have ECLOs was much less important than recognising 
that in each of the sites, all four categories of patient could theoretically be present.6 This was not a 
formal re-categorisation, but Figure 2.3 attempts to show the overlaps between the previous typology 
(Table 2.4) and that all four categories of patient experience (as represented by Figure 2.2) could be 
present in any one site.  
                                                     
5
 These needs were self-reported and determined during the interviewer-led patient outcome questionnaire completion 
process. 
6
 Except of course for those that had their support needs met by an ECLO, as this is only possible in ECLO sites. 
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FIGURE 2.2 · Categories of patient used during the study 
Support 
needs
No 
support 
needs
A. Support needed but not 
provided
Support needed and 
provided by...
B. ECLO C. Other
D. No support needed or provided
 
FIGURE 2.3 · Revised typology of sites to reflect categories of patient 
SITE
CATEGORY OF PATIENT
CATEGORY B
“Support needed 
and provided by 
ECLO”
‘TYPES’ 1 and 2
RNIB/Action 
trained ECLOs 
employed by 
RNIB/Action or 
NHS
SITE ‘TYPE’ 
CATEGORY C
“Support needed 
and provided by 
other”
‘TYPE’ 3
Non-RNIB/Action 
trained ‘ECLOs’ 
employed by local 
voluntary sector 
organisations
CATEGORIES A & D
“Support needed 
but not provided”
“Support neither 
needed nor 
provided”
‘TYPES’ 4 and 5
Very little in the 
way of informal 
support, or no 
support at all 
provided
 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 27 
2.3.3 SITE VISITS 
Having learned from the pilots, the study team continued to iterate the methodology before 
undertaking the remaining 27 site visits. In total, of the 30 site visits (completed between September 
2015 and April 2016), 24 were undertaken in sites with an ECLO present, and 6 without. Similarly, 21 of 
the site visits were undertaken in English sites, and three in each of Wales, Scotland and Northern 
Ireland. That said, for the purposes of the analysis all 30 sites will be treated as one case, although we 
will comment on differences between the types of site where relevant. 
2.4 STUDY DESIGN AND METHODS 
During the site visits a number of methods were adopted to gather relevant data in order to answer the 
study questions above. 
2.4.1 INTERVIEWS 
In order to gauge the impact of the ECLO (or equivalent role) on the clinic, we conducted 141 semi-
structured interviews with key staff such as ophthalmic consultants, ophthalmic nurses, administrative 
staff, ECLOs, and rehabilitation officers for visual impairment among others. Prior to the interview, 
informed consent was obtained and typically took place on the day of the site visit by the evaluation 
team. A smaller number were completed over the telephone at a different time. Interviews ranged in 
length from five minutes to two hours, but usually lasted around half an hour. Interviews were 
transcribed and analysed by the researchers (described in more detail in chapter 5). Table 2.5 provides 
an account of who the researchers spoke to during the course of the study.7 
2.4.2 PATIENT OUTCOMES QUESTIONNAIRE 
The purpose of the patient survey was to evaluate the patient experience and outcomes of the ECLO 
service where it existed, and clinic staff where no ECLO service was available.  The survey was 
administered in a 1:1 interview by the researcher at the site (see Appendix 1).  We also used the survey 
to get a baseline value of health-related quality of life (HRQoL) following that up after three to four 
months with another survey (data collected via a phone call).  The survey was administered after 
obtaining informed consent (all patients were given time to read the information sheet and consent 
form prior to survey administration by the researcher).   
The patients were asked if they are willing to complete a brief survey about any support services they 
have received.  In order to collect HRQoL outcomes, the EuroQoL-5D-5L (EQ-5D) was administered at 
the same time. As many participants had visual impairments, they completed the survey with a member 
of the evaluation team in the clinic.  The evaluation team member went through the information sheet 
with the patient if they were unable to read it themselves. Patients were also asked to take part in a 
                                                     
7
 Interviews with patients were not undertaken as part of this study given that at the outset of the work RNIB stated that 
they had collected much qualitative data from patients. Instead they wanted to prioritise gathering the views of those 
professionals who interact with ECLOs. 
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follow-up questionnaire and were contacted at a later date to complete the survey over the telephone 
three to four months after the initial contact. 
TABLE 2.5 · Number and role of interviewees8 
Role of interviewee Number of interviews 
ECLO 26 
Nurse 28 
Consultant 24 
Clinic/directorate manager 13 
Optometrist 12 
Commissioner (health and/or social services) 9 
Rehabilitation Officer for Visual Impairment 8 
Orthoptist 6 
Registrar/other doctor 5 
Medical secretary 5 
Others (including family members and volunteers) 5 
TOTAL 141 
Background to the EQ-5D Questionnaire 
The EQ-5D 5L (EQ-5D) is a HRQoL questionnaire that captures patient-reported outcomes in two ways.  
Firstly, patients are asked to report their assessment of their health state on 5 dimensions: mobility, 
self-care, usual activities, pain/discomfort and anxiety/depression at five levels ranging from ‘no 
problems’ to ‘severe problems’.  These patient responses generate a 5-figure profile that is converted to 
an individual utility score that represents that person’s current HRQoL which is used for health economic 
evaluation to enable estimation of quality adjusted life years (QALYs).  The resulting EQ-5D utility scores 
range from 1 (perfect health) to worst possible health (-0.594).   A Visual Analogue Scale (VAS) is also 
included in this questionnaire, which is a thermometer-type scale that requires a self-rated valuation of 
the health state experienced by the respondent on a scale of 0 to 100.9  The utility scores are derived 
from a survey of the general public and represent a preference based valuation of a health state 
                                                     
8
 It should be noted that whilst this table records the overall number of interviews undertaken, participants were asked to 
consent to recordings being made of the discussion, and/or noted being taken during the interview. A small number of 
interviewees (n=11) did not consent to their interview being recorded or notes being taken (this number incidentally included 
a relatively high proportion of commissioners). Accordingly, the study team did not have permission to produce a transcript 
from these interviews from which to quote evidence. 
9
 This was an interviewer-led process in this study, and in situ the researchers were instructed by participants as to how they 
wished to record their scores on the VAS. 
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characterised by the EQ-5D.  This in effect is the ‘tax payers’ valuation.  The VAS score however is a self-
rated valuation and represents the respondent view of their health state and how it affected their life 
on the day.10 
Various validation studies of the EQ-5D have been carried out for patients with sight loss and for 
patients with other conditions.11  This  generic questionnaire can be administered in a variety of ways, 
on paper as a self-completed survey or interviewer administered (as we used it here).  It is quick and 
easy to complete (reduced patient burden) and is NICE’s (National Institute for Health and Care 
Excellence) preferred method of gathering HRQoL data for economic evaluations (cost effectiveness and 
cost utility analyses, using QALYs).  NICE has outlined their requirements for the methods and conduct of 
carrying out economic evaluations on their website.12 Particularly relevant is Section 5.3, which states 
NICE’s preferred methods of assessing HRQoL for economic evaluations, and confirms its validity on a 
range of patient populations. Essentially, this instrument enables ‘before’ and ‘after’ comparisons for 
health-related interventions (services, treatments, etc.) to be made and also enables the NHS and NICE 
to make comparisons of cost effectiveness and HRQoL differences within and between a wide range of 
health conditions.  In the current study, EQ-5D and VAS patient responses are gathered at baseline and 
at follow up in order to record any changes in general HRQoL over time.  They are also used to describe 
the study population in terms of their self-reported HRQoL to explore whether ECLOs and other staff are 
engaging with those patients who most need support. 
Eligibility criteria 
Patients eligible for the survey included those with sight loss and an eye condition and/or who have a 
CVI, who could receive support from an ECLO (such as those with AMD, glaucoma, diabetic retinopathy). 
2.4.3 STAFF SURVEY 
In addition to the interviews, clinical staff were also asked to complete a pro-forma which aimed to 
assess how much of their time is spent providing the kinds of support to patients that ECLOs provide, so 
                                                     
10
 For a sample copy of the EQ-5D-5L, go to: 
http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Products/Sample_UK__English__EQ-5D-
5L_Paper_Self_complete_v1.0__ID_24700_.pdf 
Useful academic references on EQ-5D-5L include: Devlin N, Shah KK, et al (2016) Valuing Health-Related Quality of Life: An 
EQ-5D-5L Value Set for England. HEDS Discussion Paper Series (16.02),  Health Economics and Decision Science, School of 
Health and Related Research, University of Sheffield , Sheffield; Igarashi A, Fukuda T, et al (2015) Development of a national 
tariff for EQ-5D-5L in Japan.   EuroQol Proceedings, Krakow, 10-09-2015; Kiadaliri AA, Eliasson B and Gerdtham UG (2015) 
‘Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and 
Denmark among type 2 diabetes patients’  Health Qual Life Outcomes, 13145, 01-01-2015; Van Hout B, Janssen MF, et 
al (2012) ‘Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets’ Value in Health 15, pp.708-715; 
Janssen MF, Pickard AS, et al (2013) ‘Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight 
patient groups: a multi-country study’  Quality of Life Research, 22.7, pp.1717-1727 
11
 Longworth L, Yang Y, Young T, et al (2014) ‘Use of generic and condition-specific measures of health-related quality of life 
in NICE decision-making: a systematic review, statistical modelling and survey’ Health Technology Assessment, 18.9, NIHR 
Journals Library: Southampton (see: http://www.ncbi.nlm.nih.gov/books/NBK261619/) 
12
 See Guide to the methods of technology appraisal (2013): https://www.nice.org.uk/article/pmg9/chapter/the-reference-
case#framework-for-estimating-clinical-and-cost-effectiveness 
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that this could be compared between sites and crucially act as inputs to the economic model which 
explored the potential of the ECLO to release staff capacity. The pro forma is included in Appendix 2. 
The clinic staff varied by site but were usually ophthalmologists consultants, registrars and senior 
doctors, ophthalmic nurses, optometrists, orthoptists, imaging technicians, administrative staff and 
health care assistants.  Additionally, the qualitative interviews with staff were used to collect data to 
evaluate the staff mix in clinic and how staff spent their time performing activities typically undertaken 
by an ECLO. The survey at each site was conducted over one day and the staff willing and available at 
the time of survey completed the pro forma regarding the level of support they were able to provide the 
patients attending their clinic. Staff were also asked to report their role, employment band and contract 
type i.e. whole time equivalent (WTE) or other.  
2.4.4 OPHTHALMOLOGY OUTPATIENTS DATA 
Further, the study team had a short questionnaire which was left with an administrator asking about 
typical clinic staffing and the number of appointments per clinic, per month.  The purpose of this was to 
inform the economic analyses. 
2.4.5 ECONOMIC EVALUATION METHODS 
The health economic objectives of the study were: 
 To establish the resources used and costs related to the ECLO service comprising: 
· The impact of the ECLO service on the ophthalmology clinic services and the patients using 
the service; and 
· The relative cost and consequences of providing the ECLO service compared with the status 
quo. 
The perspective adopted for this study was the UK NHS. The scope of the study did not include looking 
at the wider societal perspective. 
Sources of ECLO activity data 
In addition to the data collected by survey, two sources of routinely collected data were utilised for our 
analyses. The first was the dataset relating to the daily activities of each RNIB ECLO, throughout the UK. 
This dataset contained records from one calendar year split by the constituent countries in the UK. 
Whilst there have been moves to address this since, at the time of the study each country in the UK 
collected different data in a different way but every effort was made to attain consistency, largely 
through the efforts of the staff of RNIB and Action for Blind People. A second source of data related to 
England alone and contained information relating to the time spent on completing certificates of vision 
impairment (CVI) and information on the patients who are given them. These data inform the cost-
consequence analysis of the ECLO role and an analysis of the impact of the ECLO on patient outcomes 
and the eye clinic.     
Resource utilisation and costs 
The costs and consequences framework used for this study identified both the direct costs of the range 
of ECLO roles and those employed by the NHS that provide support services in the absence of ECLOs.  
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These were evaluated in relation to the outcomes which can be affected at sites with and without an 
ECLO. The costing exercise involved estimating the NHS salaries required in order to perform ECLO 
activities by ECLOs or substitute staff. Unit costs for staff (hourly rates) were derived from the PSSRU’s 
Unit Costs of Health & Social Care13 and NHS Reference Costs (2014-15)14 based on costs by professional 
roles and include salary on-costs (employers’ National Insurance contributions, superannuation, etc) as 
well as ongoing training and qualifications, indirect and capital overheads.    
Unit costs for community-based scientific and professional staff15 were used to guide the calculation of 
ECLO salary on-costs and overheads, etc.  For NHS staff undertaking support services in sites where no 
ECLO role existed, unit costs were derived according to their NHS role/band/grade.  Self-reported 
assessments of time spent on support services (from the staff pro forma) were used to inform the 
analysis. These resources and associated costs were used to compare the costs of the ECLOs and those 
performing similar support roles elsewhere, and the sources of costs are fully referenced to aid 
transparency of the analysis (see in particular Table 5.19 in chapter 5 below).  
Health economic modelling 
A model-based analysis was undertaken to assess the impact of the provision of the ECLO service 
compared to the other clinical and non-clinical staff covering the work.  The analyses were conducted 
using a de-novo discrete event simulation (DES) model developed in SIMUL8. The model reflects the 
clinical pathway for patients defined and agreed by the project team based on the ECLO services 
(Intervention) and no access to ECLO services (Comparator).  The model follows a patient through the 
pathway (with/without the ECLO service) over a 12 month period. The model was informed by: 
 Population- Adults aged 18 years and over with low vision ; 
 Intervention: ECLO support 
 Comparator:  No ECLO support 
 Perspective: UK NHS 
 Outcomes: The main impacts of the service for the NHS and patients 
Questionnaire data from the study (as described in section 2.4.2 above) and data from the RNIB ECLO 
activity dataset were used to populate the model.  Where necessary, data from the review of the 
literature ‘spot- searches’ of the previous systematic reviews/ epidemiological/HRQoL literature were 
used to inform ‘gaps’ in the model.  These inputs were validated as appropriate by the RNIB project 
team prior to final analysis. Where data were unavailable, assumptions were made and verified by the 
RNIB project team prior to inclusion. 
Study Outcomes for the Economic Analyses 
The main outcomes utilised for the economic analysis were:  
                                                     
13
 Curtis L and Burns A (2015) Unit Costs of Health & Social Care. Personal Social Services Research Unit, The University of 
Kent, Canterbury 
14
 Department of Health (2015) Reference Costs 2014-15 – accessed from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/477919/2014-
15_Reference_costs_publication.pdf 
15
 Curtis and Burns (2015), op. cit, p.164 
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 Patient demographics and cause of sight loss; 
 The EQ-5D (utility and VAS scores) at baseline and follow up;  
 The mean overall scores, VAS scores and domain scores for patients at baseline and follow up and 
percent of population reporting problems and no problems; 
 Patient mean scores  and change scores (baseline to follow up)  whether seen by an ECLO, and 
whether at an ECLO or non ECLO site;  
 Utility and VAS scores and change scores in patients at baseline and follow up who had contact 
with an ECLO and those who did not, those who had their support needs met and those who did 
not .  
ECLO activity data included: 
 The number of people reporting falls and/or fear of falls at baseline and within the follow up 
period; 
 Rates of provision of advising, signposting and referral to services provided by ECLOs; 
 The rates of Certificate of Vision Impairment (CVI) generation under a variety of scenarios; 
 Costs of providing ECLO services; 
 Consequences of providing ECLO support for patients and NHS. These are:  
· Capacity of service and estimated changes and resource release the ECLO services may 
deliver; 
· Impact of changing level of ECLO services; 
· Impact on health related quality of life; and 
· Potential impact of falls and mental health when an ECLO is giving support. 
Data were analysed using STATA and MS Excel software packages. Distributional analysis was 
undertaken using Stat:Fit. The DES model was run in Simul8. A plausibility check on the dataset and 
preliminary findings was undertaken by the health economics team.  Prior to statistical analysis, the data 
were reviewed. Sub group analyses were also performed comparing the three main eye conditions 
where sight loss may occur and where the availability of an ECLO may be most beneficial: age related 
macular degeneration (AMD), glaucoma and diabetic retinopathy (DR). Also, age subgroups were also 
used. The time horizon employed for the study was 12 months. A base-case analysis for the model was 
undertaken based on the collected data. The findings from the collected data were used to model the 
likely effects over the particular time horizons and costs and effects were discounted at 3.5% where 
appropriate (i.e. a time horizon over 12 months).  All assumptions included in the model were agreed a 
priori with the RNIB project team. 
Sensitivity Analyses 
Univariate sensitivity analysis and scenario analysis were used to examine the best case (i.e. where the 
most optimistic inputs are used) and in the worst case (i.e. where the worst inputs are used). 
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2.5 ETHICS AND GOVERNANCE 
Ensuring compliance with research governance and ethical principles was a very important 
consideration for the study. In the first instance, the methodology and approach was presented to the 
University of South Wales Faculty of Life Sciences and Education Ethics Committee for guidance. In 
conjunction with their view, and the guidelines produced by the National Research Ethics Service, the 
study was determined to be a ‘service evaluation’. This meant that no formal ethical review was needed, 
but rather the study team had to approach the research governance officers of the individual NHS 
health trusts and health boards in order to satisfy their local arrangements for such study. These 
requirements varied across the UK, and the study was successfully registered with all 30 sites.16  
2.6 CONTEXTUAL FACTORS 
As with all such service evaluations, this study is inevitably limited by the lack of formal controls on the 
‘interventions’ that we observed. That said, the fact that one fifth of the site visits were in places where 
no ECLO was present, provide us with the ability to make meaningful comparisons between different 
types of circumstances. We would however need to bear in mind the points raised in Section 2.3.2 
above as in practice the differences between the four groups of patients proved to be a more relevant 
unit of analysis for the study than between ‘ECLO’ and ‘non-ECLO’ sites. 
It is also very important to note the complex nature of ophthalmology outpatient departments. No two 
sites in our study were the same, as organisations chose to arrange their services in ways that clearly 
reflected their local priorities and circumstances. As such, no two ECLO services (where we encountered 
these) were the same and a large part of the study was focused on encountering and dealing with that 
complexity. 
2.7 STRUCTURE OF THE REPORT 
This report follows with a literature review which covers both the existing evidence on the role of the 
ECLO and other similar roles, and the economic and health outcomes of such services. There follows a 
substantive chapter on each of the qualitative and quantitative findings derived through the course of 
the evaluation. The qualitative data is structured into four areas – concerning the capacity, patient-
centred, skills and knowledge and relationship-based nature of their service. The quantitative chapter 
focuses on activity data associated with ECLOs, information on health-related quality of life, and the 
economic implications of ECLO services. A discussion chapter follows which considers the overall impact 
on patients, clinics and services, and the conclusions summarise the findings whilst reflecting on how 
this study builds on previous knowledge. 
   
                                                     
16
 A copy of the Study Protocol that was sent to all research and development offices of the sites is included in Appendix 3. 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 34 
3 LITERATURE REVIEW 
There are two foci for the review of the literature. Firstly, there is a review of the literature regarding 
the role of the ECLO; and secondly, a review of the literature on health and economic related to 
ophthalmology and those experiencing sight loss.17 
3.1 ROLE OF THE ECLO 
3.1.1 SIGHT LOSS IN THE UK 
More than two million people are living with sight loss that has a significant impact on their daily lives in 
the UK. According to a 2009 report commissioned by RNIB, the leading causes of sight loss are 
uncorrected refractive error, age-related macular degeneration, cataract, glaucoma and diabetic 
retinopathy.18  The same report also estimates that the number of people in the UK with sight loss is set 
to increase in the future. The prevalence of sight loss increases with age, and the UK population is 
ageing. It is predicted that by 2020 the number of people with sight loss will increase to over 2,250,000. 
By 2050, the number of people with sight loss in the UK will double to nearly 4 million.19  
Since 2005 in England and 2007 in Wales, registration as blind or partially sighted has been initiated by 
completion of a designated certificate – the Certificate of Vision Impairment (CVI) in England and the 
CVI-W in Wales.   
For England and Wales between April 2012 and March 2013, 24,009 CVI certificates were received, of 
which 10,410 were people certified with severe sight impairment (blindness; SSI) and 13,129 certified 
with sight impairment (partial sight; SI). A total of 22,647 forms were completed in England and 1362 in 
Wales. An additional 470 (2%) forms did not state whether or not the individual was SSI or SI.  Although 
AMD was the most commonly recorded main cause of certification for SSI, AMD has decreased as a 
proportionate cause of sight impairment, from 58.6 to 50% for SSI and from 57.2 to 52.5% for SI.  
Glaucoma remains the second most common cause (11% SSI; 7.6% SI) but hereditary retinal disorders 
overtook diabetes as third leading cause of SSI.  Thus, diabetes was displaced into fourth position being 
responsible for 5.4% of SSI certifications in 2013 compared to 6.3% in 2007–2008.20   In an analysis of 
blindness certifications in working-age adults (age 16-64 years), the main causes of CVIs were hereditary 
retinal disorders (20.2%), DR/maculopathy (14.4%) and optic atrophy (14.1%).21  
                                                     
17
 It should be noted that a review of the clinical guidelines impacting on ECLOs, or services that ECLOs provide, is contained 
in Appendix 6. 
18
 Access Economics (2009) Future Sight Loss UK 1: The economic impact of partial sight and blindness in the UK adult 
population. London: RNIB 
19
 Ibid. 
20
 Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, and Bunce C (2016) ‘Leading causes of certifiable visual loss in England 
and Wales during the year ending 31 March 2013’ Eye doi: 10.1038/eye.2015.288 
21
 Liew G, Michaelides M and Bunce C (2014) ‘A comparison of the causes of blindness certifications in England and Wales in 
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It has been suggested that many eligible patients may not be registered but also that many of those 
registered may not meet the clinical criteria for registration.22  However, current guidelines for 
completion of CVI forms state that the criteria should be interpreted in the context of the patient’s 
functional status rather than as strict cut-offs because the purpose of the CVI is to initiate registration 
with social services, thereby providing a reliable route for someone with sight loss to formally be 
brought to the attention of local social service departments for assessment and early intervention.   
Registration is voluntary but enables the individual to access a range of support including financial 
concessions and the loan of aids and equipment.   
However, access to benefits and social services is not dependent on registration.  The Referral of Vision 
Impaired Patient (RVI) letter can also be used where registration is not appropriate or where the patient 
has declined registration but wants advice and information about the difficulties caused by loss of 
vision. The Low Vision Leaflet (LVL) is for optometrists to enable people to self-refer to social services if 
they wish to be contacted for help. Unlike CVIs, there appears to be no national datasets about the 
number of RVIs or LVLs received by social services.  One study that profiled seven different low vision 
services in England reported that 40-50% of social services referrals came via CVIs. One traditional 
(optometry-led) hospital service reported an additional 15% of their referrals from RVI and LVL 
combined.  LVL referrals from local optometrists made up a very small percentage of total referrals (2% 
in one externally purchased and multi-agency service; “very small” in a traditional hospital service and 
an orthoptist led service). The exception was the social services led service where around 20% of 
referrals came from LVLs, mostly coming from the optometrists specifically involved in the low vision 
scheme operating in that area.23 
3.1.2 INFORMATION AND SUPPORT NEEDS OF PEOPLE WITH SIGHT LOSS 
The impact of sight loss has been well documented, with significant effects on psychological wellbeing, 
social isolation, depression, mobility, being able to live independently, financial difficulties, employment, 
and daily activities such as travel, shopping, cooking, reading, watching television, and using technology. 
24,25,26,27,28  The need for information and support services for those living with sight loss has also 
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received growing attention.  There is considerable variation in the level of service provision across the 
UK.  Following certification or referral to social services individuals may be offered a range of low vision 
services including rehabilitation, mobility training, low vision aids, advice about welfare benefits, and 
emotional support. Again there is variation in the way these services are configured in the UK, with a 
variety of providers delivering rehabilitation using different strategies to operate between the health, 
social care and voluntary sectors.29 It can therefore be difficult for people to negotiate the complex 
networks of agencies involved in delivering these services, with people not knowing what is available 
and who to contact.30 There is also evidence that registration status, visual function, and support needs 
change over time and that people should be given multiple opportunities to receive information and 
support for their visual impairment.31 People often access support and rehabilitation through clinical 
services and once they are discharged because nothing can be done for them clinically, they may not 
receive any information about other services that could benefit them.  Therefore, access to services is 
often largely dependent on the initiative of the service user.32 This may be especially true for those who 
do not have a CVI, which is often the key to accessing vital financial, practical, and social support.   
3.1.3 EVALUATIONS OF LOW VISION AND VISION SUPPORT SERVICES 
Patients are able to access a range of clinical services in hospital eye clinics, including:  medical 
diagnosis, treatment, and advice by ophthalmic and optometric professionals. Patients might also 
receive non-medical support and advice. This type of service may be formal  or non-formal and may be 
staffed by, for example, nurses, rehabilitation workers, or volunteers. One study which interviewed 
health professionals from nine eye clinics in England found that services within the eye clinic differed 
from each other in terms of having clear paths of referral within the eye clinic, clear links with social 
services (or equivalent), and keeping detailed records.33 All the services provided a ‘link service’ 
referring patients onto others beyond the eye clinic.   Since the publication of this study over 10 years 
ago, more formalised early intervention services have expanded in UK eye clinics, including the growth 
of the role of  ECLOs, who can provide initial support and advice including signposting and referral to 
other sources of support.  ECLOs can also therefore be thought of as providing a link service for patients 
between health care, social care and the voluntary sector.  Other models of service delivery for eye clinic 
patients have also been developed, such as an emotional support and counselling (ESaC) service 
delivered within an integrated low vision service.34, 35   
                                                     
29
 Dickinson et al. (2011), op. cit 
30
 Thetford et al. (2011), op. cit 
31
 Hodge S, Thetford C, Knox P and Robinson J (2015) ‘Finding your way around: Experiences of health and social care 
provision for people with a visual impairment in the United Kingdom’ British Journal of Visual Impairment  33.3, pp.200-211 
32
 Ibid. 
33
 Douglas G, Spurgeon P and Pavey S (2005) ‘An exploratory study of the impact of non-medical eye clinic support services 
(ECSS) in hospital eye clinics’ International Congress Series 1282, pp.105-108 
34
 Hodge S, Barr W, Bowen L, Leevan M and Knox P (2012) ‘Exploring the role of an emotional support and counselling service 
for people with visual impairments’ British Journal of Visual Impairment 31.1, pp.5-19 
35
 Barr W, Hodge S, Leeven M, Bowen L and Knox P (2012) ‘Emotional support and counselling for people with visual 
impairment: Quantitative findings from a mixed methods pilot study’ Counselling and Psychotherapy Research 12.4, pp.294-
302 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 37 
All clients who attended the low vision service were given information about the ESaC service and, if the 
service was taken up by the client, they were offered individual counselling from a qualified counsellor 
for up to 12 sessions lasting up to 50 minutes each.  Improvements in psychological well-being were 
seen during the course of the treatment which ranged from counselling to less formalised emotional 
support depending on the needs of the client.36  A systematic review of low vision services reported that 
improvements in psychological status may be seen in low vision services, even without the provision of a 
specific counselling component,37 however there was limited evidence to support this as most studies 
see greater improvements in functional status than psychological status. This could be because most 
conventional optometrist-led low vision rehabilitation services in UK hospital eye clinics are primarily 
focused on minimising limitations in activities by providing low vision aids (LVAs), usually magnifiers, and 
teaching people about the importance of controlling illumination.  One trial compared (a) conventional 
low vision rehabilitation (LVR) for people with AMD as provided by the hospital eye service, (b) 
conventional LVR “enhanced” by home visits from a rehabilitation officer for the visually impaired 
(ELVR), and (c) conventional LVR supplemented by home visits from a community care worker. The 
latter arm was intended to act as a control for the contact time with subjects allocated to ELVR. This trial 
found no evidence of benefit from the model of enhanced LVR, compared with conventional LVR in 
terms of vision specific QoL, general health-related QoL, and psychological adjustment to vision loss.38   
In 2004, the primary care based Welsh Low Vision Service (WLVS) was established to improve access to 
low vision services in Wales. The WLVS exists alongside hospital-based services but is located in 
accredited community-based optometric practices.  At the WLVS a patient’s vision is assessed, low vision 
aids are provided on loan, advice is given about lighting and other methods of enhancing vision, and 
signposting and referral to other services is provided where necessary (e.g. social services or 
ophthalmology).  In the year after the WLVS was implemented, an additional 127 optometry practices 
provided low vision services and the number of NHS funded low vision appointments increased by 
51.7%.  The proportion of patients waiting for less than 2 months for an initial LVA increased from 11% 
to 60%.  Journey times for patients also decreased. Visual disability scores also decreased significantly 
and of the patients who had been prescribed magnifiers, 92% had used at least one in the previous 
week.39  When the community-based low vision service was compared with the hospital-based low 
vision service, there were no significant differences in patient satisfaction, use of low vision aids and 
visual acuity, suggesting that they are both effective methods of service provision in Wales.40   
A recent report on vision rehabilitation services in the UK showed that there is a wide variety of vision  
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rehabilitation provision across England, in terms of the type of providers, specialism within the teams, 
case loads and waiting times.41 The two predominant types of providers are local authority in-house 
providers (61% of services) and voluntary sector providers (28% of services). The most common type of 
team found within local authority in-house providers was a sensory impairment team (57%); 75% of 
voluntary sector providers were specialist vision rehabilitation teams.  In terms of the type of training 
and support offered to service users, independent living skills, orientation and mobility and training in 
the use of aids, adaptations and equipment were predominant types of training offered.  
Self-management courses were provided for service users in just over a third of services. Other types of 
training which services mentioned included low vision aid, confidence building and training in 
accessibility issues. In terms of support, provision of aids, adaptations and equipment (99%), and an 
information/signposting role (100%) were most commonly reported, followed by emotional support for 
service users (79%) and support for partners and carers (80%). Counselling was less likely to be offered 
(24%).  Benefits/financial advice was offered in 59% of services and support for leisure/social activities in 
65%.  Respondents were asked to rank how easy it was to work with other organisations and 
professionals involved in supporting service users.  68% of services ranked ECLOs as ‘easy’ to work with, 
whereas other health professionals such as GPs were rated as ‘easy’ to work with by 23%. This study 
also highlighted the importance of offering rehabilitation intervention in the early stages of sight loss. A 
general view was that rehabilitation officers could achieve much better outcomes when the clients still 
had some vision. However, participants reported that they did not always get to know about the clients 
(for example, through the ECLO, the eye health personnel or a GP) at early stages of their sight 
impairment.  Clients were often not referred until after they had been registered, by which time they 
could have suffered for a long time and lost a lot of vision and hope. 
An exploratory trial is underway in Wales to explore the impact of a Visual Rehabilitation Officer on self-
reported visual function, depression, well-being, loneliness, adjustment to visual loss and generic 
health-related quality-of-life outcomes in individuals with low vision.42  The aim of the rehabilitation 
(which will be provided by two experienced Visual Rehabilitation Officers based at the Sight Cymru 
rehabilitation service) is to promote independence by helping individuals learn new skills or regain lost 
skills and rebuild confidence following sight loss. This support may be implemented by the provision of 
information, equipment, encouragement, training and/or referral to other agencies.  
3.1.4 FACILITATING ACCESS TO VOLUNTARY AND COMMUNITY SERVICES 
A crucial part of the ECLO role is providing a link for patients from healthcare settings to other statutory, 
community and voluntary sector organisations.  In this way ECLOs could be seen as facilitating ‘social 
prescribing’ defined as “a mechanism for linking patients with non-medical sources of support within 
the community”.43  Very few social interventions, like social prescribing schemes, have been empirically 
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evaluated.  A scoping review to understand the effectiveness of linking schemes from healthcare 
providers to community resources to improve the health and well-being of people with long-term 
conditions identified only seven papers.44   
The aim of the review was to identify the types and benefits of linking mechanisms adopted by social 
interventions to support people in healthcare settings access wider community-based resources.  This 
review highlighted enablers and barriers to implementing social interventions.  Almost all interventions 
were facilitator-led.  The facilitators helped to engage participants through being flexible, trustworthy, 
empathetic and accessible. Developing relationships with both clinical staff and voluntary and 
community groups was also considered important.  Having a single point of contact based within the 
general practice was reported by healthcare staff as making the referral process easy and 
straightforward.   
The physical proximity of the facilitators was also important to ensure engagement of healthcare staff.  
Recognised barriers included ambiguity of the facilitator role, inappropriate referrals to the services, 
clinicians apprehensions about referring to voluntary organisations and the sustainability of services.  
One of the studies included in the review measured cost-effectiveness and reported that the mean cost 
of the intervention arm was significantly greater than normal GP care, but that there were also 
significant improvements in levels of anxiety, ability to carry out everyday tasks, feelings about general 
health and quality of life.45 
3.2 ECONOMIC AND HEALTH OUTCOMES 
Prior to the analysis, a rapid review of the health economics literature related to the likely health and 
economic outcomes of the ECLO on patients with low vision was conducted to inform the report and to 
identify possible candidate models for adaptation and data inputs (e.g. the costs and benefits of the 
outcomes) to inform the model where additional data (alongside findings from the questionnaires) are 
required. The aim of the literature review was to identify the key outcomes associated with sight-loss, 
comprising psycho-social effects and injuries from falls, potentially influenced by and avertable by ECLOs 
support, and their economic implications to the NHS and humanistic implications to patients. In 
addition, further pragmatic structured searches to identify literature to inform relevant health outcomes 
were undertaken as issues emerged requiring more understanding as the research progressed. 
3.2.1 SCREENING PROCESS 
Titles and abstracts of all citations initially identified were screened against predefined exclusion criteria 
listed below. Citations not of interest were eliminated accordingly, these included: 
 Qualitative studies 
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 HRQoL validation studies 
 Inpatient outcomes (costs or HRQoL) 
 Editorials  
 Animal or in vitro (non-human) studies  
 Diseases and disabilities other than vision-related  
 Non-English language  
 Outcome not in scope  
Most of the cost studies identified originate from the UK, with HRQoL, where relevant to the remit of 
the report, also from western European countries, the US and Canada. 
TABLE 3.1 · PICO approach to guide search strategy 
Population Interventions Comparison 
Outcomes 
(Health and Economic) 
Adults aged 18 years and 
over with low vision 
impairment 
All settings/countries will 
be considered 
Eye liaison clinic officers 
Low vision services 
No intervention  
All other interventions e.g. 
usual care 
Mortality 
Morbidity  
Outcome rates  (e.g. fall 
rates, depression rates)  
Health-related quality of 
life 
Cost 
Cost-effectiveness 
Cost-consequences 
Cost-benefit 
Cost-utility 
3.2.2 DATA ABSTRACTION 
Data were abstracted and reviewed manually in a two-step process. Initially, key article statistics were 
abstracted into an Excel database. Selected articles (full-text) were then reviewed thoroughly and a 
narrative output produced. The adopted approach was subject-driven, such that the output represents a 
review of key economic and HRQoL topics insofar as they are supported by articles, rather than an 
explicit review of each article. 
3.2.3 LITERATURE SELECTION 
All data inputs for the model were extracted and summarised in an MS Excel spread-sheet as part of the 
‘look-up’ tables for the model.  All inputs that were obtained from the literature review used the best 
possible evidence and where required, point estimates and variances (e.g. standard deviation, 95% 
confidence intervals) utilised.  
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On a human level, sight loss, its consequences and its incident morbidity create important effects to 
health-related quality of life (HRQoL) and economic well-being; especially for those in paid employment 
who are unable to continue with their vocation due to reduced visual function, further burden is 
appreciable46 and added to the societal toll of sight loss in those beyond their employable years. 
The body of literature investigating the epidemiologic, economic and humanistic burden of sight loss has 
informed healthcare prioritisation decision-making from global47 to local levels,48 for both prevention 
and treatment pathways as well as supportive services, and its growing size is representative of the 
heightened concern by healthcare policy makers and society of the increasing population-wide risks and 
consequences of sight loss. Such studies emanate from investigators and institutions world-wide, some 
of which have been summed by recent systematic reviews49,50,51,52,53,54,55,56,57 to establish economic 
burden,58, with one identifying up to 390 related studies.59 In such surveys in particular, direct costs of 
treatment or service provision and indirect or intangible effects related to blindness and severe visual 
impairment have been surveyed, with the latter ensuing as most critical in the cost equation, and 
                                                     
46
 Hirai FE, Tielsch JM, Klein BE and Klein R (2012) ‘Relationship between retinopathy severity, visual impairment and 
depression in persons with long-term type 1 diabetes’ Ophthalmic Epidemiology 19.4, pp.196-203 
47
 World Health Organization (2014) Universal Eye Health: a global action plan 2014-2019 – accessed from: 
http://www.who.int/blindness/AP2014_19_English.pdf?ua=1  
48
 Tian Y, Thompson J, Buck D and Sonola L (2013) Exploring the system-wide costs of falls in older people in Torbay The King’s 
Fund – accessed from: http://www.King’sfund.org.uk/sites/files/kf/field/field_publication_file/exploring-system-wide-costs-
of-falls-in-torbay-King’sfund-aug13.pdf  
49
 Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N and Waugh N (2015) ‘Pan-retinal photocoagulation and 
other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and 
economic evaluation’ Health Technology Assessment  19.51  
50
 Mowatt G, Hernández R, Castillo M, Lois N, Elders A, Fraser C, Aremu O, Amoaku W, Burr J, Lotery A, Ramsay C, Azuara-
Blanco A (2014) ‘Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-
related macular degeneration: a systematic review and economic evaluation’ Health Technology Assessment 18.69 
51
Frampton G, Harris P, Cooper K, Lotery A and Shepherd J (2014) ‘The clinical effectiveness and cost-effectiveness of second-
eye cataract surgery: a systematic review and economic evaluation’ Health Technology Assessment 18.68  
52
 Bourne RR, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Parodi MB, Pesudovs K, Price H, White RA, Wong TY, 
Resnikoff S and Taylor HR (2014) ‘Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of 
vision loss in high-income countries and in Eastern and Central Europe: 1990-2010’ British Journal of Ophthalmology 98.5, 
pp.629-38 
53
 Pearson I, Rycroft C, Irving A, Ainsworth C and Wittrup-Jensen K (2013) ‘A systematic literature review of utility weights in 
wet age-related macular degeneration’ Journal of Medical Economics 16.11, pp.1307-16 
54
 Bennion AE, Shaw RL and Gibson JM (2012) ‘What do we know about the experience of age related macular degeneration? 
A systematic review and meta-synthesis of qualitative research’ Social Science and Medicine 75.6, pp.976-85  
55
 Tosh J, Brazier J, Evans P and Longworth L (2012) ‘A review of generic preference-based measures of health-related quality 
of life in visual disorders’ Value Health 15.1, pp.118-27 
56
 Binns AM, Bunce C, Dickinson C, Harper R, Tudor-Edwards R, Woodhouse M, Linck P, Suttie A, Jackson J, Lindsay J, 
Wolffsohn J, Hughes L and Margrain TH (2012) ‘How effective is low vision service provision? A systematic review’ Survey of 
Ophthalmology 57.1, pp.34-65 
57
 Peto T and Tadros C (2012) ‘Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom’ Current 
Diabetes Reports 12.4, pp.338-45  
58
 Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J and Goss TF (2007) ‘Burden 
and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration: Findings of a Multicountry Study’ 
Archives of  Ophthalmology 125.9, pp.1249-1254  
59
 Köberlein J, Beifus K, Schaffert C and Finger RP (2013) ‘The economic burden of visual impairment and blindness: a 
systematic review’ BMJ Open 7.3 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 42 
consistently pointing to outcomes such as depression, emotional distress, loss of independency, loss of 
HRQoL, limitations in activities of daily living and physical hazards and injuries particularly from falls. 
To this end, the aim of this targeted secondary research was to inform, with a summarisation of these 
indirect outcomes largely focussed on the UK where relevant and possible, the valuation of ECLO 
services in the care pathway of people who have vision impairments. With falls and psycho-social effects 
being the most prevalent indirect outcomes of sight-loss, it is expected that any enhancements in 
supporting patients to reach related services, as that provided by ECLO services, that reduce these 
outcomes can bring significant value to both the NHS and patients and carers. 
3.2.4 FALLS RELATED TO VISUAL IMPAIRMENT 
Epidemiology of falls 
While population-level health risks related to the aging UK demographics are well established, the 
significance of falls in particular in the older age groups was brought to the fore by the Royal College of 
Physicians and NICE Falls Prevention Guidelines60 highlighting that annually, over 500,000 older people 
attend UK emergency departments following a fall and account for over 4 million bed days per year in 
England alone. Falls in the over-65 age group amount up to 200,000 fractures and the leading cause of 
disability and accidental death in this age group in the UK.61 Furthermore, the Royal Society for the 
Prevention of Accidents (RoSPA) estimates that one in three people aged 65 years and over experience a 
fall at least once a year – rising to one in two among 80 year olds and older.62,75 
Although the causes of falls are often multifactorial, increased risk of falling in the elderly is 
compounded by visual impairment causing poor balance and reduced depth perception which can lead 
to trips over obstacles or on stairs due to reduced central and/or peripheral vision or eye movement 
disorders.63 The relative risk of a fall in people whose visual impairment is caused by visual field loss or 
glaucoma particularly high64,65  
Outcomes of falls: resource use and cost 
The economic implications of falls in the UK have been established at national and regional levels, and 
acute hospital settings. On a national level, costs of falls to the NHS in 2011 were estimated at more 
than £2.3 billion per year,66 while direct cost estimated to the NHS of falls associated with visual 
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impairment specifically was at least £25.1 million per annum, without accounting for wider and longer-
term community and social care.67 Average acute costs per fall, on the other hand, have been estimated 
at £1,088 and £15,133 for falls leading to a hip fracture.68  
While now dated, analysis of 1999 healthcare records by Scuffham et al revealed that there were 
647,721 A&E attendances and 204,424 admissions to hospital for fall-related injuries in 1999 in the UK 
population aged 60 years or over.69 The associated cost of these falls to the NHS was £908.9 million and 
63 per cent of these costs were incurred from falls in those aged 75 years and over, and £269 million 
was spent on the population with visual impairment and £128 million was directly attributable to visual 
impairment. However, the 2013 report published by the King’s Fund70 was critical in revealing the true 
extent of healthcare costs, beyond the inpatient cost of the core event itself, and decomposed by 
health, community and social services costs. The report was aimed to assist commissioners across health 
and social care to better understand where the costs of treating patients are incurred across health, 
community and social care services for making more integrated commissioning decisions for this group 
of patients. Data were from Torbay for 421 patients in each of the 12 months before and after the fall 
event, from Torbay’s seven linked health and social care data sets. It was the first detailed analysis of 
the cost to the health and social care system in relation to falls patients in England. The following cost 
breakdown of falls to the health and social care system suggest that on average, the cost of hospital, 
community and social care services for each patient who fell were almost four times as much in the 12 
months after admission for a fall as the costs of the admission itself (Figures 3.1 and 3.2). 
 Over the 12 months that followed admission for falls, costs were 70% higher than in the 12 
months before the fall. (Figure 3.1) 
 Comparing the 12 months before and after a fall, the most dramatic increase was in community 
care costs (160%), compared with a 37% increase in social care costs and a 35% increase in acute 
hospital care costs. (Figure 3.2) 
 While falls patients in the study accounted for slightly more than 1% of Torbay’s over-65 
population, in the 12 months that followed a fall, spending on their care accounted for 4% of the 
whole annual inpatient acute hospital spending, and 4% of the whole local adult social care 
budget. 
 The majority of the costs of caring for patients after a fall are outside the acute hospital setting; 
this is not always recognised by commissioners, because data on costs is never brought together.  
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FIGURE 3.1 · Costs of the core event, and other health and social care costs in the 12 months before 
and after the event (permission for use of figure to be obtained from authors)71 
 
FIGURE 3.2 · Total cost of hospital, community and social care by month in relation to the core events 
(permission for use of figure to be obtained from authors)72 
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The comprehensiveness of the Torbay health services data presented in the King’s Fund report73 will 
likely have captured the wide range of outcomes associated with falls as classified in the NICE 2013 
Guidelines on assessment and prevention of falls in older people74 including: 
 hypothermia 
 pressure-related injury 
 infection 
 loss of mobility, leading to social isolation and depression 
 increase in dependency and disability  
 further psychological effects, for example, a fear of falling and loss of confidence in being able to 
move about safely75 
In addition to primary prevention of falls, the guidelines also consider secondary prevention strategies, 
including: 
 improving the diagnosis, care and treatment of those who have fallen 
 rehabilitation and long-term support 
 ensuring that older people who have fallen receive effective treatment and rehabilitation 
 ensuring that patients and carers receive advice on prevention, through a specialised falls service. 
Impact of falls on HRQoL 
Apart from costs related to health services, the human cost of falling by the elderly is deep in terms of 
HRQoL as well as wide-reaching to family and informal carers. HRQoL consequences such as distress, 
pain, loss of confidence, anxiety/fear of falling76, loss of independence and mortality are significant.75 
Furthermore, physical and psycho-social debilitation is not precluded in minor falls, these even cause 
losses of confidence and falling fears, creating further reduced mobility, further isolation and increased 
dependency on others. These issues are particularly heightened in those with sight loss.77,78,79,80,81   
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The construct of ‘fall fear’ is also considered a predictor in the likelihood of having a future fall, sharing a 
complex relationship with other psychological consequences of falling, such as depression and anxiety.77 
Importantly, fear of falling can lead to activity restriction and avoidance, which contribute to functional 
declines, social isolation, depression, falls, and institutionalization, in the general elderly 
population82,83,84,85 but particularly in the elderly with sight loss.78  
The prevalence of fall fears across various vision impairments has been examined in the literature, as 
recently surveyed.64 Visual field loss has been implicated to have association with increased levels of fall 
fears, as particularly observed in studies of older adults with glaucoma.81,86 Similarly, reduced contrast 
sensitivity has similar association with fear of falling81,87,88 and fear related activity restriction.82,87,89,90,91 
3.2.5 PSYCHO-SOCIAL IMPACTS OF VISUAL IMPAIRMENT 
Epidemiology psycho-social impacts 
The large and growing size of the literature on psycho-social outcomes related to visual 
impairment92,93,94 reflects the recognition by society, health providers, and researchers on the degree 
that a patient’s life changes after reaching even the initial stages of visual impairment, and its far 
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reaching consequences thereafter as expressed by the variety of emotional, cognitive, behavioural and 
social responses to loss of sight.95,96,97, 98 It is comparable to the grief experienced by terminally ill 
persons.99,100   
Feeding into these constructs, functional disability101 and the loss of leisure activities and hobbies, 
impaired self-esteem, being socially less active and experiencing challenges with regard to interpersonal 
relationships and communication have been implicated in the toll of sight loss on patient mental health, 
especially depression and anxiety,102,103,104,105, and predictors of suicide in the elderly.106,107,108 
In the UK, the prevalence of depression in people with sight loss, as informed by large-scale 
epidemiologic studies, has been estimated at 13.5%, up to 3 times greater than the 7.4% prevalence of 
depression measured in the general population.109   
Recently, screening results of the DEPVIT study, which sought to establish the prevalence of significant 
depressive symptoms in people attending visual rehabilitation centres in the UK. The aim of the study 
was to conduct an exploratory trial to assess whether problem solving treatment or physician referrals 
were effective at reducing depression in people with impaired vision and significant depressive 
symptoms. In those accessing the low vision rehabilitation study centres, the prevalence of depression, 
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at up to 43%, was observed to be higher than previous cross-sectional studies had indicated. Of those 
who screened positive, 75% were not receiving any treatment for their depressed mood.  
One important finding from the DEPVIT study was that the prevalence of significant depressive 
symptoms in visual rehabilitation clinics in Britain, at 43%, is among the highest reported anywhere in 
the world, in particular, compared with the rates measured in North America (22% to 38%).110,111  Such a 
rate is noted to be comparable with rates for depressive symptoms in people with a cancer diagnosis at 
initiation of chemotherapy – estimated at 45%.112 The investigators also note that while people seeking 
help for their sight loss are a high-risk group for depression, the fact that three-quarters of those who 
screened positive were not receiving any form of treatment suggests that depression is being routinely 
overlooked in this vulnerable group, which is conceivable given that there are currently only two low 
vision services in Britain that screen people regularly for depression.113 
The increased burden of depression in the sight impaired people compared with those with no 
impairment in the UK has also been underlined.114 These investigators found in their secondary analysis 
of national survey data that the sight-impaired vs those with no impairment, respectively, are up to 
seven times more likely to have been feeling unhappy or depressed a lot more than usual (14% vs 2%); 
nine times more likely to have been feeling worthless recently a lot more than usual (9% vs 1%); three 
times more likely to not feel optimistic about the future (9% vs 3%); nine times more likely never to feel 
useful (9% vs. 1%); five times more likely to never feel close to others (5% vs. 1%). 
3.2.6 HEALTH-RELATED QUALITY OF LIFE OUTCOMES OF DEPRESSION 
The significance of untreated depression having a profound negative impact on HRQoL and reducing life 
expectancy in the general aged population is well-recognised in the literature.115,116,117,118 The 
association between depression and HRQoL in the visually impaired, in particular has recently been 
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established via systematic review of 13 studies implementing HRQoL and depression measures in 
studies in visually-impaired populations. Comparison of HRQoL scores between participants with and 
without depression (Cohen’s d) and correlations between depression and HRQoL (Pearson’s r) were 
examined. The evaluation revealed that lower health-related or vision-related HRQoL was associated 
with greater symptoms of depression.119 
3.2.7 OUTCOMES OF INTERVENTIONS 
Psychological interventions such as self-management programmes and problem solving treatment 
incorporated into low vision rehabilitation to potentially reduce depression in visually impaired older 
adults is based on the notion that functional ability and depression are closely related in this group.  
The results of the DEPVIT study99 indicated that problem solving treatment and referring people to their 
physician achieved higher scores on the Beck Depression Inventory measure than doing nothing for the 
treatment of depression in people with low vision, however, the results were not compelling and 
attributed to potential flaws in treatment delivery. Yet, the results of this trial added to those of other 
similar trials recently published, for example, on a stepped care approach, which comprised watchful 
waiting, guided self-help based on cognitive behavioural therapy, problem-solving treatment, and 
referral to a general practitioner significantly reduced the risk (relative risk 0.63) of a depressive 
dysthymic and/or anxiety disorder at 24 months. Investigators suggest that ‘stepped care’ seems to be a 
promising way to deal with depression and anxiety in visually impaired older adults which could lead to 
standardised strategies for the screening, monitoring, treatment, and referral of visually impaired older 
adults with depression and anxiety. 
An online survey of the provision of emotional support and counselling for people affected by sight loss 
was recently conducted;120 their aim was to evaluate the need for a national standardised framework 
for the provision of emotional support and counselling services for the blind and partially sighted people 
in the UK. The sample comprised voluntary sector organisations and parts of the NHS across the United 
Kingdom. The survey revealed that services providing counselling relied mostly on self-referral; 
emotional support was most likely to receive referrals via self-referral or via an eye clinic; and services 
providing both counselling and emotional support similarly received the majority of their referrals via 
these routes, and also via vision rehabilitation officers. While numerous unmet needs of the visually 
impaired were revealed, the investigators concluded on a clear need for both emotional support and 
counselling to be available at both, the point of diagnosis as well as when needed and as such 
“embedded into the sight loss care pathway”. The investigators also noted that for these needs to be 
met, collaborative working among all professionals supporting people who are affected by sight loss, 
from GPs to ECLOs to ophthalmologists was clearly warranted. 
3.2.8 PSYCHO-SOCIAL OUTCOMES ON CAREGIVERS 
The wider psycho-social impacts of visual impairment have been shown on caregivers. Reviews of the  
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literature on caregivers for the visually-impaired has revealed demonstrable association of depression 
and burden with communication theory, emotional contagion, and care burden. Caregiving is also 
associated with greater hours of supervision to the patient, multiple chronic conditions in the patient or 
caregiver, the patient not completing vision rehabilitation, and female gender of the caregiver cited as 
implicating factors.121 By identifying those at risk for decreased HRQoL outcomes, health care providers 
may be able to alter the management of the visually impaired, such as advocating the use of vision 
rehabilitation clinics in order to minimize the caregiver burden and depression.122 
3.2.9 RESOURCE USE AND COSTS OF PSYCHO-SOCIAL FACTORS 
Estimates of overall resource use and costs in the UK directly related to psycho-social factors of visual 
impairment are limited. However, the DEPVIT study measured total health and social care costs, 
incurred by those in the treatment waiting-list, referral, and problem solving treatment arms of the trial 
during the 6-month study period and found them to be,£1444 (Standard Deviation £1941), £1362 (SD 
£1842), and £962 (SD £1051), respectively. Furthermore, the treatment of vision-impairment associated 
depression via problem solving treatment ranged between £1176 in Wales and £1296 in London (see 
Table 3.2).123 
In the 2013 study of the forms of provision and cost of ECLO services,124 while depression per se was not 
captured or evaluated, it might be inferred that the emotional support provided by ECLO services (as 
absorbed in the time and costs of the service) addressed the needs of patients with depression. An 
estimate of £17.94 per patient per ECLO contact was reported; furthermore, approximately £247.76 for 
ECLO intervention over a person’s lifetime was estimated for proportions of people registered as 
severely sight impaired at each age group, assuming an ECLO is seen once per year. The literature also 
points to some indirect costs of depression, in terms of the impact on vision care and costs thereof, 
particularly for age-related macular degeneration and diabetic retinopathy. It is suggested that 
increased healthcare costs via reduced treatment outcomes are due to the negative attitudes toward 
and related lowered adherence to treatments caused by depression.125 
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TABLE 3.2 · Mean NHS and Local Authority Costs (£) (over 6 months by group)126 
Health Care Service Use Control (n=27)* GP Referral (n=26)* PST (n=22)* PST vs. Control† PST vs. GP Referral† 
GP consultation (surgery) 156 (271) 138 (129) 122 (119) -34 -16 
GP consultation (home) 10 (32) 4 (14) 49 (209) 39 45 
Practice nurse consultation 25 (58) 24 (76) 43 (67) 18 19 
Primary care antidepressant prescribing 1 (4) 3 (11) <1 (1) -1 -3 
TOTAL PRIMARY CARE 192 (303) 169 (137) 214 (222) 22 (-124 TO 162) 45 (-48 TO 158) 
Community health workers‡ 124 (642) 353 (1302) 212 (908) 88 -141 
Mental health support services§ 0 (0) 71 (172) 20 (94) 20 -51 
Occupational therapy 3 (11) 2 (5) 4 (14) 1 2 
Social services 21 (63) 74 (202) 51 (159) 30 -23 
Physical rehabilitation services** 33 (116) 36 (94) 43 (136) 10 7 
Other 21 (30) 214 (930) 85 (235) 64 -129 
TOTAL COMMUNITY SERVICES 202 (761) 750 (1540) 415 (948) 213 (-273 TO 705) -335 (-1066 TO 349) 
TOTAL LOCAL AUTHORITY DAY CARE SERVICES 68 (351) 38 (194) 0 (0) -68 (-248 TO 89) -38 (-404 TO 267) 
Ophthalmology inpatient 0 (0) 0 (0) 75 (351) 75 75 
Ophthalmology outpatient 138 (385) 110 (232) 103 (168) -35 -7 
Low vision assessment 30 (49) 7 (24) 20 (47) -10 13 
Inpatient (other) 601 (1824) 166 (601) 0 (0) -601 -166 
Outpatient (other) 202 (371) 107 (158) 128 (228) -74 21 
Day case (other) 0 (0) 15 (76) 0 (0) 0 -15 
Accident and emergency 11 (41) 0 (0) 4 (20) -7 4 
Therapy/counselling services 0 (0) 0 (0) 3 (12) 3 3 
TOTAL SECONDARY CARE 982 (1826) 405 (622) 333 (583) -649 (-1421 TO 4) -72 (-404 TO 267) 
TOTAL SERVICE USE COST AND INTERVENTIONAL COST 1444 (1941) 1362 (1842) 1775 (1044) 331(-554 TO 1099) 413 (-439 TO 1193) 
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4 QUALITATIVE FINDINGS 
In this chapter, we will outline some of the main findings from the qualitative work carried out as part of 
the research.  We will also seek to illuminate two fundamental questions, namely: 
 How does the ECLO ‘value add’ for a service and for the patient? 
 What is the impact of an ECLO on clinic activity? 
We will attempt this through exploring the main themes generated in the interviews and which formed 
the basis of our coding of those interviews, our thematic framework. We will use extensive quotation 
throughout, because we feel it is important to hear the voices of those who gave their time to our 
research, and were often very passionate about the way they saw the ECLO role in their local context. 
However, we have restricted the details of who said what (and where) to the generic job title of the 
interviewee, thereby preserving anonymity but also extracting as far as possible the general from the 
local context of what it means to be an ECLO. 
That said, the local context here is key to an extent, because a qualitative framework will evidently 
produce a different form of data and analysis from the quantitative work that forms part of this report. 
This evidence, by its very nature is contingent, locally based and often reflects the extensive professional 
expertise that the local health and social care systems offer across the nations and regions of the UK. 
Our evidence base is the words given in the accounts, the lived experiences of those who were 
interviewed; but these words were spoken by as wide a pool as possible of ophthalmologists, nurses, 
rehabilitation officers for visual impairment (ROVIs), commissioners, optometrists, clinical leads, 
consultants, support workers, volunteers, managers, health care assistants– and of course the ECLOs 
themselves.  
Undoubtedly, some interviews stood out for us as we became more familiar with the field, and 
developed a feel for the subject matter: many of our interviewees were very articulate and passionate 
about the role of the ECLO. Though we had a semi-structured interview schedule, we felt that it was 
important to let the interviewees speak at length when they wanted to, though the time pressures in a 
clinical environment can preclude this. However, we are as confident as it is possible to be that through 
our months of analysis, we have found enough consistent categories and themes to give a meaningful 
response to the research questions as posed, and provide a substantial picture of the growing 
importance of ECLO practice in all its forms. 
Given the size and breadth of our sample – 141 interviews across 30 sites in four countries – we’re 
confident also that we’ve been able to capture the dynamic nature of ECLO practice in these local 
contexts. We’ve attempted to give voice to those everyday practitioners within the multiple systems 
and frameworks which ECLOs operate, and hope that we have listened as closely and as systematically 
as possible to what is being said. As experienced field researchers in health and social care, we are not 
‘neutral’ - we bring our own fields of expertise to this – but we’ve sought to look with fresh eyes at what 
is familiar to those lived professional experiences in each site.  
We would also like to bring attention to how we refer to possibly the most important people not in the 
data to an extent, namely the people who are living with sight loss. Having discussed this as a team, we 
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will refer to them in this chapter as ‘patients’ but also ‘patient/citizens’ interchangeably, as we felt that 
a key aspect of ECLO practice was the support they give to people who cannot be thought of as purely 
subjects of medical care. In fact, this is a major point of definition: we felt that ECLOs offer a way of 
continuing care as people who are visually impaired often have to navigate a new set of frameworks, 
rights and entitlements as visually impaired citizens, outside of purely medical care. 
4.1 METHOD AND APPROACH TO ANALYSIS 
In this section, we will outline our approach to the qualitative data collection and analysis. In total, 141 
interviews were completed the length and breadth of the nations and regions of the UK, with a wide 
range of practitioners, not least ECLOs themselves. The fieldwork was completed over 12 months, and 
we visited 30 sites during the study.127 
We devised a topic guide which would orientate each researcher without being too prescriptive, and 
which we felt would set out to answer our key questions. The practicalities of fieldwork were such that 
the researchers often had to be able to interview in clinical environments, which were by their very 
nature very busy; although many interviews were pre-arranged, we were keen also to take 
opportunities, where possible, to speak to as many members of a clinical team as possible in each site. 
We felt that this snowball approach meant that, on occasion, we were able to speak to more people and 
gain more insights as to the worKing’s of a given site. 
Once collected, interviews were transcribed verbatim. To manage such a large qualitative dataset, it was 
decided to use NVivo 11 software, using a framework analysis approach128 that by now is commonly 
used with such large qualitative datasets. This method takes into consideration pre-identified issues that 
the researchers wish to investigate in accordance with the research questions, but allows flexibility for 
new themes.  
We felt the framework approach was appropriate to help us explore the data as systematically as 
possible, given the multiple contexts and number of researchers who did the fieldwork and analysis, and 
the sheer amount of data that was generated. Getting the interpretation right, when such qualitative 
data is so voluminous and discursive, meant that the team had to maintain an analytical dialogue 
throughout.  In this way, the subsequent construction of the thematic framework and other stages of 
analyses were agreed by all authors. 
4.1.1 THE FRAMEWORK PROCESS  
In essence, framework analysis seeks to condense the sometimes unwieldy amount of thematic coding 
that can be generated when we look at so many interviews. By doing so, it helps to clarify the key 
themes which emerge, and to compare cases across those themes. NVivo 11 has a built in facility to aid 
                                                     
127
 As noted in Section 2.4, Interviews with patients were not undertaken as part of this study given that at the outset of the 
work RNIB stated that they had collected much qualitative data from patients. Instead they wanted to prioritise gathering the 
views of those professionals who interact with ECLOs. 
128 
Ritchie J and Spencer L (1994) ‘Qualitative Data Analysis for Applied Policy Research’ in A Bryman and R 
Burgess (eds) Analyzing Qualitative Data London: Sage, pp. 173-194 
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this approach, but we were keen not to be over reliant on the software; analytical memos, field notes 
and mind maps, often separate and on paper were used in combination with the data management tool. 
However, the five stages of analysis used in the framework approach are usually:   
1. Familiarisation - gaining an overview of the literature, research objectives and data (including 
proposal, literature review, interview topic guides, sample characteristics, interview and 
observation and themes found in the interview transcripts). Around thirty scripts were read at 
this stage with direction given from the interviewing team. Codes and themes were developed 
using a combination of software and paper-based notes. We also double coded some interviews, 
using more than one researcher, so that we could check for consistency of interpretation. 
2. Identifying a thematic framework - this was constructed from the codes and notes developed in 
the familiarisation stage. This was then verified with the rest of the research team in terms of 
relevancy and how far the themes would answer the research questions. 
3. Indexing - systematic coding of all interview transcripts using the thematic framework. Indexing 
can be done manually or by using a qualitative software package to code sections of data against 
the thematic framework. Indexing was carried out at this stage using the software. 
4. Charting - creating a set of thematic charts for each theme using a matrix format, using the 
software. Within each matrix, each interviewee is assigned a row and each sub-theme is 
allocated a separate column. The data were further condensed, linking the coded data to a 
synopsis. As noted, this stage allows researchers to identify any recurrent themes across the 
dataset, and add to any analytical notes for the final interpretation of the data. It also becomes 
apparent at this stage which themes are redundant or can be amalgamated with others. 
5. Mapping and interpretation - reviewing the charted data and analytical notes, comparing and 
contrasting participants' accounts, identifying patterns and connections in the data and seeking 
explanations for these within the data. As in previous stages, the findings of this stage are shared 
across the research team. 
As will be explored in the next chapter, the key categories which we identified from our dataset were:  
Capacity, Relationships, Patient-centred and Skills and Knowledge, and within each one of these, there 
were further themes which we will also explore in that chapter. 
4.2 FINDINGS BASED ON THE THEMATIC FRAMEWORK 
These constitute the main findings which came under the four most prominent categories in our coding 
framework, which evolved throughout the research project, namely Capacity, Relationships, Patient-
centred and Skills and Knowledge. Using the framework analysis approach, we developed our coding 
framework as systematically as possible. This included double coding some interviews – having more 
than one researcher code the same data – to make sure our categories are as grounded as possible in 
the accounts given by our interviewees, and to try and achieve a degree of consistency in a task which is 
necessarily about the interpretations of each researcher.  
From the initial ‘free’ coding and familiarization stage, which generated many themes, we then reduced 
the data to the essential ones we felt were relevant to our research questions. After further coding, it 
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became apparent that some of these themes were either redundant, or could be amalgamated with 
others.  
FIGURE 4.1 · Coding framework - summary129 
 
As noted, the corpus of interviews used for analysis is large, another reason for using the framework 
analysis approach as a means of managing it all. Our analysis ran alongside the data management from 
the start. Field notes, analytical memos and mind maps were all used to help interpret what was being 
said, as we took into account factors such as time, place, busyness of the clinic etc. Through regular 
meetings, we maintained lively internal discussions about interpreting the data throughout the project. 
We therefore feel confident that we are providing as accurate a picture as possible of the data, but 
furthermore, we have sought to interpret what was seen and heard through our own ‘lenses’ of 
academic, professional, expertise. 
So in this chapter, we will explore the main categories included in our coding framework, and we’ve 
highlighted the most relevant themes in each one. 
4.3 CAPACITY 
‘They’re like a little cog that makes all the others spin. They’re a central link that the patient can go 
to and the ECLO can start all the other cogs spinning for them’ [Operations manager] 
                                                     
129
 It is important to note that when we talk about ‘efficiency’ in this chapter, we do not mean it in the technical sense of 
reducing waste and time as we will be used in chapter 5. Rather it is used here in the sense that respondents meant – as a 
general way of describing the ability to do things well, successfully and in a more streamlined manner. 
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This category encompasses the myriad of ECLO practices that seem to be common and everyday within 
clinical and other services, and which ECLOs might be reasonably expected to perform. The themes that 
became apparent under this category include questions about how ECLOs affect the capacity of each 
service: whether or not they add or subtract from that capacity in each clinic or service to work in the 
most efficient, patient-centred manner, and what are the effects ECLOs have on fundamental issues 
such as CVI registration, or the various pathways that have to be negotiated by patients.  
We examined issues such as time-saving or identifying the complexities of the various pathways, as well 
as the more systems-wide position of the ECLO, recognizing that they often act within more than one 
dynamic system e.g. clinical and social care, and act as a critical point or node of bi-directional 
information between various communities of practice.  
As we discuss in chapter 6, it would seem that ECLOs often have both networked power and networking 
power, the former being the means to enact, interact and facilitate core aspects of the ‘care’ system for 
those losing their sight, such as completing the CVI process. The latter, networking power, would be the 
use of tools such as referral and signposting to activate other relationships across the various networks 
in which ECLOs operate, and in which they are important nodes. We also coded for feedback given by 
others about how they perform or are perceived within these systems, as well as how integrated the 
ECLOs felt they were within the systems. 
4.3.1 THE CVI PROCESS 
‘Historically people would be told I’m registering you blind today, you’re losing your eyesight and 
they just go home. I can’t bear to think of anybody doing that and not knowing that there’s tons of 
help out there.  I’m thankful that I do have all these services to pass people onto’ [ECLO] 
‘Everything’s now filled out properly and there’s proper processes in place for everything and that is 
really important especially for the doctors. That’s because they can get on and see patients quicker, 
so they can register the patient and then any patient that patient wants to ask they can go straight 
to [the ECLO] and she can take them away from the doctor and the doctor can get on with his 
patients’ [Senior Nurse] 
‘You often would find in the olden days piles of CVIs waiting in the consultant’s office – that doesn’t 
happen anymore’ [Head of Optometry] 
‘…how could the secretary fill that in if they don’t have any patient involvement?’ [ECLO] 
ECLOs have made CVI processes more efficient compared to previous systems that were in place. As 
noted already, the process of registration for CVI is probably one of the most fundamental practices in 
the eye clinic, one that is often life changing for the patient. Our research would suggest it is increasingly 
carried out by ECLOs, wherever they are: they would seem to be taking the bulk of the administrative 
burden.  
Furthermore, many of our interviewees, professionals working alongside ECLOs (e.g. managers, 
ophthalmologists, consultants), reiterated that ECLOs seem to have 'sorted out' the CVI pathway, in a 
comprehensive manner, in many of the sites visited. Repeated accounts were given of how the CVI 
process had previously been severely blocked in many places. We heard of ‘piles of CVIs waiting to be 
processed’, or other inefficiencies such as people 'slipping through the system' e.g. driving when they 
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shouldn't be, or not being assessed at home – potentially therefore putting others at risk. With an ECLO 
in place, we heard that many of these problems simply don’t exist anymore.  
In several areas, it was suggested that without ECLO support, this process wouldn't get done in a timely 
way, which apart from the risks highlighted above, also had implications in terms of getting the 
appropriate support for things that can make a real difference in people’s lives, such as finances, for 
example. We heard how ECLOs in clinics often facilitate the smooth running of the CVI pathway in 
practical ways, right from the start, by making sure the doctors have the right forms, or by flagging up 
registration requests which haven't happened. Often, it is an ECLO who completes the majority of the 
form, thereby saving time for others in the clinic. 
We also heard that in some places, they can initiate the CVI process, though more often than not, they 
get them through referrals. In some places, other staff or volunteers help with this process also. 
Equally importantly, it would seem that ECLOs have more time to explain the significance of the 
document clearly – it is seen as an opportunity to kick off and consolidate support, in what can be an 
emotional process for the patient. Crucially, ECLOs are also more likely to follow up on the process, 
including setting up any further support from that point onwards e.g. with social services or others. 
When there are perceived blockages in this system, we heard accounts from people from within and 
outside the team e.g. ROVIs, that they turn to the ECLO for help; in many localities they are the trusted 
first port of call. By taking more time to explain the process, we heard how this reduces the stigma felt 
by some, especially older patients, if there’s a referral to social services. 
It is useful at this stage to reflect on the nature of the findings above, and that follow. There was a clear 
view among participants that ECLOs have made a significant contribution to the efficient running of 
clinics, but (as will be seen in chapter 5) hard metrics to evidence this are difficult to control for, 
measure and attribute. We would assert though that a near universal qualitative finding from our 
participants that efficiency has been improved by ECLOs is compelling. 
4.3.2 TIME SAVING 
‘[Before] the person could sit there with no contact at all, on this waiting list, for, you know three 
months, six months, nothing….What the difference is that the ECLO has been in my opinion, is it’s 
caught a lot of people before certification.  And they’ve had contact… she’d put in a referral, ‘oh I’ve 
referred, I’ve had a conversation with a lady, she’s agreed for it to be a referral to yourself, but what 
I’ve done as well, I’ve made a referral to raise with regards to benefits’…  So that kind of 
rehabilitation sometimes has actually started already, and then the person comes to us, and then 
they sit you know three months on the waiting list, but that rehabilitation process and connection, in 
my opinion, has actually started’ [ROVI] 
Many of our interviewees were convinced that having an ECLO in post saves a lot of clinical time. We 
heard this from clinical managers, matrons, nurses, consultants and others, and it is a theme that 
appears throughout this section, not just as a standalone theme here. As commented on above, these 
proved difficult to measure in a quantitative sense (see chapter 5 below), but are no less valid as 
findings for having been established qualitatively. 
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Generally speaking, many interviewees acknowledged that they save time primarily by taking pressure 
off the medical staff, who themselves are often under pressure to move people through the system 
quite quickly, more so with ever tightening budgets. ECLOs also do a lot of follow up e.g. phoning 
patients months later to see if anything's changed. As one interviewee pointed out ‘it releases some of 
the time for the trained staff to do what they trained for’. 
Some ECLOs are even able to order equipment and post it out directly for people, so people are able to 
get things they need quickly instead of waiting. We also heard how they save time outside the clinic – 
initial contact from ECLO, working closely with a patient can facilitate further work by ROVI, making it 
quicker and easier, for instance. 
4.3.3 EFFICIENT PROCESSES AND PATHWAYS TO CARE 
‘I would suggest to people that ECLOs have an impact on the throughput of a clinic and allow us to 
see as many people as possible, and also that given the very positive feedback we’ve had about their 
support, that there is a direct service quality and patient benefit argument for having one in any 
clinic’ [Consultant Ophthalmologist] 
‘So it definitely does have an impact on the smooth running of the clinic and that’s how it saves 
money.  I think falls is a classic example, because falls do come with poor sight and most of these 
people have falls, apart from being frail and drugs they may be taking, poor vision is a huge 
contributory factor’ [Clinical Lead] 
‘I think the ECLOS have a fantastic role in that they take away the patient from the clinical 
side…where the treatment has been given or terminated or could not be completed for one reason or 
other…and they get them prepared for life after. So from being sympathetic as to what their clinical 
condition is they quickly move onto what is available and accessible outside…and also what is 
available here in the hospital…’ [Consultant Ophthalmologist] 
‘…[referring to an ECLO] it’s not the case of passing the buck, it’s about putting the patient in the 
right place for the right reasons at the right time – that’s how it works’ [Orthoptist] 
‘I think that it’s a poor service without an ECLO, having someone ‘on tap’ makes a big difference’ 
[Consultant Ophthalmologist] 
Overwhelmingly, most interviewees believe that ECLOs contribute to the smooth running of eye clinics.  
They would seem to enhance efficiency within clinics and streamline processes to release capacity, not 
only through the CVI process as outlined, but by referring and signposting appropriately and according 
to the needs of patients, in a timely way.  
As we have already pointed out, many interviewees are of the opinion that time is also saved for other 
staff through ECLOs taking ownership of the CVI process. Inappropriate referrals are avoided. In more 
than one account it was stated that if there is early engagement with patients (e.g. pre-CVI), people will 
impact less, further down the line. Part of an ECLO job is early intervention and prevention, not waiting 
until the patient is registered. 
Without the ECLO, the system slows down to the sum of its parts. In some places that operated without 
an ECLO, we heard of staff at times struggling to keep up with the emotional and support requirement 
of patients, and being unable to offer the kind of specialized advice e.g. around benefits, which ECLOs 
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often give. Any advice given was ‘ad hoc’.  For many sites operating without an ECLO, it was suggested 
that having an ECLO would vastly improve their service; some were in the process of recruiting, and we 
talked to consultants who were looking forward to having one as part of their team. 
Some interviewees indicated that ECLOs also could have a positive effect on pathways such as falls care, 
for example. Several anecdotal examples of this were given, but ECLOs in various localities were also 
involved in glaucoma care, diabetic or pediatric pathways.  
However, falls is a major area of concern and cost - proactive ECLOs probably have an effect on this 
primarily by registering people at the right time, but also raising awareness among clinical teams of 
what the ECLO service can do to help e.g. among junior doctors. We heard how fully embedded ECLO 
practice helps clinics to function better by linking to outside world and the services available locally. 
Often other members of clinical teams are not as aware of processes and support available in the 
outside the clinic e.g. the role of ROVIs, or right and entitlements in the welfare system.  
We noted in several interviews that ECLOs often work well with ROVIs, through good efficient 
communication, joint working, shadowing roles, and ultimately being able to give people an all-round 
care package that extends into their lives outside of the clinic. This relationship also works in terms of 
queries and scrutiny, a way of checking the quality of service as a whole: if there is a blockage in terms 
of registration, for example, we heard repeatedly how ECLOs sort things out. It is a natural feedback 
loop between systems. 
It was noted that, according to our interviewees, when it is difficult to convey all the information around 
diagnosis, often because of time constraints, ECLOs communicate more effectively. They often link the 
patient to the community support needed in a timely way. They also often have an advocacy role for the 
patients within the pathways, especially relevant in large hospitals, with patients potentially on several 
different pathways. 
4.3.4 FEEDBACK AND HOLISTIC SERVICES 
‘We used to say ‘sorry there is nothing we can do for you’ – now we can send them to [the ECLO] for 
support.  We have a moral duty to give patients the best possible treatment and it’s nice to give 
them something positive in the form of ongoing support from the ECLO’ [Consultant 
Ophthalmologist] 
‘When we refer them to you [the ECLO], it means we haven’t finished with the patient and it means 
that we don’t have the expertise…’ [Consultant Ophthalmologist] 
‘In the low vision clinic sometimes the barriers are down a bit more because you really are getting 
into people’s proper world, but I feel because of the confidence I’ve got in the ECLO, we can relax a 
bit and dig deeper knowing I can follow through’ [Orthoptist] 
‘If the ECLO weren’t here and I was being thick-skinned, I’d say that the impact on me wouldn’t be 
very much. I’d spend all the time I had available with patients and then it’d be out the door and off 
you go, and to say to patients “if you have any questions, ask me at the next clinic”. From my point of 
view that would be a very incomplete service – patients at least need to be much clearer about what 
they can do, and how to live their life after they walk through the door, and that’s the big difference 
that the ECLO can bring’ [Consultant Ophthalmologist] 
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As we are already indicating, when asked, most feedback given about ECLOs in our research were 
positive, either from clinical colleagues or other outside partners. Nevertheless, some of the ECLOs 
interviewed were also very keen on trying to evaluate their own services, primarily to make sure that 
they were giving people the service that they need, but also to make sure that funders knew what they 
were getting locally.  
However, it was noted that there is no overarching evaluative framework or national standard by which 
they can measure this as yet. Some ECLOs have carried out patient satisfaction exercises in the past, 
though certainly not all. Many are keen to be able to evaluate own services to maintain funding and 
justify service levels.  
As noted also in the previous theme, within the system(s) that they operate, it could be argued that 
ECLOs, in conjunction with others also act as a feedback loops e.g. linking Social Services and clinical 
teams, but also able to spot any potential problems through the often close joint working that they do, 
and their extensive knowledge of the local eye health network. 
It was also pointed out in interviews that people are at most need of support when there’s no more 
clinical support to be given, and this is often what ECLOs provide. By doing this, many of our 
interviewees believe that the presence of ECLOs in clinical eye services makes them more of a 
‘complete’ service, in contrast to pre-ECLO times where there was less support, and the support was less 
structured when offered. Joint working e.g. with ROVIs is far easier, so looking at a more integrated 
model of health and social services for visually impaired citizens, ECLOs are key to delivering some of 
this. 
4.3.5 TIME TO TALK 
‘We’ve given her a slot [in the Bardet-Biedls syndrome clinic] as part of our ophthalmology slot, so 
that even if it is just to introduce herself or if there’s something that they need that we pick up on, 
she’s got that time allocated within the clinic programme to actually have a consultation which is 
really good’ [Clinical Nurse Specialist] 
Giving patients time to talk and get used to their diagnosis is a key function of ECLO practice. Most 
interviewees recognize this, and this was a comment made by many across the nations and regions. 
Many skilled ECLOS will be able to talk to patients about anything and everything which might worry 
them in terms of work, how they'll manage etc. and understand the deep emotional need for this, to 
‘enable people to live life after they walk out of the door’. However, in this category, it should be 
understood that by giving this time to talk, an ECLO also releases capacity, allowing other clinical staff to 
carry on with their tasks i.e. see more patients. 
4.3.6 INTEGRATION AND NEED FOR ADDITIONAL ASSISTANCE 
It became apparent in interviews that some ECLOs often feel more integrated in teams when they are 
funded by NHS.  Some already come from nursing backgrounds, and work part-time as an ECLO, so 
already feel integrated in clinical services. For many ECLOs there is a constant need to remind clinical 
colleagues of the existence of the service. 
In some clinics, as demand has grown, some ECLOs felt also that they needed some additional assistance 
to keep up with administrative work.  In many areas, the very success of the service has meant that 
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demand for it has grown also; ironically, what was once, in some senses, an additional service assisting 
more clinical services, now needs assistance in some places because it’s reaching capacity. We heard of 
volunteers providing this in some places. 
4.4 PATIENT–CENTRED 
‘We fill the gap where patients used to fall, and give them the help to remain independent’ [ECLO] 
Another major category developed in our data was that of ‘patient-centred’ practice. By being ‘patient-
centred’, there is slight shift in emphasis in ECLO practice, where the focus is on the need of the 
patient/citizen rather than the needs of the service. It could be argued that giving time to talk to 
patients could also fall under this category: the very act of doing so not only has implications in terms of 
day to day capacity for a clinic, but also in providing a more holistic service for the patient, where all the 
needs are met as fully as possible. If one of the fundamental ECLO domains is that of planning for the 
future of people who are visually impaired, then their role as enablers, in developing emotional 
resilience once people lose their sight, is an important one. The themes developed here also take into 
consideration once more where the ECLOs sit in relation to other services. 
4.4.1 BRIDGE BETWEEN CLINICAL AND NON-CLINICAL SERVICES 
‘I’m a bridge between the health service and the wider world – whether that’s on social care or 
voluntary sector groups or whatever it is. Financially I think if we can catch people early and support 
them, I think they won’t then be a drain on the external services quite as much. It’s difficult to build 
that argument though – there isn’t a robust case that I’m aware of to be honest’ [ECLO] 
‘She [the ECLO] has got much more access to social services which before I’d just literally be phoning 
up and trying to find the appropriate person and she has all this at her fingertips where she knows 
someone that can help’ [Clinical Nurse Specialist] 
ECLOs are clearly the bridge between services both within the clinical environment and services outside 
of the hospital, and this is a key practice – linking the health service and the wider world – whether that 
is to social services, social care, local sight loss charities or other voluntary sector groups. By linking 
services together, this benefits patients, their families and carers. It also enables care to continue once 
medical options have been exhausted. Above all, we found in our interviews that ECLOs give practical 
support – each one will be different in how they do it - but at base they will always link them up with 
other people and services. To an extent, an ECLO will be as good as their network of connections allows 
them to be, and their network will constantly be evolving and changing. 
As we have seen, there are clear examples of when the ECLO takes over in the clinic for ‘non-clinical’ 
work e.g. certification, but also raising patient awareness around things like the Amsler grid, vitamins. 
But equally, the work that is needed outside of the clinic is dealt with by the ECLO.  One of the prime 
examples of this is that they are an important point of contact for making sure that benefit issues are 
dealt with. Previously, without an ECLO in place, we heard how this would often be the responsibility of 
low vision nurses, but with an ECLO in place they are free to concentrate on their own clinics. We also 
heard how in clinics that did not have an ECLO, these issues tended to be dealt with in an ad hoc 
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manner, resulting in poorer outcomes for patients. We would also stress that in a real sense, when we 
talk of patients, we are also talking of patient/citizens; by being a bridge and support to the outside 
world, ECLOs often ensure that rights and entitlements of the patient/citizens are cared for. 
Many of our interviewees indicated that ECLOs often refer to local rehab officers and sensory teams 
where available, and that this is often a key relationship locally in terms of the eye health care network. 
With early intervention and encouragement from the ECLO, rehab officers often get people doing 
practical tasks early on, so that people gain a gradual awareness of the difficulties they can face. The 
service also gives support to relatives and carers connecting them to local networks also.  They offer 
support around employment transitions, assistive technology or benefits, as well as emotional support.  
4.4.2 EMOTIONAL SUPPORT 
‘The really tough patients, the patients that really need a lot of emotional support, there’s no way 
we would be able to provide it without [the ECLO], no way at all.   Thankfully we seem to have a 
good clinic setup and a good team in that we don’t have that many patients where we need to get 
her involved but it’s really useful to know that there’s a backup there if someone’s very upset, say 
they’ve just developed glaucoma and they’re not understanding the context that we’re putting it in 
for them then we need [the ECLO] to be the shoulder to cry on’ [Optometrist] 
‘I tick emotional support for everyone that I see on the spreadsheet because ultimately that is what 
we do for everyone, even if it’s seems like something quite small, it can help them with their feelings 
and whether they feel down’ [ECLO] 
‘People in need aren’t interested in titles or uniforms…they just want someone who is genuine, who 
is interested in them and will help them whenever they need help’ [Ophthalmic Nurse] 
Providing a wide range of emotional support is obviously a key practice for ECLOs. They provide support 
for patients who are anxious about their condition, even when it's relatively mild, and are able to 
manage expectations. Many are trained to deal with giving people bad news, and we heard how RNIB 
courses were an essential part of training to prepare for this aspect of practice.  
ECLOs fill that gap in services which meant that people weren't been given enough emotional support 
previously; we heard in our interviews how this used to be the case, pre-ECLO, and in clinics without 
ECLOs, the impression was that the time needed to sit with people wasn’t there. That’s not to say that it 
didn’t happen, just that the capacity was less.   
As we have already indicated, ECLOs are able to save time of other staff by 'mopping up' the emotional 
support needed by patients. Psychological adaptation to visual impairment is often compared to the 
grief process, but people often need some kind of emotional support as they have to navigate other 
administrative processes and frameworks also. We heard of ECLOs helping out with the work of applying 
for benefits, and getting more support in the outside world. 
But by having an ECLO in the clinic, when people are really upset, we heard several accounts of how the 
ECLO takes over, which both clinicians and ECLOs perceive saves time in the clinic and gives the 
clinicians permission to move to the next patient. We heard how people who are anxious about their 
condition are referred to ECLO immediately in many clinics, and that they will often sit with a patient as 
long as it takes if they're upset: this is accepted practice in many clinics. Eventually, they also offer 
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signposting to other emotional support, but that initial support and the fact that they provide time and 
space for a detailed conversation in the clinic is very important. 
In addition, by being able to explain and interpret the diagnosis, on occasion we heard how they're also 
able to calm things down when the communication is difficult between the clinician and patient. An 
ECLO, herself sight impaired, described how it’s fundamental to make people realise that they are not 
alone, right from the start: 'that it's not the end for them, it's the start of a new part'. 
4.4.3 DEVELOPING EMOTIONAL RESILIENCE AND ENABLING  
‘It’s the quality you can bring to a patient’s life I think, the quality service, a way of life, a coping 
strategy.  It is just a good experience, an all-round experience, and it is part of our patient care, and 
it enhances the patient experiences and enhances their lives I would say’ [ECLO] 
‘The practical support is just that – the things that we do like writing letters, or making phone calls, 
or linking them up with people and services. It might be showing them equipment, and I only do a 
very basic demonstration of the basics. You see again, every ECLO is different as to how they do it, so 
I don’t make too much of this – I touch on some of the household stuff, but I don’t go anywhere near 
the equipment that needs to be prescribed. I’m not an expert in that so I leave it to the people who 
prescribe the equipment to show them how it works, like magnifiers’ [ECLO] 
‘We have a lot of patients who don’t want to have social services involved, especially the very elderly, 
because they think it’s an intrusion and [the ECLO] will have more time to explain to them that 
they’re there to help and it’s, they don’t have to come to your house and intrude, you know, it’s just 
the help that’s there. A lot of people don’t know what’s on offer’ [Clinic Manager] 
ECLOs are enabling in the sense that they help patients to get on with their lives outside of the clinic, 
and help them develop the necessary coping mechanisms, what is now commonly called emotional 
resilience. The clinician is able to pass on the patient with confidence - their needs will be seen to as 
fully as possible by the ECLO, beyond the starkness of the diagnosis and details of the treatment.   
Leading on from our previous theme, some clinicians said that they wouldn't be able to provide the 
emotional support for the 'really tough patients', without the ECLO. In addition, we heard how some 
patients want to show the doctor that they’re doing well, and don't want to feel a burden on clinical 
time. Having an ECLO in the clinic gives them other options, other types of non-medical support and 
above all, the space to talk. ECLOs therefore give patients the space  to express their emotions about 
their condition, and then provide the support needed.  However, some clinicians acknowledged also 
that communication is also part of their role, not just the ECLO, and that it shouldn’t be a 
straightforward split between them and the ECLO's pastoral role in that sense: clinicians also need to 
have the listening skills. 
However, we also heard how ECLOs can be enabling on a practical level: we heard how some, with a 
background perhaps in low vision clinics, were able to help with showing how equipment can be used, 
with day-to-day, practical tools e.g. bump-ons, technologies which help with living life. We heard that 
through doing the initial work of supporting patients, they make people more open to further support 
outside of the clinic, for example, into the helping hand of the ROVI. As one ROVI put it, ECLOs often 
help ROVI services to 'get past the gate' i.e. clients will have developed some resilience and acceptance 
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of condition before ROVI begins helping them. By breaking down barriers, and sometimes the stigma 
associated with asking for help, they make people more accepting of ROVI help. Some of our key 
interviews revealed that the relationship between ROVIs and ECLOs can be pivotal locally. Several ROVIs 
interviewed were of the opinion that ECLOs are a real help to engagement, and they prefer it when the 
ECLO refers to them, because they can explain fully what ROVIs do:  
'when they find out that you’re not a social worker, you’re a rehab worker and you’re there to teach 
them to stay independent, you find that they will take the service up' [ROVI] 
4.4.4 PREVENTATIVE WORK - EARLY INTERVENTION 
‘You see him talking to patients and hopefully he captures them ideally before they get to the point 
of registration which is what we want now so when they are registered it’s not such a massive thing. 
Their life hasn’t fallen apart quite so much. Before it used to be that people had the information at 
the point of registration. So now we give them that information so that when they do get to that 
point their life’s come together’ [Ophthalmic Nurse] 
‘In the macular or diabetic clinics I’ll have a look through the files and flag people that have got a 
little bit of reduced vision that could potentially hinder their everyday life. Usually I’ll put a flyer in so 
that the nurses know I’d like to have a chat with them and they’ll talk to the patients to say ‘we’ve 
got Julie here if you’re having any difficulties, would you like to have a chat?’  If they say yes then 
they come to me. That usually happens after they’ve had their visions done and while they’re waiting 
for their scan. They all get given a leaflet so sometimes they self-refer back again at a later date if 
things change’ [ECLO] 
‘Part of an ECLO job I feel is early intervention and prevention not waiting until the patient is 
registered. Getting that patient before they get to the registration stage. Getting things in place so 
that they cope with the visual impairment before they fall and become an inpatient...We felt it was 
important to say to the doctors we’ve made contact with every new person should they need it’ 
[ECLO] 
‘….at the end of the day, I want to be cautious and say ‘you’re certified’, and can always take it back, 
rather than say ‘no, no, no’ and then something serious happened’ [ECLO] 
Many ECLOs are proactive, not reactive, often working to fill gaps and provide the patient/citizen with 
tools to take things further.  We detected an approach from some ECLOs that could be seen as 
analogous with a ‘harm reduction’ approach, often found in preventative work in other health and social 
care fields. We heard, for example, that some ECLOs will look at files in macular and diabetic clinics for 
people with a bit of reduced vision, and who are potentially experiencing some 'hindrances' – clinics can 
then raise or suggest meeting with ECLO for more support.  
In this sense, ECLOs add value because if they spot a patient earlier (not at the point of CVI), more work 
can be done to help. We heard several times during our interviews how delays in the system can have 
knock on consequences for the patient e.g. with mental health, and that early intervention by the ECLO 
can avoid some of this. At least one of our interviewees was also keen to point out that early 
registration in the CVI process can have a beneficial effect for some – a ‘belt and braces’ approach even 
if the sight loss hasn’t completely gone, can enable adjustment and the preventative support to be put 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 65 
in place: this very experienced ECLO was adamant that this is an approach which saves money in the 
long term because it lessens the likelihood of falls and other mishaps, which are more costly to the 
systems – both health and social care. 
So by linking to the outside world, ECLOs often facilitate early intervention and rehabilitation, and the 
'work' starts before they see the ROVI, for instance. Likewise, getting financial help early, as part of their 
support, means that things will be easier later on, with less anxiety and associated psychological effects.  
4.4.5 MAINTAINING ENGAGEMENT AND CONTINUITY OF CARE 
‘ECLOs mean that you feel that the patient is safer - you pass over to a person who is more 
specialised to follow up, and it also saves time’ [Consultant Ophthalmologist] 
‘You’ve not left the patient to go home wondering if they’re safe, but you pass over to a person who 
is more specialised to follow it up. Whereas the doctors and nurses they don’t have the time and 
they don’t have the skills just for that purpose because there are so many other things clinically to 
do.  If I have a patient, I do encourage them to speak with [the ECLO].  It makes a difference and you 
feel safer’ [Clinic manager] 
Engagement with patients can be an opportunistic process; ECLOs have to be able to improvise and be 
flexible with the time it takes.  This again is analogous with the ‘harm reduction’ approach we’ve 
explored in subsequent themes. Some patients are long-term, and might be on the books for years, 
others might only be seen the once. An ECLO needs to be there at the precise point when the 
patient/citizen asks for help, which might be immediately, or because of circumstances or attitudes 
towards support, later on. Either way, this can be a long-term commitment.  
We heard from interviewees that when people find it difficult to accept their diagnosis, often the day-
to-day reality of running a clinic is that there's no more clinical time to help them, so it often up to the 
ECLO to step in. As we’ve also indicated, ECLOs often reach parts which ROVIs can't: our framework 
analysis pointed to examples of long-term clients whose sight gets worse suddenly are helped with joint 
working approaches between both ECLO and ROVI, and of ECLOs who had patients on their books for 
many years, even though the majority were often helped within months.  
Another aspect to this is the follow-up, to maintain that engagement, and many interviewees indicated 
that it is often the ECLO who does a lot of the follow up work to make sure that care continues beyond 
the medical care of the clinic. By supporting the patient/citizen early on in their journey, we heard how 
it then helps other professionals in the local eye health network to maintain their engagement.  
Equally important, because of the bi-directional nature of the ECLO within the system, engagement with 
the world outside of the clinic is made available to the rest of the clinical team: we heard of how many 
ECLOs were proactive in providing updates on subjects such as changes to benefits, changes to the local 
voluntary sector provision or any other services available outside of the clinic. We then heard how this 
can then translate into practical help being offered by the whole team, not just the ECLO.  
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4.4.6 QUALITY OF SERVICE 
‘Our service would be very incomplete without the ECLO component: people need to know how to 
live their lives after walking through the door – this is what an ECLO brings’ [Consultant 
Ophthalmologist] 
‘Given the very positive feedback we’ve had about their support, there is a direct service quality and 
patient benefit argument for having one in any clinic’ [Consultant Ophthalmologist] 
From most of our interviewees, it would seem that ECLOs, where in post, have been a major 
improvement to services across the nations and regions of the UK.  As discussed, ECLOs have a real 
impact on the throughput of a clinic, and allow clinicians to see more people, the feedback from many 
clinicians was clear-sighted about the patient benefit argument for having one in a clinic.  The major 
points made in several interviews were that patients are being referred at a better point in treatment, 
making a difference to their quality of life, and that they free up other resources e.g. the low vision 
nurses to concentrate on the things that matter - making sure that patients get the right courses 
according to needs. 
Though some services measure this quality through key performance indicators, this is by no means a 
consistent feature of ECLO posts across the UK. Rather than concentrate on those managerial and 
accounting features in this chapter, we think that the breadth of experience and expertise in our 
interviewees speaks the loudest when we’ve asked about the nature of having a high quality service; 
barring one or two exceptions, there was almost universal agreement that an ECLO adds to the quality 
of care offered. 
4.5 SKILLS AND KNOWLEDGE 
Under our ‘Skills and knowledge’ category, we were able to look at other aspects of day-to-day ECLO 
practice. It is a very wide category and encompasses descriptions of a range of practices, from the 
awareness raising or administrative roles to advocacy and communication with external stakeholders. 
Again, there are plenty of overlaps with previous themes to be found here, but we feel that this 
category illuminates aspects that might not be covered elsewhere. 
4.5.1 ADMIN AND PAPERWORK  
Apart from the CVI process, which seems central to everyday practice, we heard how ECLOs also have a 
fair amount of administration and other paperwork to complete, both for internal audit and tracking 
functions but also, more importantly, on behalf of the patient/citizen.130 
This includes what was called by one interviewee the 'light touch stuff' as well. Examples included the 
BT195 form, cinema cards, arranging fire safety checks, blue badges – ‘practical’ work which gets 
services, ensures the rights of patients/citizens and enables them to live fully and safely with their 
condition.  
                                                     
130
 Not all of these processes apply in Scotland. 
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We detected that there were differences of emphasis in the systems used across the nations, regions 
and local authority areas, depending on local need e.g. some adapted the way that ECLOs had to record 
contacts because many of the ECLOs are partially sighted. 
We also found that some ECLOs are keen on documenting everything (for audits, key performance 
indicators etc), and that depending on funding arrangements, we detected that this was in part because 
they felt insecure: there seemed to be more pressure on some to justify their roles, and this translated 
into more time taken recording outcomes. However, we also heard very practical reasons for keeping 
detailed reports, such as having a job share: it’s far easier to hand over to colleagues if detailed records 
and notes are kept.  
As indicated, the CVI process itself is seen as a starting point for some in terms of getting a conversation 
going with patients, and we heard how before ECLOs were in place, a large part of this work was done 
by secretaries. Some ECLOs divided their workflow by having dedicated admin days, as they have a lot of 
referrals, stats and other paperwork to keep up with. We heard also how some use OneVision, and they 
maintained that this generated more evidence of activity than others systems they had tried.  
4.5.2 ADVOCACY 
‘There’s often situations with benefits where benefits have been cut or changed or job issues where 
things are getting very awkward for the person because the visions failing due to visual field defects 
and their workplace isn’t being overly helpful, so our ECLO is very good with that, she can get 
involved and help them and get some benefits for them’ [Optometrist] 
‘It would be terrible for patients if there were no ECLO. Patients would lose out financially and we 
don’t have the skills for either helping people with their benefits or counselling’ [Orthoptist]  
‘What the ECLO service does, is that by actually providing that advice, information and guidance at 
the point of diagnosis, or deterioration or crisis, they’re able to connect people and identify what 
those maybe critical or urgent at that time and being able to advocate for the patient. To ensure that 
they get that support rather than just a CVI document being completed and going into the local 
authority, then being sat in somebody’s in-tray because they haven’t got the capacity to deal with 
the weight of referrals because of the budget cuts and the change in their sort of set-up’ [Consultant 
Ophthalmologist] 
ECLOs advocate for patient/citizens on a regular basis. We heard how this could be both within clinical 
system and pathways – so perhaps sitting with patient when she's talking to the consultant to make sure 
that they're not too anxious – or outside the clinic. It might be making sure that somebody is registered 
at the right point, in a timely manner. ECLOs will also advocate in the workplaces of people with failing 
sight, as well as when benefit issues come up. Because their practice is patient-centred, they often 
reduce stigma, and ensure people aren’t ignored as they try to navigate complex systems and 
frameworks of rights and entitlements, whilst at the same time going through profound changes in 
health status. 
By helping people to deal with their worries and concerns, we found evidence through our interviewees 
that they often demystify challenging situations, and encourage people to benefit from the offer of 
support that exists: 
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‘We have a lot of patients who don’t want to have social services involved, especially the very elderly, 
because they think it’s an intrusion and [the ECLO] will have more time to explain to them that 
they’re there to help and it’s, they don’t have to come to your house and intrude, you know, it’s just 
the help that’s there. A lot of people don’t know what’s on offer’ [Clinic Manager] 
4.5.3 COMMUNICATION 
‘Patients at least need to be much clearer about what they can do, and how to live their life after 
they walk through the door, and that’s the big difference that the ECLO can bring’ [Consultant 
Ophthalmologist] 
The ECLO role is very much about communication between patient and community as they get used to 
the diagnosis.  Equally, it would seem from our interviewees that good internal communication also part 
of ECLO role – they often make sure that parts of the eye care team, and the eye care system as a 
whole, work together. Internal communication between teams is essential to keep up to date with 
what's going on locally also, and as indicated previously, ECLOs provide that link to local provision and 
services.  
The evidence suggests that there is a very ‘embodied’ nature to the role of ECLO; it became evident 
from many of the accounts heard that the ECLO role is a very physical presence in the clinic. We heard 
how much easier it is if they're physically there in the clinic, not only to help immediately with those 
who are upset, but to connect the various part of the team. Also, for patients, we heard how it is often 
essential that ECLOs are able to communicate clearly about the diagnosis, and that some patients were 
more prepared to talk with ECLOs than the doctor because the ECLO was trained to use language which 
could be understood by all. 
However, we heard from some clinicians that they are anxious that communication isn't something that 
can be exclusively left to the ECLO and some recognise that they still need to improve their own skills. As 
part of the advocacy role, ECLOs can also improve the communication that happens between clinical 
staff and patients, especially if people are upset about their diagnosis. 
We heard that high staff turnover in clinics can present a challenge to ECLOs and can sometimes mean 
that people are unaware of what ECLOs offer, so there is a continual need to educate staff about what 
they do.  
4.5.4 AWARENESS RAISING ROLE 
‘I’m sure if you can increase awareness and go to departments where there isn’t an ECLO and ask 
them first how do you manage with all this information and do you have the time?  I can tell you 
99% would say no, we are absolutely stretched but we have to do it or we do it patchily or I just give 
them the booklet’ [Clinical Lead for Ophthalmology] 
‘It is important to have someone who knows about the patient’s condition so that they can give 
them the appropriate information. Not to take over from the doctor, but to support the patient on 
their terms’ [Consultant Ophthalmologist] 
In our interviews, we heard how ECLOs are trained to help people understand their condition, identify 
problems and signpost them on, and provide ongoing support outside clinic.  Fundamentally, they help 
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people by providing a lot of information, 'tools to take things further', and as mentioned, having good 
communication skills for this is key. We heard how they are often able to explain the eye condition in 
terms that are understood by patients. We also heard of how they have an important role in the internal 
workings of teams and training for medical professionals.  
Their awareness raising role can be quite varied. For example in some places, the ECLO is part of the 
induction process for medical staff – in at least one place, this included taking part in the mandatory 
training on falls prevention for all doctors. Introducing the ECLO is part of the staff induction process can 
be crucial because 'if you don't make the connections you just won't get the referrals'.  As was indicated 
in the previous section, 'it needs a constant education to new staff and to keep pressing the message 
across', and this can include activities such as giving blind awareness talks to medics. In some places, we 
heard that because of high staff turnover, there is a continuous need to 'bang the drum' about the ECLO 
service.  
We heard also that some ECLOs are very involved in patient awareness initiatives such as how to 
administer drops, which in some places, meant saving a certain amount of clinical time for others. One 
interviewee maintained that by explaining the day-to-day reality of processes such as anti-vascular 
endothelial growth factor (anti-VEGF) treatments, they are able to put the patients mind at ease. Some 
ECLOs also get involved in awareness raising and facilitation roles outside of the clinic, a form of 
outreach as well as providing practical help: we heard of several who were running ‘Sight Loss’ courses 
in the community, for example. 
4.5.5 EXPERIENCE AND BACKGROUND 
'I was always a nurse, and someone who believed in this but it is hard for ECLOs because we don’t all 
share a common identity. We’re not quite like Macmillan nurses but it’d be good if we were' [ECLO] 
ECLOs come from a wide variety of backgrounds.  There is a whole range of background in our 
interviews, from those with nursing experience, to those who have the lived experience of being 
partially sighted, to others who have spent years in the voluntary sector, working for social enterprises 
or as Independent Living Coordinators. Some of those with nursing backgrounds still maintained their 
nursing practice on a part time basis. 
A lot have a previous background in working with people who are visually impaired, but many do not 
have any formal medical background; this is seen as a strength by some, but some ECLOs value the 
nursing experience, and are still practicing nurses on a part time basis; they also felt that somehow this 
was more reassuring to patients.  
In one or two cases, it was indicated from other health professionals that this was somehow important 
to them also, that those from a nursing background would be trusted more by clinical colleagues – but 
this was a minority view. 
We heard that most ECLOs have a degree of clinical knowledge but the vast majority aren’t formally 
trained as clinicians. As mentioned, for a minority, having a background in nursing is seen as an 
important component in the team 'makeup', and gives another way of experiencing the gaps in the 
system. It is a moot point whether or not this then equips the ECLO with the skills which are necessary 
to network beyond the clinical environment, which as we have seen is a key skill. Either way, many of 
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those interviewed seemed to have completed a lot of training to become ECLOs in the first place, with 
some able to add value by being able run things such as low vision clinics, for example. 
4.5.6 KNOWLEDGE OF LOCAL SERVICES/ LOCAL KNOWLEDGE 
Having good local knowledge of services available in several sectors, and being able to maintain that 
knowledge through networks, would seem to be a key skill for ECLOs. As we’ve explored previously, 
ECLOs act as a bi-directional node, with knowledge about local services coming into clinical teams also 
through the role. From our interviews it would seem that one of the starting points for the role is to 
communicate often with the social services in general and rehab teams in particular, and build up some 
good working relationships.  
We will explore this further below, but equally important are the local networks of voluntary sector, 
community-focused, and advocacy groups. From our interviews with some, it would seem to be that 
ECLOs need to be in touch with a vast range of services outside of the clinic.  
A couple of interviewees pointed out that, in particular, local services for young people were very 
important as they are often overlooked because the visually impaired population tends to be older, as it 
was important to have connections to services that help people living with diabetes, or financial help, 
for those more worried about their bills, for example if they couldn’t work as sight loss progressed. 
4.5.7 OUTREACH 
ECLO outreach services would seem to be more common in rural areas, so it became apparent that not 
all ECLO practice is based in a single acute hospital.131 We interviewed ECLOs who could be better 
described as peripatetic, and who move from clinic to clinic in rural areas as well as those that practice 
in non-hospital based community settings. This practice can include going out to talk to groups about 
sight loss, as well as running courses in the community, thereby raising awareness of help available. In 
contrast, we heard how in some rural areas, services have been brought into a central, non-acute 
hospital-based clinic, though it was unclear whether this was an attempt to improve services or cut 
costs. As we indicated in a previous section, some ECLOs try to anticipate future needs of patients e.g. 
by doing diabetic clinic work, and thereby making sure that people are aware of their services long 
before they might need it, so they can self-refer if needed. More referrals are generated through the 
awareness raising/staff training work, as well as through talking to voluntary services locally. 
4.5.8 REFERRAL AND SIGNPOSTING 
‘Referrals can come from the staff in this building, from word of mouth, the internet. I get a lot of 
emails these days from people enquiring about services for their parents.  We’ve just done a 
presentation with community optometrists last week to try and encourage them to refer. Any avenue 
we can reach people, that’s what we’re going for’ [ECLO] 
‘It would be a disaster in clinic without the ECLO – patients would not be directed to the proper 
places’ [Senior Doctor] 
                                                     
131
 It should be noted that for this reason, in Scotland and elsewhere, the term ECLO is not always used – Vision Support 
Workers or Sight Loss Adviser is preferred in certain places. 
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Referrals seem to be the most common way that patients come to ECLOs, and for many, a key point of 
contact, enabling support to begin. As we’ve already established, ECLOs are very focused on connecting 
people, so when they get referrals, from whatever source, they often refer on to other services also. 
Some of those interviewed used the terms 'referrals' and 'signposting' interchangeably, and saw 
signposting as a form of ‘onwards referral’ to the appropriate service.  
Some ECLOs maintained that the CVI itself constitutes a referral. We heard how ECLOs in some areas 
receive them through a variety of avenues: through the post, from different clinics, from primary care. 
Many patients are referred because they’re being registered.  That constitutes the referral from the 
consultant that’s registering them. We also heard that the ECLO, because of their connections and 
network e.g. with rehab teams, can often speed up the whole referral system. As discussed, they can act 
as a feedback loop which discourages blockages in the system: if a ROVI knows that a patient has been 
referred, but cannot act until the registration is completed, they will contact the ECLO to sort this out.  
In general, ECLOs are trained to signpost after helping the patient gain some understanding of their 
condition and they signpost for a diverse group of patients, from older people with macular 
degeneration, to young diabetics.  What we heard from several ECLOs was that because it's constantly 
changing, one of the main challenges for ECLOs is to keep up with what’s happening locally through 
their networks, and having strong relationships within those networks is key. 
4.6 RELATIONSHIPS 
Finally in this chapter, we touch upon the fourth key theme in our framework – that of relationships. 
Building and maintaining a strong network of relationships with other services both within the clinical 
environment and outside the clinic with other sectors would seem to be a key ECLO role. 
‘The ECLO isn’t just about lending an ear –it’s about efficiently liaising with services’ [Outpatients 
Sister] 
In fact, we would argue that ECLOs play a very important role as critical nodes within what could be 
called the local eye health network; their ties to this network, and the strength of their ties not only 
provides one of the fundamental ways in which they ‘add value’ to clinical services, but also helps to 
integrate and align the care pathway for patients/citizens across different systems. 
4.6.1 CONNECTIONS WITH THE COMMUNITY 
‘[The ECLO] communicates between the patient and the community, often when people have had a 
little time to get used to the diagnosis’ [Clinic Manager] 
‘[The ECLO] gives them information about what financial support, what other services are available, 
what other support is out in the community as well, it’s not just in-house, she has a whole remit out 
there where she can give patient connections…It’s a holistic approach really because not only does 
she give the visual aids and the internal support, she’s got the connections outside as well and she 
gives a lot of information.  And she also helps me with other things in clinics, gaining information for 
other specialties and things like that’ [Matron] 
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Having good relationships with local eye health networks is a fundamental part of ECLO practice.  This 
means constantly having to update information about what's going on in the local community or 
voluntary sector, for a wide range of patient ages and interests, and maintaining those relationships 
over time.  
As we heard from our interviewees, this can be a challenge in itself, because things are constantly 
changing: staff turnover, charities that open or close, budget cuts affecting services. However, we would 
maintain that this is a fundamental part of ECLO practice, reflected strongly in our interviews, and it 
represents an important point of difference and added value that ECLOs bring to the overall care of 
patients/citizens. Many clinicians admitted in our interviews that ECLOs make the connections that are 
very difficult for them to make, and therefore they complete the care needed for their patients. Patients 
are handed over to the ECLO not so much because clinicians can do no more for them, but because the 
job of care isn’t finished. 
4.6.2 CONNECTIONS WITH SOCIAL SERVICES 
‘As an ECLO you have to keep your networks with social workers as up to date as you possibly can. 
They change relatively quickly so you need to keep abreast of any changes that they are making to 
the referral process’ [ECLO] 
ECLOs save waiting time for patients in making connections with social services. In some places, this 
relationship is quite formalised and meetings will take place on a regular basis. We heard how ECLOs 
help with the important background work that’s needed so people are more open to getting their right 
and entitlements as patients/citizens.  
Not only do they signpost or refer to rehab teams if they are present locally, but they also do the 
preparatory groundwork so that people feel confident in engaging with these services, often at a time of 
life when they feel very vulnerable. Social services are usually part of a package offered by ECLO, 
involving the voluntary sector, practical help and so forth, but in our interviews, it was the connection to 
ROVI that seemed to be key. 
4.6.3 CONNECTIONS WITH THE VOLUNTARY SECTOR 
We heard how ECLOs signpost to a very wide range of voluntary sector organisations, from the small 
local groups to services offered by large charities.  Again, this is an important part of their practice and 
they have to keep up with what’s going on locally, often through the relationships built up in their own 
networks. We also heard of the important contribution that volunteers from charitable organisations 
make in some places, helping out with running clinics, but also able to help with some of the increasing 
administrative burden that success has brought to some ECLOs. 
4.6.4 TRUST AND VALUE 
As a trusted link between clinical services and other sectors, ECLOs do the necessary support work, 
beyond the clinical work. We heard in our interviews how clinicians often rather refer to the ECLO first 
than straight to other places e.g. local rehab teams, social services. 
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Many clinicians reiterated that without the ECLO it would be really difficult to offer the emotional 
support to people who are having a tough time with their diagnosis. On a one-to-one level also, some 
maintained that people are more likely to be honest with an ECLO - not to try to 'please the white coat'. 
As noted previously, however, some ECLOs believe that being identified as part of the NHS means that 
they are more trusted, but in general it would seem that ECLOs thrive on relationships of trust – so 
being a ‘trusted’ member of the clinic staff is important for them to be able to work effectively: 
'When my badge said I worked for a charity, people didn’t want to see you. The minute that badge 
changed my numbers trebled, because they know you’re trained, they know you are a trained 
professional, they know that you’ll be telling them the proper stuff.  The NHS see you as a 
professional' [ECLO] 
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5 QUANTITATIVE FINDINGS 
This chapter presents quantitative analyses on the ECLO’s impact on patients, clinics and NHS services.  
These were conducted on data for ECLO activity, patient experience, HRQoL and a staff survey. On ECLO 
activity, data were examined for two data sets, one from English patients only and the other from 
patients in Wales, Scotland and Northern Ireland. Descriptive analyses for all data are followed by the 
main findings of the economic analysis and modelling based on these ECLO, patient and staff data.  
5.1 ECLO ACTIVITY DATA 
5.1.1 SUMMARY 
Background 
The ECLO activity data discussed in this section include information on the key aspects of first and 
follow-up appointments with the eye clinic patients in England, Wales, Scotland and Northern Ireland, 
covering information on new and returning patients, patient enquiries, interactions between ECLOs 
and patients, and appointment outcomes. The data reported here covers the 12 months from April 
2015 to March 2016. 
Other than in England where data are aggregated, the ECLOs record the outcomes of the meeting with 
the patient on three categories: ‘informed about’ relates to providing information related to patients’ 
main concerns, such as giving leaflets to patients; ‘signposted to’ relates to providing specific source of 
support or services that patients can seek help from; and ‘referred to’ relates to making referrals for 
patients with the purpose of getting further specific support. 
Key findings 
 During the 12 months of the study period (April, 2015 – March, 2016) a total of 16,887, 2,934, 
2,341 and 4,126 meetings with ECLOs were recorded in England, Wales, Scotland and Northern 
Ireland respectively. 
 Overall, Welsh patients tended to re-visit the ECLOs more than those in the other three UK 
countries, and in each country, women and people between the ages of 60 and 89 years are the 
main age groups seen by the ECLOs 
 While living with family members was the most frequently recorded living arrangement for 
patients in all four countries, over half of patients of age 80 years and above reported living 
alone. 
 Age-related macular degeneration (AMD) was the most commonly seen eye condition among 
ECLOs’ patients. 
 Various interaction types between the ECLOs and patients have been adopted, including face-to-
face and via phone (most frequent type of interaction) and email, letters and texts. In most 
cases, ECLOs spent 16-30 minutes either face to face or on the telephone with patients and also 
another half an hour undertaking activities on behalf of patients where necessary.  
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 Overall rates of falls in patients age 60 years and above show that 60% reported a previous fall.  
By country, 29% of patients from Wales claimed at least one previous fall, up to four times more 
than reported in Scotland (7%) and seven times more than reported in Northern Ireland (4%). 
Overall rates for fear of falling in patients aged 60 years and above shows that the over-60s have 
higher rates of a fear of falling than the general population, with the highest prevalence in Wales 
(60%). 
 Following patient contact, the data indicate that up to 70% of patients receive information about 
eye related services, with referrals provided less often. The main concerns patients express at 
ECLO meetings relate to their independence and reading ability. Up to 90% of patients received 
emotional support from the ECLOs. 
_____________________________________________________________________________________ 
After each visit ECLOs record the key aspects of their appointments with the eye clinic patients in 
England, Wales, Scotland and Northern Ireland.  These data were collated by RNIB and sent to the 
researchers.  We received the RNIB ECLO activity data from the routine activity data collected by ECLOs 
after their appointments with patients in all four countries. The data were provided as four separate 
datasets over the study period.  English data have been sorted into six files in MS Excel, showing new 
and returning patients, their enquiries, interactions between ECLOs and patients, and appointment 
outcomes.   Each file contained patients’ ID and contact date that are used as an identifier to merge the 
files together (see Appendix 4 for further detail). For the other three countries, one single file was 
created in MS Excel for each country and variable names are recorded consistently, therefore, the three 
files can be appended. Simply speaking, there are two ECLO data sets, one contains English patients only 
and the other contains patients in Wales, Scotland and Northern Ireland.  We believe that this 
inconsistency in recording data has now been resolved. 
The data analysis reported here covers the 12 months April 2015-March 2016.  Data were anonymised 
prior to sending from the RNIB and aggregated. The data contains patients’ demographic information, 
including age, gender, education status and ethnicity, living status, employment status, CVI certificate 
status, patients’ eye conditions and main issues concerned. During the contact with patients, the ECLOs 
record the referral source of patients, their interaction types with patients, location of meeting, time 
spent with patients and on behalf of patients, and their meeting outcomes, such as the type of support 
given, and any other sources the patients have been signposted to, referred to or informed about. The 
data are recorded at every visit and are categorised as a follow up appointment or a first appointment.  
Unfortunately there were no identifiers that enabled linking the same patient through the series of 
appointments in Wales, Scotland and Northern Ireland. 
Compared with the other three UK countries, some differences exist in data collected in England in both 
the content and recording methods. For example, regarding patients’ falls, only patients’ fear of falling is 
recorded by the ECLOs in England but not the history of falls. The English data do not contain 
information on patients’ main concerns and ECLO’s support to patients, either emotional or practical. 
English data collection had also been reduced to alleviate the burden on ECLOs, and there is an 
assumption that giving emotional and practical support is assumed being intrinsic to the ECLO role. 
Other than in England, the ECLOs record the outcomes of the meeting with the patient on three 
categories; ‘informed about’ relates to providing information to address patients’ main concerns, such 
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as giving leaflets to patients; ‘signposted to’ relates to providing specific source of support or services 
that patients can seek help from; and ‘referred to’ relates to making referrals for patients with the 
purpose of getting further specific support.  
In England, appointment outcomes, on the other hand, are recorded in a different way.  These 
differences somewhat limited the extent to which we could use UK data to inform our analyses. 
5.1.2 DESCRIPTIVE DATA 
The following tables summarise the ECLO activity data and; clearly this restricted our reporting to only 
clinics with ECLOs in place.  Unfortunately, there were no sources of data, other than our survey data 
reported in section 4.3.1 that reveals the activities in these categories that staff other than ECLOs, 
undertake in eye clinics. During the 12 months of the study period (April, 2015 – March, 2016) a total of 
16,887, 2,934, 2,341 and 4,126 meetings with ECLOs were recorded in England, Wales, Scotland and 
Northern Ireland respectively, summarised in Table 5.1. 
TABLE 5.1 · Demographics of patients 
 England Wales Scotland Northern Ireland 
N % N % N % N % 
Total appointments 16,887 - 2,934 - 2,340 - 4,126 - 
Returning patients 2,657 15.73 520 17.72 287 12.20 395 9.57 
Age range (in years) 
0-16 609 3.61 36 1.23 49 2.09 75 1.82 
17-25 340 2.01 26 0.89 57 2.44 66 1.60 
26-39 647 3.83 65 2.22 83 3.55 166 4.02 
40-59 1,854 10.98 226 7.70 267 11.41 557 13.50 
60-69 1,425 8.44 183 6.24 270 11.54 487 11.80 
70-79 2,636 15.61 383 13.05 499 21.32 1,045 25.33 
80-89 4,956 29.35 691 23.55 785 33.55 1,186 28.74 
90+ 2,055 12.17 234 7.98 238 10.17 276 6.69 
Missing information 2,365 14 1090 37.15 92 3.93 268 6.50 
Overall, Welsh patients tend to re-visit the ECLOs more than the other three UK countries. In each 
country, women and people between the ages of 60 and 89 years are the main age groups seen by the 
ECLOs. Table 5.1 also presents the age distributions of patients, with over 50% of patients’ falling into 
the age categories between 60 and 89 years old. Table 5.2 presents information on patients’ living 
arrangement and age distributions for patients who live alone.  
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TABLE 5.2 · Patients' living status and age distributions of patients living alone 
Living status 
England Wales Scotland Northern Ireland 
N % N % N % N % 
Live alone 2,595 15.37 663 22.59 923 39.3  1,239 30.03 
Residential home - - 102 3.48 137 5.9  167 4.05 
Live with family members 2,895 17.14 996 33.94 928 39.6  1,920 56.53 
Others 431 2.55 18 0.61 284 12.1  26 0.63 
Age range of patients who live alone (in years) 
0-16 7 0.27 - - - - - - 
17-25 10 0.39 4 0.6 2 0.22 3 0.24 
26-39 40 1.54 19 2.87 28 3.03 19 1.53 
40-59 222 8.55 36 5.43 74 8.02 121 9.77 
60-69 137 5.28 49 7.39 87 9.43 115 9.28 
70-79 409 15.76 120 18.1 163 17.66 317 25.59 
80-89 1,117 43.04 302 45.55 407 44.1 516 41.65 
90+ 576 22.2 127 19.16 156 16.9 124 10.01 
Missing information 77 2.97 - - - - - - 
TOTAL 2,595 663 923 1,239 
While living with family members is the most frequently recorded living arrangement for patients in all 
four countries over half of patients of age 80 years and above reported living alone.  
The patients’ main eye conditions can be found in Table 5.3.132  
TABLE 5.3 · All patients’ main eye conditions 
Main eye conditions 
England Wales Scotland Northern Ireland 
N % N % N % N % 
AMD 3,394 20.1 975 33.23 1,034 44.19 1,265 30.66 
Glaucoma 1,389 8.22 70 2.39 72 3.08 167 4.05 
Diabetic Retinopathy 405 2.4 206 7.02 191 8.16 1,084 26.27 
Others 4,440 26.29 557 18.98 1,043 44.57 1,158 28.07 
Missing information 7,259 42.99 1,126 38.38 / / 452 10.95 
TOTAL 16,887 2,934 2,340 4,126 
                                                     
132
 It is common that patients have more than one eye disease, and in the data supplied for Wales, Scotland and Northern 
Ireland, patients’ eye conditions are recorded as the main eye condition and also other eye conditions. Data for England is 
slightly different that patients’ eye conditions are all recorded under the same category; therefore the main eye condition for 
English patients is defined as the first one recorded. 
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Age-related Macular Degeneration (AMD) is the most commonly seen eye condition among ECLOs’ 
patients. Please note that as a person may have more than one eye condition and not all patients have 
records of their eye condition the totals will not always add to 100%. Information about patients’ eye 
condition is recorded more completely in Scotland, as shown in Table 5.3, the total percentage of the 
four eye conditions are 100% meaning there is no missing data. From Table 5.3, the Scottish data 
suggest that over 40% of patients that ECLOs contact with have AMD. 
ECLO interactions with patients 
Various interaction types between the ECLOs and patients are adopted, including face to face, on the  
phone and via email, letters and texts. The most frequently recorded types of interaction are meeting 
face to face and communicating on the phone. Table 5.4 also reports the time intervals that the ECLOs 
spend with patients and on behalf of patients.133 
TABLE 5.4 · Interaction type and ECLO's time with patients 
ECLO interaction type 
England Wales Scotland Northern Ireland 
N % N % N % N % 
Face to face 5,093 30.16 955 32.54 1,522 65.01 2,180 52.84 
Telephone 4,457 26.39 907 30.90 722 30.84 1,310 31.75 
Email/letters/text 1,029 3.13 9 0.31 19 0.81 7 0.17 
Time spent with clients 
0-15 mins 4,498 26.63 401 13.66 509 21.74 586 14.2 
16-30 mins 4,334 25.66 1,145 39.01 799 34.13 2,050 49.68 
31-59 mins 2,663 15.77 242 8.25 602 25.72 798 19.34 
1-2 hours 166 0.98 12 0.41 261 11.15 126 3.05 
2+ hours 21 0.12 4 0.14 84 3.59 9 0.22 
Time spent on behalf of clients 
0-15 mins - - 136 4.63 666 28.46 1,063 25.76 
16-30 mins - - 818 27.87 983 42.01 1,479 35.85 
31-60 mins - - 720 24.53 360 15.38 878 21.28 
1-2 hours - - 57 1.94 119 5.09 199 4.82 
2+ hours - - 3 0.10 125 5.34 13 0.32 
TOTAL 16,887 2,934 2,340 4,126 
It can be seen that in most cases, ECLOs will spend 16 minutes to half an hour with patients and also 
another half an hour undertaking activities on behalf of patient if it is necessary. In Table 5.5, ECLOs’  
                                                     
133
Time spent on behalf of patients is not recorded by ECLOs in England. 
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TABLE 5.5 · ECLOs' time spent with patients, by interaction types 
Interaction types by country Mean 
Standard 
deviation 
Min. Max. 
England 
Face to face 2.19 0.78 1 5 
Telephone 1.72 0.75 1 5 
Wales 
Face to face 2 0.65 1 5 
Telephone 1.86 0.57 1 4 
Scotland 
Face to face 2.56 1.13 1 5 
Telephone 2.1 0.84 1 5 
Northern 
Ireland 
Face to face 2.16 0.72 1 5 
Telephone 2.12 0.75 1 5 
time spent with patients has been further specified by interaction types, i.e. face to face and 
telephone.134 The time range typically spent with patients in the four countries, either face to face or 
telephone, is 16-30 minutes.  
Patients’ history of falls and fear of falling 
Tables 5.6 to 5.9 present the patients’ history of falls and fear of falling, by age and living status. No 
statistics are filled in for England as data recorded in England only contains information on fear of falling 
but not on the history of falls.  
From Table 5.6, it can be seen that overall, for patients age 60 years and above, over 40% reported they 
had no previous fall. However, but in Wales, 29% of patients claimed that they had at least one previous 
fall before, the rate three four times greater higher than that in Scotland (7%) and six seven times bigger 
higher than that in Northern Ireland (4%). Table 5.7 presents information on fear of falling for all 
patients, and patients aged 60 years and above It can be seen that the rates of fear of falling increases 
with age as with the this older age group of patients in the four UK countries have higher rates than 
patients overall, with the highest prevalence for this age group in Wales (60%). 
Patients’ main concern and emotional support from ECLOs 
Table 5.10 summarises the main concerns patients express when they see the ECLO; this excluded 
English data since these were not collected in England. For the other three UK countries, variations in 
the patient concerns are observed. For patients in Wales the main concern r related to their 
independence; for patients in Scotland and Northern Ireland the main concern related to their reading 
ability. 135  
The information on provision is not available in England.  The other three countries’ data are 
summarised in Table 5.10. 
                                                     
134
 As time is originally recorded as intervals, time categories are created during data analysis. The order of categories created 
are those presented in Table 5.4. For example, time interval 1 is 0-15 minutes. 
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TABLE 5.6 · Number of falls for all patients and patients aged 60 years and above 
Number of falls for all 
patients 
England Wales Scotland Northern Ireland 
N % N % N % N % 
None - - 769 26.21 1,087 46.45 1,512 36.65 
1 - - 512 17.45 144 6.15 141 3.42 
2 - - 87 2.97 99 4.23 35 0.85 
3 - - 14 0.48 42 1.79 63 1.53 
More than 3 - - 67 2.28 76 3.25 45 1.09 
N/A - - 144 4.91 563 24.06 308 7.46 
Missing information - - 1,341 45.71 329 14.06 2,022 49.01 
TOTAL - 2,934 2,340 4,126 
History of falls for all patients aged 60 and above   
None - - 602 40.38 861 48.05 1,230 41.08 
1 - - 425 28.5 123 6.86 109 3.64 
2 - - 69 4.63 74 4.13 21 0.7 
3 - - 12 0.8 29 1.62 30 1 
More than 3 - - 52 3.49 52 2.9 21 0.7 
N/A - - 119 7.98 435 24.27 162 5.41 
Missing information - - 212 14.22 218 12.17 1,421 47.46 
TOTAL - 1,491 1,792 2,994 
TABLE 5.7 · Fear of falling for all clients and clients aged 60 years and above 
Fear of falling for all 
patients 
England Wales Scotland Northern Ireland 
N % N % N % N % 
No 9,287 54.99 398 13.57 931 39.79 232 5.62 
Yes 670 3.97 1,155 39.37 716 30.60 533 12.92 
Don’t know - - 158 5.39 535 22.86 190 4.60 
Missing information 6,930 41.04 1,223 41.68 158 6.75 3,171 76.85 
TOTAL 16,887 2,934 2,340 4,126 
Fear of falling for all patients aged 60 and above   
No 6,670 60.24 398 19.99 737 41.13 173 5.78 
Yes 561 5.07 940 63.04 540 30.13 338 11.29 
Don’t know - - 128 8.58 423 20.36 118 3.94 
Missing information 3,841 34.69 125 8.38 423 23.6 2,365 78.99 
TOTAL 16,887 1,491 1,792 2,994 
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TABLE 5.8 · History of falls for patients age 60 and above, by living status 
History of falls for 
patients age above 60 
years of age 
Live alone 
Live with family 
members 
Residential home 
Other living 
circumstances 
N % N % N % N % 
Wales   
None 250 41.81 313 43.53 32 33.68 1 11.11 
1 158 26.42 223 31.02 40 42.11 3 33.33 
2 39 6.52 28 3.89 2 2.11 - - 
3 8 1.34 4 0.56 - - - - 
More than 3 20 3.34 29 4.03 2 2.11 - - 
N/A 43 7.19 57 7.93 9 9.47 2 22.22 
Missing information 80 13.38 65 9.04 10 10.53 3 33.33 
TOTAL 598 719 95 9 
Scotland   
None 446 54.86 335 53.86 45 48.39 29 12.78 
1 79 9.72 37 5.95 7 7.53 - - 
2 39 4.8 31 4.98 3 3.23 1 0.44 
3 14 1.72 13 2.09 2 2.15 - - 
More than 3 21 2.58 25 4.02 5 5.38 1 0.44 
N/A 129 15.87 118 18.97 21 22.58 162 71.37 
Missing information 85 10.46 63 10.13 10 10.75 34 14.98 
TOTAL 813 622 93 227 
Northern Ireland   
None 506 47.2 591 47.66 64 41.83 9 69.23 
1 49 4.57 40 3.23 13 8.5 - - 
2 11 1.03 6 0.48 4 2.61 - - 
3 8 0.75 22 1.77 - - - - 
More than 3 17 1.59 4 0.32 - - - - 
N/A 60 5.6 90 7.26 10 6.54 1 7.69 
Missing information 421 39.27 487 39.27 62 40.52 3 23.08 
TOTAL 1,072 1,240 153 13 
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TABLE 5.9 · Fear of falling for patients age 60 and above, by living status 
Fear of falling 
Live alone 
Live with family 
members 
Residential home 
Other living 
circumstances 
N % N % N % N % 
England   
No 2,349 90.52 2,658 91.81 - - 371 86.08 
Yes 246 9.48 237 8.19 - - 60 13.92 
Don’t know - - - - - - - - 
Missing information - - - - - - - - 
TOTAL 2,237 1,815 - - 
Wales   
No 109 18.23 171 23.78 11 11.58 1 11.11 
Yes 398 66.56 461 64.12 73 76.84 4 44.44 
Don’t know 48 8.03 61 8.48 8 8.42 3 33.33 
Missing information 43 7.19 26 3.62 3 3.16 1 11.11 
TOTAL 598 719 95 9 
Scotland   
No 355 43.67 304 48.87 36 38.71 35 15.42 
Yes 302 37.15 195 31.35 34 36.56 9 3.96 
Don’t know 114 14.02 106 17.04 21 22.58 171 75.33 
Missing information 42 5.17 17 2.73 2 2.15 12 5.29 
TOTAL 813 622 93 227 
Northern Ireland   
No 81 7.56 68 5.48 5 3.27 2 15.38 
Yes 155 14.46 162 13.06 13 8.5 1 7.69 
Don’t know 47 4.38 61 4.92 8 5.23 1 7.69 
Missing information 789 73.6 949 76.53 127 83.01 9 69.23 
TOTAL 1,072 1,240 153 13 
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TABLE 5.10 · Patients’ main issue and emotional support 
Patients' main issue 
England Wales Scotland Northern Ireland 
N % N % N % N % 
Anxiety/emotional distress - - 455 15.51 286 12.22 150 3.64 
Loss independence - - 896 30.54 551 23.55 288 6.98 
Reading - - 599 20.42 682 29.15 759 18.4 
TOTAL - 2,934 2,340 4,126 
Emotional support given to all patients   
No - - 277 9.44 546 23.33 97 2.35 
Yes - - 1,471 50.14 1,651 70.56 3,182 77.12 
Missing information - - 1,186 40.42 143 6.11 847 20.53 
TOTAL - 2,934 2,340 4,126 
Emotional support given to patients have fear of falling   
No - - 98 8.5 114 15.9 28 5.3 
Yes - - 1017 88.0 577 80.6 485 90.9 
Missing information - - 40 3.5 25 3.5 20 3.8 
TOTAL - 1,155 716 533 
Emotional support given to patients have anxiety/emotional distress (of appointments)  
No - - 10 2.2 7 2.5 1 0.7 
Yes - - 413 90.8 273 95.4 143 95.3 
Missing information - - 32 7.0  6 2.1 6 4.0  
TOTAL - 455 286 150 
For those patients reporting anxiety/emotional distress136, the majority (over 90% in Wales, Scotland 
and Northern Ireland) received emotional support from the ECLOs.  
Consequences for patients after contact with ECLO 
Table 5.11 presents the outcome after contact with ECLOs in Wales, Scotland and Northern Ireland by 
the categories: informed about, signposted to and referred to, and  further refined into 7 categories, 
including RNIB services, eye related services, health related services, CVI information and registration, 
rehabilitation, falls support and other services/support.129  
The summaries in Table 5.11 show that the ECLOs inform patients about eye related services. 
Particularly in Northern Ireland, over 70% of patients received information about eye related services.  
                                                     
136 The anxiety/emotional distress the patients report to the ECLOs may not be clinically diagnosed. 
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The more ‘interventional’ category – ‘referred’ is provided less often.  This may relate to the ECLO 
perception of patient need or the ability of the ECLO to make a referral in a direct sense, whereas 
‘informing about’ and ‘signposting to’ are more easily accomplished.  Especially in Wales, referral rate to 
all services or support are lower than 12% and only 6.5% of patients are referred to eye related services.  
TABLE 5.11 · All patients appointment outcomes: Wales, Scotland and Northern Ireland 
Appointment outcomes 
RNIB 
services 
Eye 
related 
services 
Health 
related 
services 
CVI info 
and 
registra-
tion 
Rehabili-
tation 
Falls 
support 
Other 
services 
or 
support 
Wales   
Informed about 14.72 31.14 0.99 20.41 17.99 5.72 39.91 
Signposted to 7.67 14.62 3.10 0.92 1.43 1.06 11.45 
Referred to 11.72 6.41 2.49 1.09 9.27 0.10 10.57 
Scotland   
Informed about 21.02 33.75 0.26 12.05 24.99 2.22 40.90 
Signposted to 13.50 14.78 1.88 1.07 9.10 0.51 46.07 
Referred to 12.47 11.62 0.94 1.20 15.63 1.15 44.69 
Northern Ireland   
Informed about 25.45 74.77 0.02 17.62 42.07 0.82 51.45 
Signposted to 3.13 18.13 0.12 3.78 6.93 0.22 17.23 
Referred to 20.87 32.72 0.19 10.52 22.49 0.07 22.78 
Although data collected in England does not categorize the outcomes, it records information on 
patients’ CVI completion status as one of the outcomes, which is not collected in the other UK countries.  
From the English data we see that the rate of CVI completion and time spent on completing patients’ 
CVI is seen. From Table 5.12, it can be seen that 22% of patients in England have their CVI completed 
during their contact with an ECLO and this process takes on average 30 minutes to finish.  There is no 
reason to believe that this will vary in any other UK country. 
TABLE 5.12 · CVI completion and time spent: England 
Time spent with clients 
(in mins) 
"Yes"/total % Mean Std. Dev. Min Max 
CVI completed 2712/11970 22.66 31.38 18.78 5 210 
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5.2 PATIENT SURVEY DATA:  HEALTH RELATED QUALITY OF LIFE 
5.2.1 SUMMARY 
Background 
Data collected from the patient survey includes HRQoL outcomes (including EQ-5D-5L) from a number 
of perspectives revealing differences in HRQoL between different eye conditions, types of support 
required, received and not received, and the time since diagnosis, scores of the different dimensions of 
HRQoL, and the differences between the sub groups of the people that responded to the patient 
survey.   
The “robustness” (i.e. how confident we can be of the results) of these differences in HRQoL between 
patient conditions and support categories were then tested via statistical tests (i.e. Student t-tests). 
The p-values of the t-tests indicate the probability that the samples have the same mean value (i.e. are 
similar). Typically, a maximum p-value cut-off of 0.05 (i.e. 95% probability) is used as the basis of 
accepting the robustness of the differences of the data; hence a p-value above this threshold (i.e. less 
than a 95% probability) suggests that the differences are not significant enough to accept with 
confidence. However, this may also be influenced by the size of the patient population, with larger 
sizes providing more robust outcomes. 
Whilst the results may suggest particular findings, it is important to note that the patient numbers 
responding initially to the survey were large, the patient numbers at follow up are smaller than those 
who contributed at baseline. Thus, where trends can be observed this suggests that further data 
collection may be worthwhile to get enough data to be able to confirm the observed trends. 
Key findings 
 HRQoL (mean EQ-5D scores) were lowest for Diabetic Retinopathy patients (mean 0.751, SD 
0.322), and these patients were recorded as receiving the lowest level of support from either and 
ECLO or other staff.  For other eye conditions (Dry and Wet AMD, and Glaucoma) those receiving 
ECLO support had slightly lower HRQoL than those seen by other staff. 
 Patients supported by ECLOs or non-ECLOs showed a decline in HRQoL captured in the utility 
scores at follow-up (0.011 and 0.07 respectively for the utility scores). However, the VAS scores 
showed a small increase at follow-up for those seeing an ECLO, with differences not being 
statistically robust and thus warranting further study with larger patient samples sizes. 
 For those patients who stated they needed support but did not receive it, and how they fared at 
the point of follow-up, those stating they needed support had lower baseline HRQoL (EQ-5D 
utility and VAS scores) compared with those not needing it. This may suggest that there are 
patients attending the eye clinics who expressed a need for support and did not receive it who 
are missing out on the ECLO services and support. 
 While there was a small (non-significant) decline in HRQoL scores at follow-up for patients 
supported by an ECLO or other staff, the decline was lower for those visiting an ECLO site in 
comparison to non-ECLO sites, possibility indicating that having an ECLO on-site may reduce the 
size or rate of the decline in patients’ HRQoL – and that having an ECLO on-site may influence an 
improvement in the environment of support in general within eye clinics. 
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 When changes to HRQoL after diagnosis were examined, a small improvement in HRQoL over the 
first 6 months post-diagnosis, followed by a small decline in the following 6 months was shown. 
This may suggest that the effect of diagnosis and initial treatment helps to improve HRQoL, but a 
later decline may be due to a decline in the eye condition itself, or that patient care has a lesser 
impact over time. 
 The differences of scores for the 5 domains of the EQ-5D between the whole study participant 
population and those who have received ECLO support indicates there is a proportion of all study 
patients that have moderate to severe problems with mobility, self-care, their usual activities, 
pain and discomfort, and depression and anxiety. In addition, data show that the ECLO service is 
providing support to patients with these needs. 
 Of all study patients recording moderate and severe problems with anxiety/depression (n = 29 
and 11 respectively), over half have received support from an ECLO, and of those reporting 
extreme problems (n=2), all received ECLO support, suggesting that the ECLOs are targeting the 
people who need support and potentially people needing support are engaging with ECLOs. 
 For the four other domains of the EQ-5D (mobility, self-care, usual activities, and pain and 
discomfort) ECLOs see less than half of the study population that report moderate to severe 
levels of these impairments, suggesting that there are patients who may need help who have no 
ECLO contact, and that there is a need for more ECLO or ECLO-type support at study sites. 
_____________________________________________________________________________________ 
In this section, we report data collected from the  patient survey; this HRQoL outcomes (including EQ-
5D) from a number of perspectives revealing differences between HRQoL between different types of eye 
conditions, types of support required, received and not received, and the f the time since diagnosis.  We 
also report the scores of the different domains of the EQ-5D (mobility, self-care, usual activities, 
pain/discomfort and depression/anxiety) and the differences between the sub groups of the people that 
responded to the patient survey. 
Within the analysis, we also looked at the robustness of the differences in HRQoL between patient 
conditions and ECLO support categories. This measure of robustness was obtained via a statistical test 
termed the Student t-test. The resulting p-values of the t-tests indicate the probability that the samples 
have the same mean value (i.e. differences in means are ‘not statistically significant’). Typically, a 
maximum p-value cut-off of up to 0.10 is used as the basis of accepting the robustness of the differences 
of the data; hence a p-value above this threshold suggests that the differences in means between the 
groups are not ‘statistically significant enough’ to accept with confidence. However, this measure of 
robustness may also be influenced by the size of the patient population, with larger sizes enabling 
stronger evidence.  
Whilst the results may indicate particular findings, it is important to note that the patient numbers 
responding initially to the survey were large, the patient numbers at follow up are smaller than those 
who contributed at baseline.   This was due to study closure which resulted in truncated data.  The 
patient numbers reduced even further after sub-grouping the patients further. Thus some of our 
findings are tentative and should be considered with some caution.  This is important when interpreting 
the results from a statistical standpoint, as comparing small numbers means that statistical power to 
detect ‘true’ differences between groups is lost.  However, where trends can be observed this suggests 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 87 
that further data collection may be worthwhile to get enough data to be able to confirm the observed 
trends. 
5.2.2 EYE CONDITION AND SUPPORT TYPE 
Tables 4.13a and 4.13b show the number of participants, their main eye condition and whether they 
received support from an ECLO or that this support was substituted by another member of staff.  
EQ-5D scores show that those with Diabetic Retinopathy have the lowest mean score (mean 0.751, SD 
0.322) indicating that, on average, these patients have a lower HRQoL than those with other visual 
impairments. The number of Diabetic Neuropathy patients recorded as receiving support is relatively 
small, whether by an ECLO (n=8) or other staff member (n=1).  However, this indicates that EQ-5D 
scores for those with Diabetic Retinopathy receiving support is far lower than other patients, indicating 
that those who have a much lower HRQoL are receiving ECLO support (mean 0.542) or seeing other staff 
(mean -0.016).    
For other eye conditions (Dry and Wet AMD, and Glaucoma) it appears that those receiving ECLO 
support had a slightly lower HRQoL than those seen by other staff although these are not greatly 
different. These scores (ranging from mean 0.726 to 0.853) are also comparable to the national UK 
population average EQ-5D scores of 0.81.137 
The findings of note between Table 5.13a reporting the EQ-5D utility scores and Table 5.13b reporting 
the VAS scores are the way the two sets of scores are recorded and calculated.  The EQ-5D utility score 
is calculated with a scoring algorithm which is derived from surveys of the general population whereas 
the VAS score is a direct representation of how individual patients score their state of health on a scale 
of 1-100 on the day.  It seems for the survey respondents that patients tend to rate themselves with a 
far lower score with the VAS than is indicated by the 5-dimension EQ-5D utility score.  VAS scores 
represent an individual’s perception of their own health state so the data we see here shows that the 
general population valuation of the health states that visually impaired people experience is higher than  
ECLO and non-ECLO Support 
Tables 4.14a and 4.14b provide a baseline and follow-up results for those receiving ECLO and non-ECLO 
support. Both patients supported by ECLOs and non-ECLOs show a decline in HRQoL captured in the 
utility scores at follow-up (0.011 and 0.07 respectively for the utility scores). However, the VAS scores 
(i.e. the subjective experience of the respondent) show a small increase at follow-up for those seeing an 
ECLO. Whilst these are interesting results which suggest positive impacts of ECLOs, none of these 
differences are statistically significant– that is, they are not robust and we cannot be sure without 
certainty that they have not occurred by chance. Thus further research will be needed in order to assess 
whether the decline in EQ-5D scores are ‘tempered’ or strengthened as a direct influence of ECLO 
support. Subsequent analysis in this report explores this further. 
                                                     
137
 Janssen B and Szende A (2014) ‘Population norms for the EQ-5D – Self-Reported Population Health: An International 
Perspective based on EQ-5D’ Springer pp.19-30 
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TABLE 5.13a · Baseline EQ5D scores for patients according to their main eye condition138 
 All Support received from ECLO Support from other staff 
N Mn SD Min Max N Mn SD Min Max N Mn SD Min Max 
Diabetic Retinopathy 23 0.751 0.322 -0.016 1 8 0.542 0.326 0.149 1 1 -0.016 / -0.016 -0.016 
Dry AMD 17 0.807 0.173 0.294 1 12 0.790 0.193 0.294 1 5 0.848 0.123 0.661 1 
Wet AMD 125 0.803 0.245 -0.015 1 25 0.739 0.224 0.125 1 27 0.853 0.251 0.061 1 
Glaucoma 27 0.787 0.221 0.203 1 9 0.726 0.222 0.335 1 2 0.849 0.214 0.698 1 
Other 65 0.823 0.235 -0.062 1 18 0.713 0.248 0.19 1 2 0.394 0.645 -0.062 0.85 
TABLE 5.13b · Baseline VAS scores for patients according to their main eye condition 
 All Support received from ECLO Support from other staff 
N Mn SD Min Max N Mn SD Min Max N Mn SD Min Max 
Diabetic Retinopathy 23 58.870 24.558 10 95 8 43.000 27.087 10 80 1 40.000 / 40 40 
Dry AMD 17 55.294 25.585 5 100 12 47.917 26.238 5 100 5 73.000 13.038 60 90 
Wet AMD 125 66.344 18.201 20 100 25 62.320 17.016 35 95 27 66.481 19.700 30 100 
Glaucoma 27 67.667 17.422 25 100 9 61.667 21.065 25 100 2 80.000 14.142 70 90 
Other 67 70.597 22.422 10 100 18 63.400 27.157 10 100 2 52.500 31.820 30 75 
 
                                                     
138
 Mn = Mean value, SD = Standard Deviation. 
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TABLE 5.14a · Patients' EQ-5D scores for those receiving support from ECLO and other staff 
EQ-5D 
Support received from ECLO Support received from other staff 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 0.710 0.247 0.758 0.125 1 0.804 0.300 1 -0.062 1 
TOTAL 73 37 
Follow-up 0.699 0.222 0.683 0.076 1 0.735 0.302 0.747 -0.122 1 
TOTAL 35 17 
Difference -0.011 0.208 -0.085 -0.397 0.51 -0.070 0.274 0 -0.831 0.396 
T-TEST OF DIFFERENCE 0.207 0.306 
TABLE 5.14b · VAS for those receiving support from ECLO and other staff 
VAS 
Support received from ECLO Support received from other staff 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 58.667 24.146 60 5 100 66.622 19.474 70 30 100 
TOTAL 73 37 
Follow-up 64.800 25.430 70 0 100 64.706 23.417 70 20 95 
TOTAL 35 17 
Difference 6.133 37.587 0 -100 95 -1.916 24.618 -5 -70 40 
T-TEST OF DIFFERENCE 0.38 0.274 
Support required and received 
Table 5.15 shows EQ-5D utility and VAS scores in relation to the support patients require and receive.   
TABLE 5.15 · Patients numbers by category, EQ-5D 
Patient numbers N % 
EQ-5D Scores 
Baseline (Mean) 
VAS 
Receive support from ECLO 73 28.29 0.710 58.667 
Support needed and receive 
from other staff 
37 14.02 0.804 66.622 
Support needed but not 
received 
30 11.36 0.756 65.667 
Support not needed 118 44.7 0.865 71.263 
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This indicates that those who see an ECLO have the lowest average utility and VAS scores (mean utility = 
0.710, mean VAS = 58.667), indicating that ECLOs are seeing those with a lower HRQoL, which suggests 
appropriate targeting of the ECLO activity.  This table also shows that there are a number of patients 
with the lower mean utility scores who reported that they needed support but had not received it 
(n=30, mean utility scores = 0.756, mean VAS =66.622).   These patients report lower scores than those 
receiving support from other substitute staff, although this difference should be viewed with caution as 
it does not reach statistical significance at the 0.1 (90%) or 0.05 (95%) levels. 
Tables 4.16a and 4.16b provide further information for those patients who stated they needed support 
but did not receive it, and how they fared at the point of follow-up.  Those stating they needed support 
having lower baseline scores (EQ-5D utility = 0.756, VAS = 65.667 compared with those not needing 
support (EQ-5D utility = 0.865, VAS = 71.663), which suggests that there are patients attending the eye 
clinics who expressed a need for support and did not receive it and have a lower HRQoL  than those who 
did not need support. 
TABLE 5.16a · Patients' EQ-5D scores, support not received and not needed 
EQ-5D 
Support not received Support not needed 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 0.756 0.274 0.857 -0.015 1 0.865 0.196 1 0.175 1 
TOTAL 30 118 
Follow-up 0.679 0.288 0.692 0.161 1 0.873 0.169 1 0.427 1 
TOTAL 10 42 
Difference 0.051 0.247 0.000 -0.445 0.444 -0.013 0.169 0 -0.416 0.416 
T-TEST OF DIFFERENCE 0.529 0.616 
TABLE 5.16b · Patients’ VAS scores, support not received and not needed 
VAS 
Support not received Support not needed 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 65.667 17.307 72.5 35 100 71.263 18.228 75 10 100 
TOTAL 30 118 
Follow-up 67.000 13.375 72.5 50 85 80.886 16.868 80 40 100 
TOTAL 10 44 
Difference 1.333 15.986 5 -25 30 9.623 14.179 5 -25 40 
T-TEST OF DIFFERENCE 0.349 0.004 
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While the EQ-5D utility scores show a small decline in HRQoL at follow-up, for those who had not 
received support, the VAS scores show a small increase, however, without statistical significance.  For 
those patients who do not require support, the VAS scores show an increase over the study period with 
a relatively high degree of statistical robustness. 
ECLO and non-ECLO sites 
In order to explore the explore the effect of having an ECLO on-site in an eye clinic, the results 
summarised in Table 5.17a shows the HRQoL of patients over the study period at ECLO and non-ECLO 
sites. While the previous data show there was a small (non-significant) decline in utility scores at follow-
up for patients supported by an ECLO or other staff, results in Table 5.17a shows that this decline is 
attenuated for those visiting an ECLO site (mean EQ-5D utility score = -0.016, no significant evidence of 
difference between visits) in comparison to non-ECLO sites (mean EQ-5D utility = -0.076 weak evidence 
of significance differences between visits).  This may indicate that having an ECLO on-site may reduce 
the size or rate of the decline in patients’ HRQoL – further suggesting that having an ECLO on-site may 
influence an environment of support in general within eye clinics. 
TABLE 5.17a · Patients EQ-5D scores for those attending an ECLO site and non-ECLO site 
EQ-5D 
ECLO site Non-ECLO site 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 0.782 0.236 0.836 -0.015 1 0.844 0.263 1 -0.062 1 
TOTAL 185 73 
Follow-up 0.777 0.237 0.829 -0.122 1 0.759 0.244 0.826 0.161 1 
TOTAL 84 20 
Difference -0.015 0.213 0 -0.831 0.51 -0.076 0.191 -0.084 -0.445 0.32 
T-TEST OF DIFFERENCE 0.508 0.089 
Time of Diagnosis 
The following table (Table 5.17b) provides results on the change in HRQoL over the study period 
between those recently diagnosed in the previous 3 months, 4-6 months, 7-12 months and beyond 12 
months previously.   The purpose of this analysis is to explore the difference in the effect of the time 
since diagnosis on patients’ HRQoL. 
The main observation of these results is the change in EQ-5D utility scores for the four groups (change in 
HRQoL for diagnosis at <3months = 0.086, 4-6months = 0.118, 7-12months = -0.080, >12months = -
0.047).  This shows that there is an initial small improvement in HRQoL over the first 6 months post-
diagnosis, followed by a small decline in the following 6 months, which may suggest that the effect of 
diagnosis and initial treatment helps to improve HRQoL.  The subsequent decline, albeit minor, may be 
due to a decline in the eye condition itself, or that patient care has a lesser impact over time. 
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TABLE 5.17b · Patients' EQ-5D time from diagnosis 
EQ-5D 
Eye condition diagnosed in the past 
three months 
Eye condition diagnosed 4-6 months ago 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 0.784 0.248 0.879 0.203 1 0.814 0.271 1 0.125 1 
TOTAL 28 20 
Follow-up 0.887 0.190 1 0.427 1 0.932 0.098 1 0.784 1 
TOTAL 10 5 
Difference 0.086 0.192 0.061 -0.163 0.416 0.118 0.222 0 0 0.51 
EQ-5D 
Eye condition diagnosed 7-12 months 
ago 
Eye condition diagnosed more than 12 
months ago 
Mean St. Dev 
Media
n 
Min Max Mean St. Dev 
Media
n 
Min Max 
Baseline 0.870 0.189 0.953 0.149 1 0.789 0.252 0.848 -0.062 1 
TOTAL 34 166 
Follow-up 0.865 0.138 0.837 0.654 1 0.739 0.253 0.787 -0.122 1 
TOTAL 9 74 
Difference -0.080 0.131 0 -0.346 0.028 -0.047 0.217 -0.004 -0.831 0.444 
Domains of EQ-5D 
The following table and charts (Table 5.18 and Figure 5.1) shows each of the 5 domains of the EQ-5D 
and the differences between the whole study participant population and those who have received ECLO 
support. Primarily, these tables and figures show that there is a proportion of all study patients that 
have moderate to severe problems with mobility, self-care, their usual activities, pain and discomfort, 
and depression and anxiety – and that the ECLO service is providing support to patients with these 
needs. 
As we are aware from the literature recorded in this report, depression and anxiety can significantly 
affect those with vision impairment, thus, our results are interesting.  Of all study patients recording 
moderate and severe problems with anxiety/depression (n = 29 and 11 respectively), over half have 
received support from an ECLO, and of those reporting extreme problems (n=2), all received ECLO 
support. This suggests that the ECLOs are targeting the people who need support and potentially people 
who identify themselves as needing support are engaging with ECLOs. For the four other domains of the 
EQ-5D, ECLOs see less than half of the study population that report moderate to severe levels of  
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TABLE 5.18 · Dimensions of the EQ-5D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
EQ5D 
Mobility 
All patients 
Patients with 
contact with 
ECLOs 
N % N % 
None 161 62.16 41 56.16 
Slight 36 13.9 12 16.44 
Moderate 38 14.67 12 16.44 
Severe 20 7.72 6 8.22 
Extreme 4 1.54 2 2.74 
TOTAL 259 100 73 100 
EQ5D 
Self care 
All patients 
Patients with 
contact with 
ECLOs 
N % N % 
None 212 81.85 54 73.97 
Slight 21 8.11 7 9.59 
Moderate 20 7.72 9 12.33 
Severe 2 0.77 2 2.74 
Extreme 4 1.54 1 1.37 
TOTAL 259 100 73 100 
EQ5D 
Usual 
Activities 
All patients 
Patients with 
contact with 
ECLOs 
N % N % 
None 172 66.41 36 49.32 
Slight 45 17.37 18 24.66 
Moderate 27 10.42 10 13.7 
Severe 8 3.09 6 8.22 
Extreme 7 2.7 3 4.11 
TOTAL 259 100 73 100 
EQ5D 
Pain / 
Discomfort 
All patients 
Patients with 
contact with 
ECLOs 
N % N % 
None 177 68.34 41 56.16 
Slight 31 11.97 17 23.29 
Moderate 29 11.2 8 10.96 
Severe 20 7.72 6 8.22 
Extreme 2 0.77 1 1.37 
TOTAL 259 100 73 100 
EQ5D 
Anxiety / 
Depression 
All patients 
Patients with 
contact with 
ECLOs 
N % N % 
None 185 71.71 39 54.17 
Slight 29 11.24 7 9.72 
Moderate 31 12.02 18 25 
Severe 11 4.26 6 8.33 
Extreme 2 0.78 2 2.78 
TOTAL 258 100 72 100 
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FIGURE 5.1  · Dimensions of the EQ-5D 
 
 
 
 
 
 
 
 
 
 
 
  
0 
10 
20 
30 
40 
50 
60 
70 
None Slight Moderate Severe Extreme 
P
e
rc
e
n
ta
ge
 o
f 
P
ar
ti
ci
p
an
ts
 
Reported levels of problems with Mobility  
all patients 
patients contact with ECLOs 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
None Slight Moderate Severe Extreme 
P
e
rc
e
n
ta
ge
 o
f 
P
ar
ti
ci
p
an
ts
 
Reported levels of problems with Self-Care 
all patients 
patients contact with ECLOs 
0 
10 
20 
30 
40 
50 
60 
70 
None Slight Moderate Severe Extreme 
P
e
rc
e
n
ta
ge
 o
f 
P
ar
ti
ci
p
an
ts
 
Reported levels of problems with Usual 
Activities 
all patients 
patients contact with ECLOs 
0 
10 
20 
30 
40 
50 
60 
70 
80 
None Slight Moderate Severe Extreme 
P
e
rc
e
n
ta
ge
 o
f 
P
ar
ti
ci
p
an
ts
 
Reported levels of problems with 
Pain/Discomfort 
all patients 
patients contact with ECLOs 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017         Page 95 
mobility, self-care, usual activities, and pain and discomfort, suggesting that there may be patients who 
may need help who have no ECLO contact, and that there is a need for more ECLO or ECLO-type support 
at study sites. These results need to be viewed with caution as within this population may be people 
who have stated they do not need support.  Nevertheless, we have some signals as we observe from 
other results provided in this report, it may be that ECLOs help to maintain the level of HRQoL for those 
with (worsening eye) conditions, and this table indicates that the domains of HRQoL that may be key 
signalling the need for the involvement of ECLOs in preserving these levels.   
5.3 THE COST OF AN ECLO IN THE NHS SETTING 
5.3.1 SUMMARY 
Background 
The objective of this section was to explore how and if the ECLO might release cash or capacity in the 
NHS clinic setting by understanding what the staff in the absence of an ECLO might cost the NHS.  
We also looked at the data from the staff survey, to assess how much of staff time is spent providing 
the kinds of support to patients that ECLOs provide, so that this could be compared between sites and 
crucially act as inputs to the economic model which explored the potential of the ECLO to release staff 
capacity. 
Key findings – cost to NHS 
 An estimate of £17.94 per patient per ECLO contact was reported in the literature; furthermore, 
approximately £247.76 for ECLO intervention over a person’s lifetime was estimated for 
proportions of people registered as severely sight impaired at each age group, assuming an ECLO 
is seen once per year. However these figures do not give the whole picture.   
 There is a somewhat different cost issue as we are looking at a substitution of ECLOs for NHS 
staff and existing clinics to deliver ‘ECLO type’ support.  Thus the opportunity cost to the NHS of 
not having an ECLO is the staff member who would otherwise be employed and/the equivalent 
NHS pay band. 
Key findings – staff survey 
In total 30 study sites were visited through the course of the study, from which 20 contributed to the 
staff survey. Analyses were conducted on time spent by staff in providing emotional support, 
advocacy and certification and registration. Data collected in each category is described below: 
 Emotional support (“I have spent time listening to patients/carers, talking through their worries 
or concerns”) 
Consultant ophthalmologists at ECLO sites reported provided marginally more patients per week 
with emotional support than non ECLO sites; clinical nurse specialists and ophthalmic nurses at 
ECLO sites reported providing more patients per week with emotional support than non ECLO 
sites. Staff nurses and sisters at ECLO sites reported seeing fewer patients per week for 
emotional support than non ECLO sites but spent more time providing emotional support in 
those contacts than non ECLO sites. 
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 Advocacy (“I have helped people to have their voices heard; to secure their rights and to obtain 
the support they need”)  
Consultant ophthalmologists at both ECLO and non ECLO sites reported low or no levels of 
advocacy; both clinical nurse specialists and ophthalmic nurses and staff nurses and sisters at 
ECLO sites reported low levels of advocacy support per week for patients with on average less 
than 1 patient receiving support of this nature, while non ECLO sites did not report advocacy 
support. 
 Certification and registration (“I have informed and advised patients about Certification and 
Registration and its benefits. I have helped patients in a practical way by helping to fill in forms, 
for example”).  
Consultant ophthalmologists and staff nurses and sisters at both ECLO and non ECLO sites saw a 
similar number of patients per week, supporting certification and registration but ECLO sites 
reported more time spent supporting patients with practical help such as form filling; clinical 
nurse specialists and ophthalmic nurses at ECLO sites reported marginally more support for 
patients per week supporting certification and registration than non ECLO sites.  
_____________________________________________________________________________________ 
To explore whether the ECLO might release cash or capacity in the NHS clinic setting we need to 
understand what the equivalent of an ECLO might cost the NHS compared if they undertook those 
‘ECLO-like’ activities (the opportunity cost). The Personal Social Services Research Unit (PSSRU) produce 
an annual account – Unit Costs of Health and Social Care – of the roles within the NHS and their mean 
salaries and salary on-costs, overheads, etc. based on the average of over 230 English hospitals and NHS 
institutions.139 This seems the most appropriate source to establish these substitution costs. We 
acknowledge that there are wide variations throughout the UK, but this is considered as a 
representative guide for deriving an hourly rate for staff that reflects the overall cost to the NHS.  The 
rates shown in Table 5.19 here are taken from this source.    
For some of the roles in the eye clinic cost per patient contact has been calculated where the average 
time spent per patient is relatively consistent (i.e. the role of nurses).  For others, a cost per working 
hour is used as there is a wide variation in the time spent on their patient-related activities.   Unlike 
nurse rates, the hourly rates for ‘community-based scientific and professional staff’ which equate to 
ECLO NHS rates reflect time that an ECLO has spent at the clinic including the various salary on-costs and 
overheads that apply, and is also the rate used for work done on behalf of the client (including phone 
calls, paperwork like CVI registration, travel, etc.) that may take place at other community-based 
institutions.    
It should also be considered that, when ECLOs are working in the clinic environment, they will be 
affected by the some of the salary on-costs and overheads of the hospital, raising their hourly rate. The 
hourly rate presented here is an underestimate of the true cost of the ‘NHS employed’ ECLO.
                                                     
139
 Curtis and Burns (2015), op. cit – accessed from: http://www.pssru.ac.uk/project-pages/unit-costs/2015/  
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TABLE 5.19 · Unit costs of ECLO and NHS staff140 
ANNUAL & UNIT COSTS  
Community-based scientific and professional staff  Hospital-based staff 
(p.165) (p.277) (p.233) (p.234) (p.235) 
Band 4 Band 5 Band 6 Band 7 Band 8a Band 8b 
Nurse: 
Band 6 
Nurse: 
Band 7 
Nurse: 
Band 8a 
Registrar 
Doctors 
Associate 
Specialist 
Consult’nt 
Surgical 
Wages/salary £21,248 £23,284 £31,070 £38,525 £46,038 £55,276 £31,914 £38,332 £45,240 £37,329 £78,217 £87,229 
Salary on-costs £4,809 £5,375 £7,540 £9,612 £11,701 £14,269 £7,774 £9,558 £11,479 £9,279 £20,646 £23,152 
Overheads: Management, 
admin and estates staff 
£6,384 £10,948 £9,459 £11,794 £14,146 £17,038 £7,677 £9,257 £10,980 £9,741 £20,662 £23,070 
Overheads: Non-staff £9,954 £14,014 £14,749 £18,388 £22,056 £26,566 £16,687 £20,121 £23,865 £22,792 £48,344 £53,976 
Capital overheads £4,370 £4,370 £4,370 £4,370 £4,370 £4,370 £3,687 £3,687 £3,687 £4,244 £4,244 £5,101 
Working time 
42.4 weeks per year, 37.5 hours 
per week (1590 hours) 
42.4 wks per year, 48 hrs per 
week 
42.4 wks per year, 40 hrs per 
week 
42.4 wks per year, 43.3 hrs per 
week 
Cost per working hour  £29 £36 £44 £52 £62 £74 £45 £54 £63 £41 £101 £105 
Cost per patient contact - - - - - - £109 £131 £154 - - - 
  
            
NOTE: Hourly and patient contact rates do NOT include qualification costs or travel expenses 
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Where employed by the NHS, ECLOs are typically banded at Grade 4 or 5. As we can see in Table 5.20 
below, the rates for nurses and community professional staff (including the ECLOs) are very similar (e.g. 
Band 6 nurse and community professional = £44 and £45 respectively) so when similarly graded NHS 
staff are doing the ‘ECLO-like activities’ at a clinic, the cost difference will be negligible.  In cases where, 
for example, a Band 6 nurse (£45/hour) is ‘released’ by use of a Band 4 ECLO (£29/hour), this implies 
that there would be a cost saving for that hour. However, in terms of opportunity cost and from the 
economic perspective, this represents a release of resources if this nurse can carry on other duties with 
that time.   A release of cash is only available if the nurse has hours reduced and no salary costs are 
incurred. Thus the time released must be a meaningful and useful amount of time in which another task 
or activity can be delivered or sufficient time that would mean that a staff member can be released from 
working in the clinic and the staffing costs avoided.   
At the practical level while some of this hour may be released from this nurse’s time, during the clinic it 
is likely that the nurse may still continue to provide a similar service to patients and that the ECLO 
provides additional support to these patients.   Therefore, assumptions of ECLOs releasing time for other 
NHS staff should be considered with caution, as the ECLO may provide additional value to these patients 
in this time while freeing-up a short amount of time for substitute staff.  It may be that ECLOs would 
need to carry out a number of hours work at the clinic in order to free-up a meaningful length of time 
for the nurse role – for example 2-3 hours (or the duration of the clinic) so that the nurse can perform a 
series of other activities in the clinic or elsewhere. 
The literature review highlighted a study undertaken in 2013 of the forms of provision and cost of ECLO 
services.141 An estimate of £17.94 per patient per ECLO contact was reported; furthermore, 
approximately £247.76 for ECLO intervention over a person’s lifetime was estimated for proportions of 
people registered as severely sight impaired at each age group, assuming an ECLO is seen once per year. 
We did not use these figures as we have a somewhat different cost issue in front of us; we are looking at 
a substitution of ECLOs for NHS staff and existing clinics, into which the ECLO service would be 
added/increased.  Thus the opportunity cost to the NHS is the staff member who would otherwise be 
employed and/the equivalent NHS pay band. Additionally the ECLO activity data suggests more frequent 
meetings (between 9% and 17% meetings reported in the data over the 12 months were ‘follow up’ 
meetings) with patients than the one per year suggested in this publication. 
5.3.2 STAFF SURVEY - DESCRIPTION 
In total 30 study sites were visited through the course of the study, from which 20 contributed to the 
staff survey.  The survey was opportunistic and depended very much on the busyness of the clinic and 
the willingness of staff to engage with the researchers. The respondents to the survey are summarised 
in Table 5.20 which also shows how we grouped the staff from the survey responses to role and grade.  
Table 5.21 reports the number of staff responses per staff group by ‘ECLO’ and ‘no ECLO’ site and shows 
that 78 members of staff contributed from ECLO sites compared to 20 members of staff from sites 
without ECLO. Analysis of the nine areas of patient support offered to patients by clinics was only 
conducted for staff groups where 5 or more members of staff provided responses to questions.  
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TABLE 5.20 · Analysis of staff groups responding to the survey 
Staff Group for analysis Free Text response to survey Staff grade 
Consultant 
Ophthalmologist 
Consultant, Consultant Ophthalmologist 
No grade was 
entered 
Clinical Nurse Specialist 
/Ophthalmic Nurse 
Matron, Nurse clinic manager, Nurse manager, Nurse 
practitioner, Ophthalmology nurse, Senior charge nurse 
Clinical nurse specialist, Ophthalmic nurse 
Senior nurse, Ophthalmic nurse, Sister eye clinic 
Grades 5,6,7,8 
Senior Optometrist / 
Optometrist 
Head Optometrist, Head Optometrist, Senior Optometrist, 
Optometrist 
Grade 6 and 8 
Senior Orthoptist / 
Orthoptist 
Head orthoptist, Manager orthoptics, Deputy head orthoptics, 
Orthoptist, Senior orthoptist, Specialist orthopist 
Grades 5,6,7,8 
Specialist 
Doctor/Registrar 
Associate specialist ophthalmology, Clinical fellow doctor (CF), 
Doctor (GPST2), Registrar (ST1), Speciality doctor (medical 
grade non-consultant), ST5 ophthalmology (ST) 
Grades in 
brackets 
Staff Nurse / Sister 
Senior sister, Staff nurse, Jr Sister, Nurse 
Outpatient sister, Staff nurse 
Grades 4,5,6 
Ophthalmic Technician Ophthalmic technician Grade 3 
Medical Photography / 
Imaging Technician 
Digital imaging technician, Imaging technician 
Lead imaging technician, Medical photography 
Grades 3,4,5 
Healthcare Assistant HCA, Healthcare Assistant, Senior HCA Grades 3,4 
Medical Secretary Medical secretary Grade 3 
Therefore, the descriptive analysis of resource use by ‘ECLO’ compared and ‘no ECLO’ sites was 
undertaken for consultant ophthalmologists, clinical nurse specialists and ophthalmic nurses, senior 
optometrists and optometrists, senior orthoptists and orthoptists (although response rates were just 
under 5), and nurses and for ECLO sites only specialist doctors and registrars are reported.  
Responses were reported in numerical form but occasionally in a free text format e.g. “five to ten 
minutes” and therefore needed to be collated and converted into numerical data for analysis. The 
following rules were applied to non-numerical responses: 
 Responses entered as a range, for example 1 to 5 minutes were converted into an average value, 
in this case for example 2.5 minutes; 
 Responses indicating less than 1 per week or more than 1 per week were classified as 1 e.g. 1 
patient or 1 minute; 
 Responses such as 35+ were conservatively classified as 35; and 
 Responses indicating that patient support was only provided occasionally or to 1 or 2 patients per 
year were classified as 0 patients.   
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TABLE 5.21 · Number of staff who responded to the questionnaire 
Staff Group 
Number of staff 
providing an answer 
Sites with ECLO 
Number of staff 
providing an answer 
Sites without ECLO 
N % N % 
Consultant Ophthalmologist 20 25.6 5 25 
Specialist doctor / Registrar 7 9 0 0 
Clinical Nurse Specialist/Ophthalmic Nurse 13 16.7 3 15 
Senior optometrist /optometrist 7 9 3 15 
Senior orthoptist /orthoptist 7 9 2 10 
Staff nurse / sister 10 12.8 4 20 
Healthcare Assistant 4 5.1 2 10 
Medical secretary 2 2.6 1 5 
Medical photography / Imaging technician 5 6.4 0 0 
Ophthalmic technician 2 2.6 0 0 
ECLO 1 1.3 0 0 
TOTAL RESPONDENTS 78 100 20 100 
 
It should also be noted that where responses indicating the amount of time supporting a patient was 
minimal such as “approx. 1 minute” this often referred to handing out an information leaflet or making a 
referral to another healthcare specialist so whilst brief could have had a meaningful impact.  At one site 
the ECLO also responded to the questionnaire but is not included here as it was not within the scope of 
this survey.   
5.3.3 RESULTS OF STAFF SURVEY 
Staff were asked to list any other types of support offered to patients that were not included in the 
survey. No other types of support were listed. As staff response rates were relatively low for some staff 
groups the analysis is centred on consultant ophthalmologists and nurse groups and the time spent 
giving emotional support, advocacy, certification and registration (data from other staff groups is 
presented in Appendix 5). All the responses relate to patients seen in a typical week.  The number of 
patients of course would depend on the number of clinics held at the centre per week. 
Consultant ophthalmologists 
Emotional Support: Question – I have spent time listening to patients/carers, talking through their 
worries or concerns. 
Consultant ophthalmologists at ECLO sites reported providing marginally more patients per week with 
emotional support than non ECLO sites (Table 5.22): 
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 ECLO sites reported seeing between 0 and 23 patients and spent between 2 and 20 minutes 
(mean 6.82 minutes) providing emotional support; and 
 Non ECLO sites reported seeing between 0 and 10 patients and spent between 3 and 7.5 minutes 
(mean = 5.13 minutes) providing emotional support. 
Advocacy: Question – I have helped people to have their voices heard; to secure their rights and to obtain 
the support they need. 
Consultant ophthalmologists at both ECLO and non ECLO sites reported low or no levels of advocacy.  
Certification and registration: Question I have informed and advised patients about Certification and 
Registration and its benefits. I have helped patients in a practical way by helping to fill in forms, for 
example.  
Consultant ophthalmologists at both ECLO and non ECLO sites saw a similar number of patients per 
week, supporting certification and registration but ECLO sites reported more time spent supporting 
patients with practical help such as form filling: 
 ECLO sites reported seeing between 0 and 7 patients advising about certification and registration 
and spent between 1 and 15 minutes (mean = 5.07 minutes) offering advice. They also reported 
seeing between 0 and 5 patients offering practical help such as form filling and spent between 1 
and 15 minutes (mean = 6.40 minutes) supporting patients; and 
 Non ECLO sites reported seeing between 1 and 2 patients advising about certification and 
registration and spent between 3 and 10 minutes (mean = 5.50 minutes) offering advice. They 
also reported seeing between 0 and 2 patients offering practical  help such as form filling and 
spent between 1 and 3 minutes ( mean = 2.00 minutes) supporting patients.  
Clinical Nurse Specialist / Ophthalmic Nurse 
Emotional Support: Question – I have spent time listening to patients/carers, talking through their 
worries or concerns. 
Clinical nurse specialists and ophthalmic nurses at ECLO sites reported providing more patients per week 
with emotional support than non ECLO sites (Table 5.23): 
 ECLO sites reported seeing between 0 and 100 patients and spent between 3 and 25 minutes 
(mean 11.0 minutes) providing emotional support; and 
 Non ECLO sites reported seeing between 0 and 5 patients and the one response to the question 
regarding time spent, reported spending 10 minutes supporting a patient. 
Advocacy: Question – I have helped people to have their voices heard; to secure their rights and to obtain 
the support they need. 
Clinical nurse specialists and ophthalmic nurses at ECLO site reported low levels of advocacy support per 
week for patients with on average less than 1 patient receiving support of this nature, while non ECLO 
sites did not report advocacy support. 
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TABLE 5.22 · Support provided by Consultant Ophthalmologist 
Type of support provided by Consultant Ophthalmologist 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, 
talking through their worries or concerns. 
Site with ECLO 19 3.63 6.39 0 23 11 6.82 5.19 2.0 20 
Site without ECLO 5 3.40 4.22 0 10 4 5.13 1.84 3.0 7.5 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 19 1.11 1.86 0 6 7 4.21 2.69 1 7.5 
Site without ECLO 5 0.70 1.10 0 3 2 1.75 1.06 1 2.5 
I have provided eye health information to 
patients, family members and others. 
Site with ECLO 18 5.39 6.93 0 20 10 3.15 2.35 1 7.5 
Site without ECLO 5 7.90 4.96 2 15 5 2.20 1.64 1 5 
I have helped people to have their voices heard; 
to secure their rights and to obtain the support 
they need. 
Site with ECLO 18 0.22 0.73 0 3 0 - - - - 
Site without ECLO 5 0 0 0 0 0 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 19 0.95 2.46 0 10 4 5.75 2.90 4 10 
Site without ECLO 5 0 0 0 0 0 - - - - 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 19 1.55 1.55 0 7 15 5.07 3.74 1 15 
Site without ECLO 5 1.30 0.45 1 2 5 5.50 2.74 3 10 
I have helped patients in a practical way by 
helping to fill in forms, for example. 
Site with ECLO 18 0.72 1.41 0 5 5 6.40 6.07 1 15 
Site without ECLO 5 0.70 0.67 0 2 3 2.00 1.00 1 3 
I have followed up with patients that I’ve 
referred on to other services to check that 
satisfactory progress has been made. 
Site with ECLO 18 0.31 0.99 0 4 2 10.5 0.71 10 11 
Site without ECLO 5 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 18 0.14 0.41 0 2 1 11 - 11 11 
Site without ECLO 5 0 0 0 0 0 - - - - 
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TABLE 5.23 · Support provided by Clinical Nurse Specialists / Ophthalmic Nurse 
Type of support provided by Clinical Nurse Specialists / 
Ophthalmic Nurse 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, 
talking through their worries or concerns. 
Site with ECLO 12 16.50 28.85 0 100 8 11.0 7.82 3 25 
Site without ECLO 3 1.67 2.88 0 5 1 10.0 - 10 10 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 12 2.38 4.90 0 15 4 6.0 5.05 2 12.5 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have provided eye health information to 
patients, family members and others. 
Site with ECLO 13 6.77 7.34 0 20 9 6.56 4.75 1.5 15 
Site without ECLO 1 1.50 - 2 2 1 5.0 - 5 5 
I have helped people to have their voices heard; 
to secure their rights and to obtain the support 
they need. 
Site with ECLO 13 0.81 1.55 0 5 2 8.75 1.77 8 10 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 11 0.68 2.26 0 8 1 7.50 - 8 8 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 12 0.75 1.60 0 5 3 7.0 1 1 15 
Site without ECLO 3 0.33 0.58 0 1 1 5.0 - 5 5 
I have helped patients in a practical way by 
helping to fill in forms, for example. 
Site with ECLO 12 0.83 1.95 0 5 2 5.0 - 5 5 
Site without ECLO 3 0.33 0.58 0 1 1 2.0 - 2 2 
I have followed up with patients that I’ve 
referred on to other services to check that 
satisfactory progress has been made. 
Site with ECLO 12 0.42 1.44 0 5 1 5 - 5 5 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 12 1.0 2.89 0 10 2 5.0 - 5 5 
Site without ECLO 3 0 0 0 0 0 - - - - 
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Certification and registration: Question I have informed and advised patients about Certification and 
Registration and its benefits. I have helped patients in a practical way by helping to fill in forms, for 
example.  
Clinical nurse specialists and ophthalmic nurses at ECLO sites reported marginally more support of 
patients per week supporting certification and registration than non ECLO sites. 
 ECLO sites reported seeing between 0 and 5 patients advising about certification and registration 
and spent between 1 and 15 minutes (mean = 7.0 minutes) offering advice. They also reported 
seeing between 0 and 5 patients offering practical help such as form filling and spent 5 minutes 
supporting patients; and 
 Non ECLO sites reported seeing between 0 and 1 patients advising about certification and 
registration and spent 5 minutes offering advice. They also reported seeing between 0 and 1 
patient offering practical help such as form filling and spent 2 minutes supporting patients. 
Staff Nurse / Sister 
Emotional Support: Question – I have spent time listening to patients/carers, talking through their 
worries or concerns. 
Staff nurses and sisters at ECLO sites reported seeing fewer patients per week for emotional support 
than non ECLO sites but spent more time providing emotional support than non ECLO sites (Table 5.24) 
Advocacy: Question – I have helped people to have their voices heard; to secure their rights and to obtain 
the support they need. 
Staff nurses and sisters at ECLO site reported low levels of advocacy support per week for patients with 
on average less than 1 patient receiving support of this nature, while non ECLO sites did not report 
advocacy support.  
Certification and registration: Question I have informed and advised patients about Certification and 
Registration and its benefits. I have helped patients in a practical way by helping to fill in forms, for 
example.  
Staff nurses and sisters at ECLO and non ECLO sites saw a similar number of patients per week and spent 
a similar amount of time supporting certification and registration but ECLO sites reported more time 
spent supporting patients with practical help such as form filling: 
 ECLO sites reported seeing between 0 and 2 patients per week advising about certification and 
registration and spent between 3 and 15 minutes (mean = 7.75 minutes) offering advice. They 
also reported seeing between 0 and 5 patients offering practical help such as form filling and 
spent approx. 30 minutes supporting patients.  
 Non ECLO sites reported seeing between 0 and 2 patients advising about certification and 
registration and spent approx. 15 minutes offering advice. They also reported seeing between 0 
and 1 patient offering practical help such as form filling and spent approx. 2 minutes supporting 
patients. 
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TABLE 5.24 · Support provided by Staff Nurse / Sister 
Type of support provided by Staff Nurse / Sister 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, 
talking through their worries or concerns. 
Site with ECLO 9 7.44 6.12 0 16 7 14.14 11.39 4 30 
Site without ECLO 4 13.75 13.77 0 30 3 6.17 3.40 3.5 10 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 8 1.94 2.18 0 5 4 8.75 4.79 5 15 
Site without ECLO 4 4.25 4.35 0 10 3 2.17 1.04 1 3 
I have provided eye health information to 
patients, family members and others. 
Site with ECLO 8 6.81 5.40 0 15 6 6.83 6.46 1 15 
Site without ECLO 3 8.33 2.89 5 10 3 3.83 3.18 2 7.5 
I have helped people to have their voices heard; 
to secure their rights and to obtain the support 
they need. 
Site with ECLO 6 0.67 1.63 0 4 1 30.0 - 30 30 
Site without ECLO 4 0 0 0 0 0 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 7 0.86 1.57 0 4 3 17.5 10.90 10 30 
Site without ECLO 4 0.25 0.50 0 1 1 10.0 - 10 10 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 8 0.81 0.53 0 2 6 7.75 5.67 3 15 
Site without ECLO 4 0.50 1.0 0 2 1 15.0 - 15 15 
I have helped patients in a practical way by 
helping to fill in forms, for example. 
Site with ECLO 7 1.00 1.92 0 5 2 30.0 - 30 30 
Site without ECLO 4 0.25 0.50 0 1 1 2.0 - 2 2 
I have followed up with patients that I’ve 
referred on to other services to check that 
satisfactory progress has been made. 
Site with ECLO 8 0.25 0.71 0 2 2 22.50 10.61 15 30 
Site without ECLO 4 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 8 3.50 8.75 0 25 3 8.33 4.73 3 12 
Site without ECLO 4 0 0 0 0 0 - - - - 
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5.4 ECONOMIC MODELLING 
5.4.1 SUMMARY 
Background 
While a number of studies have attempted to investigate the impact of the ECLO on falls reduction, we 
have attempted to pursue this further to quantify the impact of the ECLO on NHS costs overall. 
Deterministic modelling was used to analyse the data collected from our study combined with the 
literature to estimate the potential impact of the ECLO service on both falls and depression which, 
aside from the personal impact on individuals, are both costly to the healthcare system. In order to 
undertake these analyses, the relevant input variables were identified from the literature review and 
the analysis of the data collected within this study. Discreet event simulation was employed to explore 
clinic flows and substitution effects of ECLOs on staff capacity in a typical hospital eye clinic.   
Key findings 
 The literature indicates that the rate of falls and risk of falls and the rate of depression in people 
is unequivocally linked with sight loss. The ECLO, alert to the impact of a fall on a person with 
sight loss, is vital in making the connection between the risks, the patient and services available 
in the region. Using the quantitative data collected in our study, combined with costs and 
prevalence data on falls and depression from the literature, deterministic modelling enabled 
estimation the potential impact of the ECLO service on both falls and depression. 
 We estimated the ECLO service might lead to a 13.3% reduction in falls, equivalent to 
approximately 28,000 fewer falls, with a reduction in the total fall rate from 25% to 21.7%, based 
on the 2013 UK prevalent population of people with sight loss.  
 Cost implications of ECLO provision for fall reduction was estimated at an incremental cost per 
fall avoided of £2,813 when an ECLO is supporting patients at risk of falls. Should the percentage 
of patients able to see an ECLO increase, a proportional saving increase should also ensue. 
 The DEPVIT study reported that 43% of those presenting to low vision rehabilitation clinics have 
significant depressive symptoms. Our estimates suggest that the ECLO could prevent 
approximately 43,000 interventions from NHS services for depression, a reduction of 11.9% 
compared to a situation where no ECLO action was taken. At an average costs of £2,509 per 
depression episode per person, an estimated saving of £107.6m in avoided referrals to 
depression services is estimated.  
 After accounting for the total cost of the estimated 112 full-time ECLOs required, a total saving of 
£101m is estimated, equivalent to 11.2% saving compared with care without an ECLO. This 
represents an incremental cost per referral avoided of £2,361. Increasing the percentage of 
patients able to see an ECLO would result in a proportional saving increase. 
_____________________________________________________________________________________ 
5.4.2 BURDEN OF FALLS AND DEPRESSION 
It is clear from the qualitative and quantitative data collected and reported from this study that ECLOs 
have a vital role to play enabling people with sight loss to adjust to their diagnosis and optimise their 
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ability to cope and have as full a life as possible post diagnosis. This section of the report addresses two 
aspects of sight loss that have significant impact on people:  falls and depression. As the literature 
review (section 3.2) suggests, the rate of falls, the risk of falls and risk of depression in people with sight 
loss is unequivocally linked.  The role of the ECLO, alert to the impact of a fall or the risk of depression 
on a person with sight loss, is vital in making the connection between these risks, the patient and 
services available in the region. 
A number of studies have quantified the impact on the NHS of falls reduction. Our study attempts to 
pursue this further, in order to quantify the potential impact of the ECLO on NHS costs, overall. Using 
the data collected in this study we used deterministic modelling approaches to estimate the potential 
impact of the ECLO service on both falls and depression which, aside from the personal impact of these 
problems on individuals, are both costly to the healthcare system.  The models for falls and depression 
are presented in Appendix 6 and Appendix 7 respectively. 
In order to undertake these analyses, appropriate variables including incident rates, ECLO resource 
usage, and costs were identified from the literature review and statistical analysis of the data collected 
within this study.  Because some information is not available and some data are limited we have also 
had to make estimates based on informed and reasonable assumptions for some of the calculations.   
Care and discretion are essential in selecting appropriate variables and conservative assumptions to 
avoid criticism of overestimating the impact an ECLO service can make.  Any assumptions made to 
facilitate our estimates have been explained. Whilst assumptions are not ‘evidence’ or fact they can 
enable scenarios to be constructed and ‘what if’ estimates to be created.  We have taken this approach 
to explore ‘what if... ECLOs presently or in future initiate a chain of events that reduces the impact of 
falls or depression’.  At present the assumptions are informed by our understanding of reality but the 
objective evidence is not available. In the fullness of time, data may be available to replace our 
assumptions and these estimates can be re-calculated. 
The impact of falls and depression in the NHS is sizable.  Research undertaken for the King’s Fund 
estimated the cost of falls to the NHS - that is falls overall, not just related to sight loss - to exceed £2 
billion142. The cost of depression, overall, in England was estimated at £1.7 billion by McCrone and 
colleagues.143   
We hypothesised that the presence of ECLOs in the ophthalmology clinics improves the rate of risk 
identification, contact and referral for those that require further support for these (latent) problems.  
Through an appropriate intervention (listening, empathising, giving emotional support, informing, 
signposting, referring etc.) by the ECLO, it is assumed that fewer incidents of falls and depression would 
occur, reducing the financial burden on the healthcare system. To explore this hypothesis we have had 
to bring together data from various sources to enable us to make estimates of the potential impact of 
ECLOs on the costs of falls and depression. 
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The Wales Eye Clinic Liaison Report conducted by RNIB Cymru144, an assessment of the impact of the 
ECLO service in Wales reported that the service supported 6,730 patients in 2012/13.  A report from 
Access Economics published in 2009,145 estimates that 1.8m individuals in the UK have sight loss.  Of the 
53.5% reported by Access Economics, to have sight loss due to uncorrected refractive error (RE), which 
would typically be corrected by High Street optometrists with the use of glasses or contact lenses.  The 
remaining 46.6% - equivalent to approximately 838,000 people - would require support from secondary 
care based clinics for issues including age-related macular degeneration (AMD), cataract, diabetic 
retinopathy (DR), glaucoma and other rare eye diseases.  This is a prevalent population which is the 
basis for our estimates.  This is perhaps a smaller number than is prevalent in the present day as 
numbers of people with eye conditions related to older age is increasing.  These are also broad 
assumptions and a simplification of reality as secondary care support may be required for those with 
severe RE related sight loss but not required for those with mild sight loss related to other conditions.  
And of course people with RE may also have eye conditions that would be treated in secondary care. 
In order to get an estimate of the people in the UK that would have contact with an ECLO (accepting 
that some people may be in need of support but not get it due to lack of service) we have worked up a 
series of informed estimates.  We have also assumed that once contact is made with an ECLO the 
support is open ended, though in reality there may be a finite number of initial contacts which tail off as 
things settle for an individual. Assuming an equal prevalence rate of sight loss across UK regions, and a 
Welsh population of 4.8%146 of the UK total, a total of 87,000 individuals in Wales are estimated to have 
sight loss.  Of the Welsh sight loss population, 46.6%, equivalent to approximately 40,500 people, have 
conditions other than RE and thus require secondary care interventions.  This is the population of 
interest for our model and resulting estimates. 
We used the RNIB Cymru Eye Clinic Liaison Report data published in 2013, 147 which reports 6,730 
patients were supported by an ECLO in 2012/3, to give us a rate of 16.7% for people with sight loss in 
Wales receiving secondary care support in this time period.  From a UK perspective, for 2012/13, scaling 
these estimates using the 16.7% rate would equate to 139,500 patients both requiring support and 
getting it from an ECLO. This is a conservative estimate as the patient survey data reported in section 5.2 
suggests a higher percentage of 28% patients attending an ECLO supported clinic want and get support. 
Based on the ECLO activity data  reported in section 5.1 we have conservatively estimated that an ECLO 
spends 76 minutes per patient, overall, of which a little under half the time (35 minutes) is spent 
undertaking activities on behalf of the patient, the rest of the time in contact with the patient.  As stated 
above, 139,500 patients are estimated to receive support from an ECLO, in 2012/13, which means that 
they utilised a total 170,689 hours of ECLO time.  In order to estimate the costs of an ECLO service 
supporting this prevalent population we estimated the salary costs at NHS rates based on a 37.5 hour 
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working week, and 42.4 week working year (1590 hours per year).  A total 112 full time ECLO’s would be 
required to deliver this level of service.     Using the equivalent NHS rates (see Table 5.19) an ECLO 
funded in Band 4 costs £29 per hour so we can estimate that provision of this level of service costs total 
£5.1m per year.  It should be noted that by no means all ECLOs are funded by the NHS, but in many ways 
from many sources – though the benefits of employing ECLOs accrue to NHS patients and services. 
As we now have an estimate of what ECLO resource and cost it might take in terms of ECLO provision, 
based on 2012/13 data, to influence outcomes for people with sight loss, we can estimate what the 
economic impact of this for falls and depression – two common problems for people with sight loss.    
Falls 
Having analysed data related to falls for 421 patients from Torbay, Tian et al148 report a total cost to the 
NHS associated with these falls of £1.2m, or £2,850 per fall which we can use to help with our estimates.  
Inflating from 2013 prices to 2016 prices, the cost per fall is estimated to be £2,997.149   
Data from the same Wales Eye Clinic Liaison Report150 estimates that 25% of those with non RE sight 
loss ultimately have falls.  As stated above, if approximately 838,000 people in the UK require support 
for sight loss, using this rate, we estimated that of these people 209,400 will experience falls, equating 
to an estimated cost to the NHS of £628 million per year.  
Our next steps were to estimate how much the ECLO services can impact and reduces this substantial 
amount of money. 
Based on the ECLO activity data reported in Section 5.1, fear of falling and actually having a fall, 
subsequently, has a relationship, so we can bring this knowledge into our calculations on rates of falling. 
As described above, we assumed that 16.7% of the UK population with sight loss had contact with an 
ECLO, equivalent to approximately 139,500 patients; we assume based on the ECLO activity data 
reported in section 5.1, that of these 47%, have a fear of falling.  In order to explore the potential for the 
ECLO service to influence the rate of falls for these people we have to make some assumptions 
alongside using reported data. 
From the RNIB Cymru Wales Eye Clinic Liaison report,151 it is noted that 47% of those with sight loss 
have a fear of falling, which scaled up is equivalent to 393,700 UK patients.  This is within the range 
reported by the ECLO activity data in Table 5.7 where the fear of falling across the four UK countries 
ranges from 77% in Northern Ireland, 41% in England and Wales and 7% in Scotland (rounded 
percentages).  An assumption has been made that whilst some people who fall would not have had a 
prior fear of falling, the majority would have a fear of falling, given their condition or a previous history 
of falls.  In the absence of available evidence linking the number of falls to those with a fear of falling we 
made an assumption that, of the people reported to fall in the RNIB Cymru Wales Eye Clinic Liaison 
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report152, 80% also had a fear of falling prior to the fall, with the remaining 20% of falls were 
experienced by people with no fear of falling. From these assumptions it has been estimated that 
167,500 (42.6%) of the ‘fear of falling’ group ultimately have a fall.  In addition, because there will be 
some people who have no fear of falling may have a fall, based on the ECLO activity data rates, we 
estimate that 41,900 (9.4%) of the people who have no fear of falling (‘non-fearers’) actually do have a 
fall. 
Table 5.11 shows that the ECLO referral rate to falls services was surprisingly low, given the remit of 
ECLOs.  We queried this with the managers of ECLOs with RNIB and Action for Blind People.  The 
explanation for the rate seemed to be related, in some areas, to lack of availability and means of access 
to falls services.  An informal survey with ECLOs undertaken by RNIB suggests that once the ECLO 
identifies the risk, if there is limited access to falls services, the referrals go via GPs or the 
ophthalmology clinic and are therefore not captured as a referral to falls services.  The real rate of 
people being referred through the action of an ECLO is thought to be much higher than captured in the 
activity data. Based on this information we assume that an ECLO referral rate to falls services of 30% will 
occur for people who have stated that they have a fear of falling, but we assume a reduced referral rate 
of 5% for people with no explicitly expressed fear of falling, but where the ECLO recognises that a risk 
does exist and something needs to be done to address the risk. 
Our next assumption is that referral to relevant services is deemed to be effective and reduce the 
likelihood of falls with some reports identifying a significant reduction in the fall rate following 
intervention of approximately 1/3.  This is supported by published research by Close and colleagues.153  
Based on this evidence, we can assume a reduction in the likelihood of falls of 1/3 following referral, 
leading to estimates of fall rates amongst ECLO referred patients of 28.4% and 6.3% for the ‘fearing fall’ 
and ‘not fearing fall’ groups respectively.  Assuming that ECLOs make appropriate referrals, the fall rate 
amongst those who receive support from an ECLO, yet are not subsequently referred to falls services, is 
assumed to be very low; however we have to assume some failure in the system, so conservatively our 
calculations assume a residual fall rate of 1% for these patients.  The fall rate for those people not seen 
by ECLOs is assumed to remain unchanged relative to the background rate of falls. 
If we put all this information together in our model of the potential impact of the activity of ECLOs, we 
estimate that this could lead to a 13.3% reduction in falls, equivalent to 28,000 fewer falls across the UK, 
with a reduction in the total fall rate from 25% to 21.7% (see Appendix 6 for the detailed calculations).  
However ECLO service cost implications have to be taken into account.   
As described earlier, the costs of providing ECLOs that can support the 139,500 patients is estimated at 
£5.1m. At an average cost per fall of £2,997154, the estimated cost of 181,500 falls related to sight loss, is 
estimated to cost £544m.  Assuming the ECLO service reduces the overall number, rate and cost of falls; 
for each fall avoided the NHS benefits by saving £2,813 compared with the ‘no ECLO’ situation.  This 
reduction, equivalent to a 12.5% saving to the health services, relative to the cost to the NHS in a 
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situation where either clinics are not supported by an ECLO service or for other reasons a patient does 
not get access to an ECLO.  Should the percentage of patients able to see an ECLO increase, a 
proportional saving increase will occur. 
Depression 
A similar deterministic approach was also used to evaluate the potential impact of the ECLO service on 
depression.  Those with sight loss are reported to have a higher risk of developing depressive symptoms, 
with the recent DEPVIT study presenting results on the observed rate of depression in people attending 
low vision clinics (43%)155 and the RNIB Cymru Report claiming that older people living alone were up to 
three times more likely to demonstrate depressive symptoms in comparison to those with normal sight. 
Using the same approach for estimating the impact on falls, the calculations exclude the 53.5% of sight 
loss patients with RE, and assumes that 100% of those with other sight loss conditions have contact with 
the eye services in secondary care.  From a UK perspective this equates to approximately 838,000 
patients.  The DEPVIT study156 reported that 43% of those presenting to low vision rehabilitation clinics 
have significant depressive symptoms.  Using this figure in our calculations would mean that the 
equivalent to 360,000 of the population may be in need of support because of depressive symptoms.  
The cost of services that are in place to support people who have depressive symptoms suggested by 
recent literature indicates that average service costs of £2,085 relating to managing depression are 
reported by McCrone and colleagues;157 at 2016 prices our estimates suggest that this corresponds to a 
total service cost amongst the sight loss population in excess of £900 million if they all at some point 
accessed these services. 
Using the same methodology when we looked at the impact of falls for people with sight loss, we 
assume that 16.7% of the population seeking support got time with an ECLO, equivalent to 139,500 
patients, of which we estimated 60,000 have depressive symptoms, using the DEPVIT rate of 43%.  
Based on the ECLO activity data reported in section 5.1.data, we know that ECLOs provide emotional 
support to approximately 95% of the patients seen; equivalent to 57,000 patients of the estimated 
number of people who have sight loss and depressive symptoms.  In addition to providing emotional 
support for those people ECLO’s can then choose whether to inform, signpost or refer these patients to 
services or resources that can potentially avert the onset of clinical depression.  Assuming (based on 
informal advice) that the ECLO onward referral rate for people showing symptoms of depression is 30% 
of those receiving emotional support and that these people are subsequently referred to a service that 
can help the patients’ depression symptoms, we can then estimate the potential impact of the ECLOs on 
depression rates.  Our assumption that 30% of those receiving emotional support from the ECLO, 
equivalent to 17,000 patients, are enabled through referral or signposting to gain access to depression 
services, such as Improving Access to Psychological Therapies (IAPT) to achieve resolution of symptoms 
and/or avoid clinical depression. 
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Using these estimates we can suggest that ECLOs, in the course of giving emotional support and 
subsequent actions could prevent approximately 43,000 interventions from NHS services for depression, 
a reduction of 11.9% of costs compared to a situation where no ECLO action was taken.  At an average 
NHS costs of £2,509 per depression episode per person, there is the potential to have an estimated 
saving of £107.6m from avoided referrals to depression services.  After accounting for the total cost of 
having 112 Band 4 ECLOs in place, in the UK, an estimated total saving of £102m, equivalent to 11.9% 
reduction is possible, compared with a situation where ECLOs are not in place. This represents an 
incremental cost per referral avoided of £2,389 (see Appendix 7 for detailed calculations).  Increasing 
the percentage of patients able to see an ECLO would result in a proportional saving increase. 
By utilising previously cited estimates of incident prevalence and costs, and making a series of informed, 
conservative assumptions regarding the ECLOs actions and consequences of these actions, a reduction 
in sight loss related falls and depression referrals have been calculated with the potential cost savings to 
the NHS estimated.  The estimates presented in this section, calculated using deterministic modelling 
methods, are not objective evidence of the impact of ECLOs – rather they are informed estimations that 
indicate the potential benefit of the ECLO service of the healthcare system.  These estimates are based 
on a number of assumptions and the likelihood that there is a relationship between the support 
provided by an ECLO and actions the ECLO takes on behalf of their client and the outcomes for the 
consequent actions.  It is important to exercise caution with these figures which are based on the 
premise that there is a sufficient number of ECLOs who take action appropriately and this action leads to 
a reduction in adverse outcomes for their clients.  
The value of these estimates, and the scenarios we have created, are that they provide a focus on where 
the ECLO can make a difference and where data collection could provide objective evidence of these 
specific ECLO activities. 
5.4.3 SERVICE MODELLING 
The discreet event simulation (DES) model we developed was designed to replicate a typical 
ophthalmology clinic, the number of patients, number of appointments and staff at the clinic are based 
on observations from the earlier site visits and guidance from RNIB at the start of the project.  The 
patient pathway was based on what we learned from the initial site visits and was validated by RNIB. 
The premise on which the model was established was that where ECLOs are not in place, or not 
available due to part time working or being occupied with other patients, clinic staff would be 
undertaking tasks which the ECLO would normally undertake to give patients support.  Once we had the 
staff survey results it was clear, from those centres at least, that this was not a valid assumption. 
5.4.4 MODEL STRUCTURE 
Patients enter a ‘waiting room’ within the model structure and wait (in the model) for their 
appointments with the clinic staff.  The first appointment in the model flow is with the clinical specialist 
– the ‘consultant’ – though this could be a specialist registrar or other clinically qualified specialist.  The 
time given to patients by ECLOs was based on the ECLO activity data reported in section 5.1.  Based on 
this information the simulation in the model assumes that 29 patients arrive in the clinic for any type of 
appointment, per hour.  The time spent in the appointment is based on the staff survey and it is 
assumed (on the basis of discussion) that the consultant appointments follow a normal distribution, with 
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a mean of 10 minutes per appointment (S.D = 2.5) allowing for the intrinsic variation due to the different 
appointment types encountered at the ophthalmology clinic.  
The ECLO cannot substitute for any of the ‘consultant’ roles other than giving emotional support, and/or 
signposting/informing about or referring to specialist services.  One important activity undertaken by 
the ECLO is a contribution to the CVI completion (over and above the information which it is mandatory 
for the consultant to complete and sign).  This can take an ECLO on average 30 minutes.  According to 
the staff interviews this activity is important added information to make things easier for the 
administration subsequent to the receipt of the form but is not mandatory, compared with the part of 
the form which the consultant has to do (to do takes approximately 10 minutes). However the staff 
survey reveals that in the absence of an ECLO no one undertakes the ‘added value’ role completing the 
‘nice to do’ rather than ‘consultant must do’ parts of the CVI. 
Once a patient has been seen by the consultant for their appointment, in the model the patient remains 
with the consultant for a set period of time and then goes on to see a nurse. The nurse has specific 
activities that relate to patient care but may also hypothetically, experience a situation where an ECLO is 
not available (a site without an ECLO or an ECLO is not available at the clinic at the time) may spend time 
giving emotional support, inform, signpost or refer patients to other services as the model is concerned 
with the amount of time that a nurse spends doing an ECLO role. Once patients reach this point, they 
are divided into those which require support and those which do not. This routing is governed by a 
percentage obtained from the patient survey data. These data, as used in the model, are summarised 
below in Table 5.25. 
TABLE 5.25 · Patient need for support (source Patient Outcome Questionnaire) 
Patients statement about ‘needing support’ % 
Yes 55 
No 45 
Patients reporting ‘needing support but not receiving it’ % 
Not received 21 
Received 79 
Patients who received support:  who provided support % 
ECLO 68 
Other staff 32 
Patients who do not require support have the simplest route in the model:  they are simply counted and 
leave the model and are ‘sent home’. They are given an EQ-5D value to represent the HRQoL  
experienced as they enter and leave the model as well as some values for  categorical variables relating 
to their mental health, their fear of falling, and their capability of undertaking their usual activities. The 
remainder of the patients, 55% at baseline, according to the survey say that they needed support. The 
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pathway that these patients adopt is far more complex in nature and differs depending upon whether 
the hospital is an ECLO or a non-ECLO site. 
Considering ECLO sites first, the patients first of all are routed through the simulation by whether they 
receive support (from someone) or are sent home without receiving support. The latter group are the 
patients who “fall through the net” and their needs are not met and we assume no further support from 
the ECLO or other staff. As with other patients, they are assigned EQ-5D scores based on the patient 
survey as well as the values for the categorical outcomes as above. 
The percentage of patients who require support and do receive support from the ECLO was obtained 
directly from the patient questionnaire data (68%) and the remainder have contact with other staff. The 
ECLO will then spend a set amount of time with each patient (on average 30 minutes based on the ECLO 
activity data) and then a further set amount of time as they are active on behalf of the patient outside of 
the face to face contact, also based on the ECLO activity data. Once they have done this, a certain 
proportion of patients (23.85% based in the English ECLO activity data) will have a CVI supplemented 
and completed by the ECLO. This will take a set amount of time, on average 30 minutes, also based on 
the ECLO activity data, and once the ECLO has completed this, they are free to see the next patient. The 
original patient can also be referred to falls services, or just given information by the ECLO. These 
individual times are added up to see the amount of time that an ECLO is busy on behalf of that patient 
arising from the contact. 
If the patient is seen by another member of staff rather than the ECLO, the time they spend with the 
patient is assumed to be the same as the time that the ECLO would spend with the patient, but they do 
not spend any time on behalf of the patient nor do they complete CVIs for the patients, as this is a 
senior medical task. This assumption is based on the staff survey results and the qualitative data 
collection.  The number of patients who would have had a CVI fully completed if they had seen the ECLO 
is counted and noted in the results. The patients are also referred, if necessary, to falls services or given 
information. This is an assumption since we have no data based on the other support staff, but since this 
is in an ECLO site, information in terms of leaflets and telephone numbers should be readily available for 
the patients and since the ECLO has demonstrated best practice in terms of referrals to rehabilitation 
officers and falls services, it is assumed that the other support staff will follow the same pattern.  
For non-ECLO sites, the situation is simpler yet dependent on more assumptions since very little is 
known about what provision in terms of patient support is present, other than the staff survey data.  
To begin with, patients are split into those who received support and those who do not although they 
do require support. Of these, 79% received support (as for the ECLO site) and 21% do not. Those 21% 
are sent home and are assigned outcomes as outlined above. Of the 79% who receive support, if the 
support staff are busy then they go home without getting any support. In many ECLO sites, if the ECLO is 
busy the names of the patients requiring follow up are noted and the ECLO will follow them up at a 
convenient time. This is not inconsistent with the survey data which suggests that some patients do 
leave the clinic without their support needs being met (at that time). However, it does give us difficulty 
in representing this pathway in the model, so this is handled by the patients who fall into this category 
remaining in the ‘waiting room’ and the time in the waiting room building up.  In our simulations some 
patients remain indefinitely in the waiting room suggesting that in a typical clinic represented by our 
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model it is likely that one ECLO may not see all patients who have needs in the clinic on the day of the 
clinic.   
The time spent with the patients at this stage was difficult to quantify. If the support staff are nurses or 
consultants, their times are already accounted for in the earlier stage of the model. Since we are 
interested in the consequences of the ECLOs activity we have used the patients’ questionnaire data:  
when patients were asked who supported them if it was not an ECLO, it was reported that either 
healthcare professionals or people from the voluntary sector supported the patients in their various 
needs. When their needs were practical in nature, social services, low vision services would also aid in 
the provision of these needs. However, since the focus is on resource and costs from an NHS 
perspective, these are accounted for already in the model.  
In terms of referrals from other support staff, since these hospitals are non-ECLO sites, we can assume 
that the support staff do not complete CVIs as an ECLO would and therefore anyone requiring a CVI will 
get one that has the minimum data and a consultant sign off or get one at the next visit. The model adds 
these patients up and reports this outcome.  
On inspection of the patient questionnaire data (section 5.3.2), and the qualitative data (section 4.3.1) 
we find that although the clinic staff do provide information and some signposting/referrals, they do not 
refer directly to social services (there may be a social services officer available to support them in the 
clinic but they do not have such a direct route into the social care system as an ECLO has at an ECLO 
site). Also there is no mention of any referrals to falls services from these support staff members. 
Therefore, the model does not allow such referrals from support staff at non-ECLO sites and patients are 
only given advice and information.  The model was designed and validated prior to the completion of 
the survey data collection and the last of the completed site visits in order to comply with timelines and 
be ready to run when the data was cleaned and analysed.  On receipt of the final data the model was 
populated with the survey data and simulations created.   
To explore the impact on HRQoL for patients falling into the different categories at the ECLO supported 
sites, EQ-5D utility scores based on the patient survey data, for both baseline and follow-up are fitted 
with distributions and estimated by the model for the various simulated pathways.  For those patients 
for whom support is not required, a small increase in the EQ-5D scores is observed from a baseline of 
0.869 to 0.877 (0.015) at follow up.  By contrast, for those patients for whom support is required, a fall 
in the simulated EQ-5D utility values are observed.  For those patients receiving support, the fall in the 
ECLO group, from a baseline value of 0.710 to 0.695 (0.07) at follow-up is smaller than that observed for 
the other staff group, falling from 0.816 to 0.746.  Nevertheless, these reductions in scores are 
substantially smaller compared to the group requiring support but not receiving any, with EQ-5D utility 
score falling from 0.764 at baseline to 0.677 (0.087) at follow-up.  
Additionally, outcomes were simulated for the people who have a fear of falling:  The percentage of 
patients with a fear of falling ranges between 21.4% and 22.6% at baseline and follow-up for all four 
groups.  However, our simulations suggest that whereas the number of patients with a stated fear of 
falling increases for those receiving support from other staff or requiring support but not receiving any, 
small reductions in stated fear of falling are observed for the ECLO supported group and those not 
requiring support. In a non-ECLO site the people with a fear of falling, there is little change in 
percentages between baseline and follow-up estimated for both the supported by other staff and the 
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support required but not received groups.  The results from the simulations are helpful in validating our 
findings based on other analyses, in that we have signals that the ECLO supported individuals have a 
positive change in the trajectory of their outcomes, whether for EQ-5D scores or fear of falling.   
In addition to the explorations described above, one of the main reasons for choosing DES as the 
modelling approach was to enable the team to explore the potential for ECLO substitution for clinic 
staff, based on the hypothesis that the ECLOs freed clinic staff time because clinic staff were delivering 
patient support in the same manner as ECLOs would.  However, it was apparent from the simulations 
that the ECLOs were not substituting for any clinic staff activity, as seen in the staff survey results.  
Additionally, given the level of ECLO support in the clinics where the staff completed the survey, on 
average, there were no simulations where the needs of patients were not met by existing ECLO staffing 
levels.  This does seem counter intuitive to the patient survey where needs were not met – an important 
illustration of patient expressed needs differing to objective provision of ECLO support.  The patient 
survey data does not reveal whether the lack of support was directly due to an ECLO not being available 
and this may deserve further exploration. It may be that the clinics (20 of the 30 visited) may be the less 
pressured clinics given they had time to respond to the survey. 
There was no way of knowing within the survey data used in the modelling which are services that have 
very little ECLO time allocated, and which site had the greater proportion of patients who ‘had needs 
but received no support’, as the centre data was anonymised. The case seems to be that patients in 
these no ECLO sites simply miss out on ECLO like support.  The analysis of the qualitative data supports 
the findings of the model. 
5.5 COST UTILITY ANALYSIS 
5.5.1 SUMMARY 
Background 
Cost-effectiveness analysis (CEA) is a form of economic evaluation that utilises a single, specific, one- 
dimensional, health or clinical outcome for competing health interventions. In CEA, the ultimate 
measure of interest is the incremental cost-effectiveness ratio (ICER), which is the ratio of the 
difference in costs and the difference in outcomes for one intervention compared with another.  And 
intervention can be a single drug or a complex health care intervention or service. 
Cost-utility analysis (CUA) is a special type of CEA in which multidimensional health outcomes are 
reduced to a single dimension reflecting individuals’ preferences for diverse health outcomes. The 
most commonly used outcome in cost-utility analysis is the quality adjusted life year (QALY).  
The value of a health intervention is made by measuring the additional cost per additional outcome 
compared with the alternative (e.g. an incremental cost/QALY ratio). This ratio is then compared with 
an external threshold (in the UK this is the threshold set by the National Institute for Health and Care 
Excellence) to evaluate the value of the new policy with ratios for other policies. 
Key findings 
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 A simple cost-effectiveness of the impact of ECLOs compared with no ECLO was evaluated using 
CUA.  The analysis spanned a time period of 12 months, and was from the perspective of the 
NHS.  
 Inputs to the analysis included the EQ-5D utility scores from the patient survey and the costs to 
the NHS of an ECLO employed at the equivalent of NHS salary Band 4 and Band 5 - the most 
usual bandings for an NHS employed ECLO.  
 The incremental cost- per ‘QALY sustained’ showed that the patients seen at an ECLO site 
generated an incremental cost per ‘QALY sustained’ of £2,883 for an ECLO paid at Band 4 
compared with patients attending the non – ECLO site. When the cost of the ECLO increased 
based on Band 5, the incremental cost- effectiveness ratio (ICER) increased to £3,517 per ‘QALY 
sustained’ compared with patients attending a non ECLO site. 
 For patients who received support at an ECLO site compared with patients who needed support 
but did not receive support, at an ECLO site, the cost per ‘QALY sustained ‘was £3,348 for an 
ECLO with a Band 4 salary compared with patients not getting support at an ECLO site.  This 
increased to £4,102 per ‘QALY sustained’ compared with patients who did not get support, when 
the Band 5 was used. 
 While the CUA was limited by the small patient numbers at follow up, a similar picture of small 
QALY losses across time was seen for unsupported patients, but the magnitude of differences is 
small and showed weak statistical significance.  
 ECLO support for patients could potentially be regarded as cost-effective when compared to a 
‘world without ECLO support’ by commonly accepted norms, such as the NICE thresholds of 
£20,000 - £30,000 per incremental QALY gained. These trends show promise but additional data 
collection would strengthen the statistical analysis. 
_____________________________________________________________________________________ 
Cost-effectiveness analysis (CEA) is a form of economic evaluation that utilises a single, specific, one-
dimensional, health or clinical outcome for competing health intervention.  Cost-utility analysis (CUA) is 
a special type of cost-effectiveness analysis where multidimensional health outcomes are reduced to a 
single dimension reflecting individuals’ preferences for the diverse health outcomes. The most 
commonly used outcome in cost-utility analysis is the quality adjusted life year (QALY). Both forms of 
analyses are incremental analyses comparing  an intervention with the alternative(s) For CEA and CUA, 
value for money is identified using a measure of the additional cost per additional outcome ratio (e.g. an 
incremental cost/QALY ratio). This ratio is then compared with that of an external threshold, like that of 
NICE, to evaluate the value of the new policy with ratios for other policies. 
QALYs combine quantity and quality of health to calculate outcomes based on treatment or services or 
other activities that influence health. Life years are weighted by the values (utilities) ascribed to the 
health states and are generally derived from surveys or research studies. This provides a method of 
measurement for the impact of disease or treatment on an individual's ability to function and how that 
impacts HRQoL. The utility scale ranges for from 0 (death) to 1 (perfect health); however, it is possible to 
have a minus score for a state worse than death. 
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In this section, a CUA using patients’ EQ-5D utilities scores and the cost to the NHS of an ECLO employed 
at Band 4 is reported.  The cost of an ECLO at Band 5 salary is used for sensitivity analysis. The time 
horizon for this CUA analysis is 12 months. 
5.5.2 COST EFFECTIVENESS OF ECLOS 
The results of the costs per QALY analyses are reported in two ways. The first analysis compared 
patients only within the ECLO sites compared with patients within the non- ECLO sites. The second 
analysis compared patients who saw an ECLO compared with those who did not see the ECLO 
intervention (but had self-expressed needs for support). The base-case for both analyses is based on the 
cost of providing an ECLO at a clinic at a Band 4 salary. In order to assess the impact of different staff 
costs (as these could differ in usual practice); a sensitivity analysis was undertaken by increasing the cost 
of an ECLO to a Band 5 salary.  We assumed no other costs for providing ECLOs, and that the 
ophthalmology clinic would not incur any extra costs by provision of ECLO.  In reality this may not be 
true if additional office space was required or other facilities were needed to enable an ECLO to 
function. 
Table 5.26 shows patients’ EQ-5D scores derived from the survey at the ECLO sites and non-ECLO sites, 
as well as patients receiving support from the ECLOs and those who reported that they needed support 
but not did not receive it (from anyone).  A fuller explanation of the patient types, defined by their 
responses can be found in section 5.2. As reported in Table 5.26, the average baseline EQ-5D score for 
patients attending non-ECLO sites is higher (i.e. better HRQoL) than for patients attending ECLO sites. 
However, the magnitude of difference between EQ-5D scores at follow up, compared with baseline, was 
greater in patients attending the non-ECLO site, than for those patients attending the ECLO supported 
sites.   
A similar pattern was seen when comparing patients receiving support from an ECLO compared with 
those who did not receive support, but needed it i.e. baseline utilities were higher in the latter group 
but decreased further when assessed at follow up.  These differences reveal an interesting trend, but 
the differences were not statistically significant, which may have been due to low patient numbers. 
5.5.3 INCREMENTAL COSTS 
To estimate the cost of providing the ECLO service, we used the ECLO activity data that patients had on 
average, over the 12 month period, 76 minutes (1.27 hours) of ECLO support some of which would be 
personal contact with patients and the rest where the ECLO works on behalf of the patient.  
From Table 5.19, we took the average unit cost per hour for community based professional staff (the 
equivalent staff definition and banding in which an NHS ECLO is employed) as £29 and £36 for band 4 
and band 5 respectively, therefore the total incremental cost for the ECLO over and above the usual cost 
of running a clinic is £36.83158 using an NHS band 4 staff cost and £45.72based on NHS band 5 staff cost.  
Our assumption, for the purpose of costing, based on the qualitative evidence and the staff survey data, 
is that ECLOs have a specific role and provide a valued added service and they do not substitute for 
                                                     
158
Using  band 4 salaries which are £29 per hour, the incremental cost would be £29*1.27=£36.83 for one complete visit to 
ECLO, and £36*1.27=£45.72 using band 5 salaries. 
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other clinic staff.  Thus the analysis is based on the assumption that the ECLO cost is all additional and 
that there is no substitution effect. We have taken a conservative approach to this analysis.  We 
assumed that after the follow up survey, the EQ-5D scores flattened out remaining at the level of the 
follow up score, for the remaining months in the 12 month period.  This is a conservative assumption 
because the reality might be that patients whose values fell because they did not see an ECLO might 
have further diminution of their HRQoL and this utility score would also diminish.  It might also be the 
case that HRQoL in the patients seen by the ECLO might have an increase in HRQoL and their utility 
score rise.  Either or both of these scenarios might increase the difference between groups and amplify 
the QALY gain. 
5.5.4 INCREMENTAL COST EFFECTIVENESS 
ECLO site and non-ECLO sites 
The QALY estimations over time are presented in Table 5.27. This is based on the baseline utilities 
derived from the 185 patients attending the ECLO supported clinics and 73 attending non ECLO clinics, 
of those 84 patients from the ECLO clinics and 20 from the non ECLO clinics were re-interviewed at 3-4 
months. The analyses presented in Tables 5.27 to 5.30 are incremental analyses; the definition of the 
ECLO and patient activity is shown in the upper row comparator for the analysis is shown in the lower 
row and the incremental QALY, incremental costs and the incremental cost per QALY shown in the three 
right hand rows. 
TABLE 5.27 · Incremental cost per QALY sustained with patients at ECLO and non-ECLO site, using 
Band 4 costs (base-case analysis) 
Site Time period EQ-5D score 
Change over 
time 
Incremental 
QALY 
Incremental 
cost of ECLO 
Cost per 
QALY 
Patients at 
ECLO site 
Baseline  0.78 - 
0.013 £36.83 £2833.08 
Follow up 0.77 -0.001 
Patients at 
non-ECLO site 
Baseline  0.84 - 
Follow up 0.76 -0.014 
TABLE 5.28 · Incremental cost per QALY sustained with patients at ECLO and non-ECLO site, using 
Band 5 costs (sensitivity analysis) 
Site Time period EQ-5D score 
Change over 
time 
Incremental 
QALY 
Incremental 
cost of ECLO 
Cost per 
QALY 
Patients at 
ECLO site 
Baseline  0.78 - 
0.013 £45.72 £3516.92 
Follow up 0.77 -0.001 
Patients at 
non-ECLO site 
Baseline  0.84 - 
Follow up 0.76 -0.014 
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TABLE 5.26 · EQ-5D scores for patients at ECLO sites and non-ECLO sites and patients receiving support from the ECLOs and not receiving support 
(independent of site type) 
EQ-5D 
ECLO site Non-ECLO site 
Mean SD Median Min Max 
95% 
confidence 
intervals 
Mean SD Median Min Max 
95% 
confidence 
intervals 
Baseline 0.78 0.24 0.84 -0.02 1 
(0.748 
0.816) 
0.84 0.26 1 -0.06 1 
(0.783 
0.905) 
TOTAL 185 73 
Follow up 0.77 0.24 0.83 -0.12 1 
(0.726 
0.828) 
0.76 0.24 0.83 0.16 1 
(0.645 
0.873) 
TOTAL 84 20 
DIFFERENCE (P VALUE) -0.01 (0.51) -0.08 (0.09*) 
   
EQ-5D 
Support received from ECLO Support needed but not received 
Mean SD Median Min Max 
95% 
confidence 
intervals 
Mean SD Median Min Max 
95% 
confidence 
intervals 
Baseline 0.71 0.25 0.76 0.13 1 
(0.625     
0.768) 
0.76 0.27 0.86 -0.02 1 
(0.654   
0.858) 
TOTAL 73 30 
Follow up 0.70 0.22 0.68 0.08 1 
(0.622     
0.775) 
0.68 0.29 0.69 0.16 1 
(0.473   
0.885) 
TOTAL 35 10 
DIFFERENCE (P VALUE) -0.01 (0.21) -0.08 (0.53) 
*Indication of ‘weak’ statistical significance i.e. 91% sure that the difference did not arise by chance
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TABLE 5.29 · Cost per QALY sustained for patients receiving support from ECLOs and those who 
needed support but did not receive it, using Band 4 costs 
Type of patient Time period EQ-5D score 
Change over 
time 
Incremental 
QALY 
Incremental 
cost of ECLO 
Cost per 
QALY 
Patients who 
receive support 
from ECLOs 
Baseline  0.71 - 
0.011 £36.83 £3,348.18 
Follow up 0.70 -0.002 
Patients needing 
support but not 
received 
Baseline  0.76 - 
Follow up 0.68 -0.013 
TABLE 5.30 · Cost per QALY sustained with patients receiving support from ECLOs and those who 
needed support but did not receive it, using Band 5 costs 
Type of patient Time period EQ-5D score 
Change over 
time 
Incremental 
QALY 
Incremental 
cost of ECLO 
Cost per 
QALY 
Patients who 
receive support 
from ECLOs 
Baseline  0.71 - 
0.011 £45.72 £4,101.82 
Follow up 0.70 -0.002 
Patients needing 
support but not 
received 
Baseline  0.76 - 
Follow up 0.68 -0.013 
The incremental cost per QALY shown in Tables 5.27 and 5.28 suggest that compared with patients 
attending  non-ECLO clinics, there will be £2,883 extra cost to help patients maintain one year of perfect 
health when an ECLO is paid at Band 4 salary and £3,517when an ECLO is paid at Band 5 salary.  
Patients who received support compared with patients who needed support but did not 
receive support 
Seventy-three patients received support from ECLOs, of which 35 had complete survey forms at follow 
up. As described above, the incremental costs were based on the different salary costs for the ECLO.  
Tables 5.29 and 5.30 report the QALY change over time for the two groups through reporting the ICER.  
This estimates that in patients who received support from an ECLO the cost per ‘QALY sustained ‘was 
£3,348 which increased to £4,102when the higher salary band was used (Table 5.30). However, there 
are a number of important limitations to this analysis. Aspects of selection bias and response bias need 
to be acknowledged in terms of the overall quality of the evidence on which these estimations of costs 
and outcomes were derived. The impact of an ECLO on health and social services have not been taken 
into consideration, leading to an underestimation of the total benefits and costs:  an ECLO doing a good 
job could increase uptake of social services in short term as well as save costs to NHS downstream.  
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At the time of undertaking the analyses; the final UK population norms for the EQ-5D 5L had yet to be 
published thus the recommended ‘cross–walk’ algorithm to the EQ-5D 3L version from the EuroQoL 
group was used to derive utilities (http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-
value-sets.html) from the patient survey data.  
The calculation of the QALY has been undertaken in a simplistic manner. It has been derived directly 
from the utilities derived at baseline and follow-up used to report QALY gain/loss over time with no 
consideration of the impact of truncated data taken into account. An important consideration is the 
baseline differences in utilities which could be down to a variety of factors as this was a non-randomised 
sample. Thus any comparison attributed to an ‘intervention’ effect on utilities and subsequent QALYs is 
problematic to interpret and further examination is needed to explore and deal with such baseline 
imbalances.  
The sensitivity analysis undertaken has only considered the impact of changing one parameter variation 
(cost) as part of different scenarios.  As shown in Table 5.26 there is wide variation in the 95% 
confidence intervals in the utility estimates and further data collection is needed to reduce these and 
assess the impact on the findings.  
In summary; while the two analyses undertaken are exploratory and limited by the small patient 
numbers at follow up, they revealed a similar picture of small QALY losses across time for unsupported 
patients. While these differences were weak (i.e. results were not statistically robust), the results 
suggest economic benefits, in addition to the patient benefits of an ECLO.   
The lack of statistically significant difference seen in the other sub groups is not evidence of no 
difference, but may be a function of sample size.  The original sample size estimates were based on a 
straightforward comparison between ECLO and non-ECLO sites but as our research progressed we came 
to understand that there were other important comparisons to make to explore differences between 
patients attending ophthalmology clinics – particularly those who stated they had needs but were not 
seen. However, we see some suggestion that ECLO support for patients could potentially be regarded as 
cost-effective when compared with usual care; with the sensitivity analysis showing that altering the 
costs of the ECLO would impact on the ICER but would still remain within the NICE ‘threshold’ based on 
a societal willingness to pay threshold of £20,000- £30,000 per QALY gained. However, such an 
interpretation should be considered with appropriate caution within the strengths and limitations of the 
analysis. 
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6 DISCUSSION 
In this section, we will discuss the three fundamental areas for exploration identified at the beginning of 
the study in light of our findings and explore options for moving forward in light of this research. By 
doing so, we will hopefully shed further light on how our evidence demonstrates that ECLOs can have a 
positive impact on patients, optimise management of ophthalmology clinics, and how ECLOs enhance 
and broaden the care which clinical services provide, thereby potentially reducing patients' longer-term 
care needs.   
We also describe how we believe that, informed by the findings from this project; there are seven broad 
types of valued service and support provided by ECLOs, working in ways which reflect the individual 
circumstances of different clinics and hospitals. 
In other parts of this report we indicate that the evidence of ECLOs impact on overall service costs, 
productivity and efficiency is less clear; however from the accounts that have been captured during the 
project, we believe that they make a contribution to various other NHS objectives relevant to all four UK 
nations.  We approach this discussion from the broadest possible consideration using a range of 
evidence to ensure our conclusions are linked to, informed by and relevant to those involved in the 
provision of ECLOs across the UK. One of the strengths of the study is that the team have considered the 
impact of their role in a number of ways, by interrogating the different sources of data – for example, 
the strength of the qualitative work alongside the economic analysis adds value because in context 
people value different things differently. 
6.1 WHAT IS THE IMPACT OF ECLOs ON PATIENTS? 
6.1.1 HOW DOES THE ECLO ‘ADD VALUE’ FOR THE PATIENT? 
As we have reported, in many instances ECLOs are a link between health services, social services, and 
wider community and voluntary sector groups. They point to a vision of more integrated services and 
systems which look after the needs of the visually impaired patient/citizen (as opposed to just ‘patient’), 
securing not only the immediate clinical needs but also their rights and entitlements as citizens. Equally 
importantly, to many we interviewed, they represent a welcome development in the overall care of 
those who are sight impaired. 
There is not a settled, one-size-fits-all model for ECLO activity; we would maintain that each service, 
while conforming to certain common values, actually reflects local needs and priorities to a greater or 
lesser extent. For example, whereas the majority of ECLOs are based in single acute hospital clinic, 
others we talked to were peripatetic, and cover a large geographical area, visiting several clinics. 
Whereas some ECLOs come from a nursing or medical background, and are often able to spend part of 
the week in those roles, other ECLOs come from a variety of backgrounds including the voluntary sector, 
or other care services, and being an ECLO is their full-time role. Some also have the lived experience of 
sight loss. This lack of a common professional pathway means that ECLO practice at present is 
heterogeneous in certain aspects, and can be shaped to a degree by those in post, wherever they are. 
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In terms of capacity, our findings suggest very strongly that having an ECLO service, in whichever guise, 
usually adds to the capacity of clinical teams by enhancing the efficiency of those teams, ensuring that 
patient pathways and other processes work more efficiently and in a timely manner for the patient. 
Furthermore, the services offered would seem to be more holistic, linking both the patient and the 
clinical services to the outside world through information management that uses referral and 
signposting as its day-to-day tools, but is primarily based on the relationships, networks and trust built 
up by each ECLO.  
Broadly speaking, whether formally or informally, they are an important part of the local eye health 
network, which includes clinical services, social services, private providers and the voluntary sector. By 
developing critical relationships, networks and trust, ECLOs can often be instigators and critical nodes in 
these local eye health networks, e.g. by bringing together professionals, making sure that information 
flows properly form place to place. They can have a stabilising effect on the network, because they can 
act as a feedback loop that indicates the health of that local system: if there are blockages e.g. in the CVI 
registration, which in turn might affect other systems, then they will sort things out. The information 
flow is often bi-directional; they not only refer out into other services, but they also bring in information 
to clinical teams about services available. This is reflected in the excerpt below from one of our 
interviews: 
INV: So you refer people to them that aren’t just, that aren’t registered as well? 
ECLO: Yeah, we also have the people who are not actually eligible for registration if we think they’re 
struggling and they need extra… 
INV: Yeah 
ECLO: We have another form from Social Services or we can just ring them up, and anybody who’s at 
risk, you know and needs help urgently; we can ring them up and highlight them, so...we’re pretty 
good with that. 
INV: Yeah, so is that so that patients you’re particularly concerned about, they get prioritised? 
ECLO: Yes. I mean at one point our social services, I mean quite a few years ago, were nearly two 
years behind. 
INV: Right. 
ECLO: And then I think they’re about, I think they’re about two or three months behind now 
ECLOs thrive on building collaborative relationships; becoming trusted ‘members’ of the clinic staff  was 
is seen as  crucial to ECLOs being able to work, whether or not they have clinical training. They need the 
clinical teams to refer to them with confidence. 
ECLOs are fundamentally patient-centred in their approach.  They provide the sort of immediate 
emotional support in the clinic setting which clinical colleagues might find difficult to offer.  Not only is 
this support anticipatory, in the sense that they are uniquely placed to see what support might be 
needed for certain conditions, but we have heard how they also help develop emotional resilience in 
what can be life-changing circumstances for patients. Some ECLOs take an approach that can loosely be 
modeled on ‘harm reduction’ – to reduce the risks of harms through deteriorating vision; they will 
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instigate support at a very early stage if possible. We could further connect this harm reduction 
approach to the practice of outreach by some ECLOs or indeed others who have similar roles or skills: by 
going out to the community, engaging in Sight Loss courses or giving talks to groups, they are potentially 
making clinical and other services more accessible. 
Through our interviews it also became apparent to us that with severe sight loss at the heart of the CVI 
registration, for example, giving people the time to effectively ‘grieve’ means that ultimately they might 
be able to cope better. Whilst ECLOs do engage with people at every stage of their sight loss, for those 
who are reaching the end of their treatment, the ECLO is especially important. When the limits of 
medical expertise are reached, the ECLO helps to support and guide so that life can be made bearable. 
Related to this, we have heard many accounts of how ECLOs can be proactive in their approach and will 
seek to engage early on in patient pathways such as diabetic care or falls care. ECLOs seek to help those 
patients with the greatest needs maintain their health-related quality of life by providing a wide range of 
well-targeted, well-appreciated services. They will often seek out the best practical options for life 
outside the clinic to support these care pathways. By trying to engage early on, they contribute to 
preparing the patient emotionally, developing their coping skills: 
‘It’s the quality you can bring to a patient’s life I think, the quality service, a way of life, a coping 
strategies.  It is, it is just a good experience, an all-round experience, and its part of our patient care, 
and it enhances the patient experiences and enhances their lives I would say’ [ECLO] 
We heard how many ECLOs will use the CVI process productively. Far from being just another 
administrative task, it is an opportunity to offer help and further information that is relevant to the 
individual needs of the patient: 
‘The majority of patients are referred to me because they’re being registered.  That constitutes the 
referral from the consultant that’s registering them.  I will talk to them about everything. For 
example, what problems does their sight loss pose to them at work? Do they live alone?  If so, how 
do they manage?  Of if they live with someone what sort of tasks are they having to pass on to their 
partner, mum, dad, son?...All sorts of reasons why they come, but they all get asked the same 
questions, but with registration they get extra information about what registration means’ [ECLO]  
Those who had longstanding clinical experience and expertise, and the institutional memory both within 
clinical teams and in other support roles, gave multiple examples of how the CVI system had improved 
as the ECLO role had developed:  
‘So as an in between us they’re very good, but it’s not only just between health and social care, it’s 
also between health and the community, because the ECLOs in that link to local societies and to 
other support groups.  Again, you know if a person wanted to … is struggling to get the support or 
whatever, they can always go back to the ECLO and they then can help to try and sort out the 
referral to them’ [ROVI] 
‘The ECLOs are good here because they’ve got connections that it’s really difficult for us to make…’ 
[Ophthalmic Nurse] 
The ECLO is a trusted and valued part of the provision: 
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‘They usually remind the consultant that they need to be sending off the documentation, which is 
good because then we can get it faster than normal’ [Medical Secretary]  
‘The ECLOs usually let us know that/if the document’s there. The other side of the coin too is if they 
need background information on somebody, say because the information that came through from 
the person themselves is not 100% accurate, the ECLOs can act as a link between us and the 
consultants, so we can get some background checks on, make sure that we’ve got the eye conditions 
right and everything else’ [ROVI] 
As we discussed in the previous section, ECLOs often have an awareness raising role to play within 
teams also. In some accounts, this included being part of the induction process for doctors, or having 
input into falls prevention teams. This need to ‘bang the drum’ for the ECLO role, making sure that 
everyone is aware of who they are and what they can do, is essential if the right referrals are to be 
made. 
But in some clinics, they also have a varied awareness raising role as patient-facing staff, ranging from 
explaining the realities of anti-VEGF treatments to showing the patients the correct way to administer 
drops. This can also mean time saved for other clinical staff: 
‘The main thing that patients value is for the ECLO to explain the process of anti-VEGF treatments, 
and the ‘reality’ of this and what it will mean for them. That is reassuring for them to know how this 
will go, what it will feel like as they have their treatment. This is priceless for them to have some 
education on this. Without an ECLO this would take longer, and mean that there would be much 
greater time spent in the clinic for patients and mean that we can maximise the number of people 
that we can see. It helps to optimise the running of the clinic, and the 10-15 minutes that I would 
have to spend with that person can be reallocated and I can do other things’ [Optometrist] 
Some also have an awareness raising role outside of the clinic environment e.g. running or taking part in 
Living with Sight Loss courses in the local community. It would seem to be part of the core ECLO skills, 
being able to explain the various types of eye condition in terms which can be understood. 
The point at which an individual’s low vision reaches a stage where they are eligible for CVI and 
registration is either an opportunity to access social services or a perceived threat from these services - 
‘being put in a home’ or admission of ‘loss of independence’ that may make a person reluctant to 
engage with services and the CVI process.  There are also practical tasks that can be daunting; claiming 
benefits, understanding what allowances are available and how to access these. The ECLO is in a unique 
position to engage with a person as they attend an ophthalmology clinic and provide support – whether 
that be practical, emotional or both. 
6.1.2 HOW DOES CONTACT WITH THE ECLO IMPACT ON THE QUALITY OF LIFE FOR PATIENTS? 
As detailed in our literature review, the evidence points to the significant impact low vision can have on 
in individuals, particularly in terms of the increased risk of falling, the fear of falling and actual fall events 
that may isolate people socially, and the high rates of depression experienced by the people attending 
low vision rehabilitation services reported in the DEPVIT study.159 It is also well documented that all of 
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 Nollett et al (2016), op. cit 
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these factors and others, contribute to a relatively lower HRQoL for people with low vision than a 
similarly aged person in the UK. 
Our data show some tentative indications that the support of an ECLO can maintain health related 
HRQoL, which otherwise deteriorates in the absence of ECLO support.  Our data collection was limited 
by the study timeline; if a routine EQ-5D data collection could be enabled in partnership with 
ophthalmology services these analyses could be strengthened.  Healthcare providers and commissioners 
are becoming more engaged in enabling outcomes data to be collected and analysed and value this 
information; this could be the right time to initiate discussions using this research and these data as an 
example of how this can be facilitated. 
6.1.3 ARE ECLOs TARGETING THE RIGHT PEOPLE? 
Our survey data reporting the EQ-5D scores, split by domain, show that the survey respondents 
experience problems with anxiety/depression, reinforcing the DEPVIT findings for patients attending 
general ophthalmology clinics (the DEPVIT study surveyed patients attending low vision rehabilitation 
services).  Our analyses indicate that the ECLO does see the patients experiencing problems measured in 
all the EQ-5D domains, including anxiety and depression and those who expressed the need for support 
and received it, suggesting that ECLOs are able to ‘target’ the right patients, but questions must be 
asked about the respondents who said they needed help and did not receive it.  We assured the study 
sites that we would maintain anonymity so cannot identify the sites where people fell through the gaps 
but overall our data suggest that there are not enough ECLOs to meet demand and to actively find and 
engage with patients who want support.   
6.2 WHAT IS THE IMPACT OF ECLOs ON CLINICS? 
6.2.1 WHAT IS THE IMPACT OF AN ECLO ON CLINIC ACTIVITY? 
The qualitative data is unequivocal about the value of the ECLO and how they ‘oil the wheels’ of the 
clinic and how they support patients.  One of the objectives of this project was to identify and quantify 
the economic impact of the ECLO.  One of the ways we hypothesised the ECLO might deliver economic 
benefits was through relieving other clinic staff of ‘ECLO-like’ patient support activities releasing 
capacity within the clinic.  A critical input to the economic analyses and the simulation model was the 
clinic staff data collection and the ECLO activity data collection.  
Contrary to the hypothesis that was developed in part by clinicians themselves, it has not been possible 
to prove in quantifiable terms that the presence of an ECLO does specifically free clinic staff to carry out 
more clinical activity.  This somewhat paradoxical result is simply explained by the fact that clinics 
without ECLOs apparently provide less non-clinical support ‘ECLO-like’– the clinical staff are too busy to 
offer much of such support.  The presence of ECLOs therefore generally enhances provision, rather than 
improving efficiency per se by freeing clinical staff to do what only they can do. In fact we see indications 
in the data that in ECLO sites staff spend a little more time on emotional support and other non-clinical 
activities, such as signposting to services etc. than at non-ECLO sites.  On closer inspection of our 
findings, this is not surprising – it is clear that ECLOs are enabling and adding quality and value, and in 
the judgement of those working in clinics, do much to make the clinic more cohesive and streamlined.  
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However in an environment where resources are stretched very thinly and there is a significant need for 
the ECLO activities we can understand why our survey findings do not reveal any substitution capacity – 
time is short and not much is spent on patients doing anything but the clinically necessary. Thus the 
reality of the staff data collection suggests that in non-ECLO clinics the staff do not spend much time per 
patient on performing as ‘ECLO-like’ staff. 
In a small number of centres the interviews for the qualitative research found that their ECLOs explicitly 
take on tasks such as supporting people to gain confidence in the self-administration of eye drops – here 
a substitution of the ECLO for clinic staff is evident.  However this activity is relatively rare in our study 
sample and the RNIB advised us that this type of work was not central to the ECLOs’ role as currently 
configured, unlike giving emotional support. This drives up the quality of care based on what matters 
most to people with sight loss. 
We also learn from the ECLO activity data, the staff survey and the qualitative work that CVI completion 
is best done in partnership with the ophthalmologist and the ECLO as a team – that way the most 
comprehensive and accurate information is collected and subsequently social services are best enabled 
to support the patients.  The ECLOs provide extra time and support for patients, rather than delivering 
support that other staff gives.  In fact, our data suggests that in a clinic setting where there is an ECLO, 
the staff provide the same amount of time supporting patients as in a non-ECLO site, or more, on ECLO 
like support activities.  It may be that the ECLO service supports a culture of patient centred care, or that 
clinics that have been successful in engaging an ECLO to support the service have a more patient centred 
culture than those who do not (or simply have more funding).  These questions may warrant further 
investigation; however, it is clear from our research that the ECLOs provide considerable added value 
and potentially and contributing to maintaining HRQoL for a patient who is attending an ophthalmology 
clinics. 
The ECLO activity data is a valuable resource and has been fundamental as a source of evidence for this 
research.  We acknowledge that its primary function may not be for research but we cannot overlook its 
power to provide evidence to commissioners as to where and for whom the ECLO service is targeted 
and how the ECLO impacts services and outcomes. Enriching the data collection without overburdening 
the ECLOs is something to consider if its utility for research and evidencing the impact of ECLOs is 
desired. 
From our research, we would suggest that ECLOs have a beneficial and welcome impact on the activities 
of most clinics. They are often involved in key processes and pathways which have a large impact on 
helping patients to progress and receive the care needed in the various systems that they have to 
negotiate. From the accounts given, ECLOs would seem to speed up and take the pressure off certain 
aspects of clinic activity, thereby freeing clinicians to see more patients. For example, many are involved 
in the CVI registration process; what was seemingly quite an ad hoc system in many places has been 
largely improved.  
Likewise, time spent giving ‘emotional support’ (which covers a whole range of activities) is the core part 
of the ECLO practice within the clinic. ECLOs can also improve the communication that happens 
between clinical staff and patients, especially if people are upset. It is obvious that communication isn't 
something that can be exclusively left to the ECLO, and some recognise that they still need to improve 
their own skills. Further that depending on local context, there will likely be value added by the ECLO – 
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for example in respect of having good quality discussions with people at length – over and above what 
may be provided by the clinic staff: 
‘Communication with patients is part of our CPD and part of our role. It shouldn’t be that it’s split 
between us doing a particular role and [the ECLO] doing the pastoral care. It’s an integral part of my 
job and if I can’t do it very well then I need to learn how to do it.  It’s just continually developing.  A 
patient will come in you’ll discuss their eye condition, ask them how do you feel your eyes are? You’re 
asking them general questions and gauging their reaction, how much they understand about their 
condition, what drops they are using. You tell them information as you’re going and try and gauge 
the retention and understanding of it and you just change depending.  You may get another patient 
coming in who clearly doesn’t understand their condition and is very distressed by it and they may 
need 10 minutes of my time just talking about it. It’s very difficult to put a figure on it’ [Optometrist] 
As noted, the ECLO role is very much about communication between patient and community as they get 
used to the diagnosis, but also about good internal communication – they make sure that parts of the 
eye care team work together.  
In some of our accounts, we heard that this communication is bi-directional – information flows out 
through the ECLO in terms of referrals to other services e.g. ROVI, but also the information about 
services and what’s available locally flows back in to the clinical teams through the ECLO. When a ROVI 
needs to check on a referral which might be needed to take things forward outside clinic, then the ECLO 
is the point of contact and can hurry things along in terms of getting everything signed and ready. The 
ECLO can also be kept up to date about what’s going on locally in terms of social services, rehab team 
provision etc. through the ROVI, and pass this information on to colleagues. 
INV: ‘In terms of convincing the people in the hospital that this was an investment that they should 
be making – were those processes ever questioned or negotiated or was is straightforward?’ 
ECLO: ‘No I think quite quickly because of patient feedback to the consultant – “thanks for referring 
me to the ECLO service because this has happened” – and I very quickly as well started to chip in 
education at the clinical audits in the hospital – so if there as a change in benefits I would ask for a 
slot and start to update them on what was changing and patients are likely to come in and ask for 
this information and this is why.  So they were feeling well this is informing us – this is helping us 
deliver a better service to patients. So it depends on how good your ECLO is, but merely the fact that 
you’ve got an ECLO means that there is a lot of stuff that you don’t have to do in the clinic apart 
from the bare essentials that you have to do.’ 
We would argue that ECLOs stimulate change, provide a valuable feedback loop in terms of the health of 
systems, and improve the offer of clinics in general. By connecting everything that needs to be 
connected for the patient/citizen, they lift the overall quality of the clinic by looking beyond the vision 
and the visual:  
‘Because I’ve never not had one so I don’t know why you would not have one. The role for doctors 
here is just to see patients and treat them and not really consider what happens beyond. I think they 
wouldn’t think of the role of ECLO…but if you are going to give the whole package as I call it from not 
just looking at their visual needs but looking at more than just their visual needs, I think the ECLO 
role is indispensable…they are essential’ [Consultant Ophthalmologist] 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 130 
6.2.2 CORE ECLO ACTIVITIES AND THE SEVEN DOMAINS OF ECLO PRACTICE 
Although ECLO practice differs across sites and the UK nations, certain ‘domains’ of activity emerge from 
this research, which offer a useful framework for considering the role.160  We were able to discern seven 
domains of ECLO practice which seemed to be common and reflect some underlying characteristics of 
the role, depending on those local contexts, needs and the skill-set brought to the role by individual 
practitioners. We would contend that that there is a dynamic element to ECLO practice which enables 
the role to evolve according to local needs – and this adaptability might be a valuable feature of the role 
– but there are also domains of practice which came through in the data and seem worth examining.  
These are mainly indicative categories, and in no way mutually exclusive i.e. an ECLO’s day-to-day 
practice might have elements of all these activities at different times and with different patients (see 
Figure 6.1). 
FIGURE 6.1 · Seven domains of ECLO practice 
 
The enabling aspect here is key.  As we have heard in the interviews, when one set of (healthcare 
professionals may have said that they can do no more, an ECLO can be the gateway to other options in 
terms of help and support. In this way they build a capacity for care which is not only restricted to the 
clinic, but is networked across the local eye health support network.  As in social work and other 
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professions, ECLOs often have both networked power and a networking power. 161 In the former, ECLOs 
interact and facilitate aspects of the ‘care’ network e.g. by taking charge of the CVI process. In the latter, 
ECLOs use the tools of referral and signposting to activate other relationships. ECLOs help their ‘clients’ 
to navigate several different systems and frameworks: clinical, welfare, social care – their networking 
power is central to how they do this, as they build up their local knowledge and contacts. 
Core ECLO activities 
By this we mean the activities which seem to be ubiquitous in the data when interviewing the whole 
range of those who participated - like providing emotional support, expediting certification and 
registration processes, engaging in signposting and referral, seeing people as people and undertaking an 
‘embodied’ practice where connection at a basic human level is valued and practised. These are 
seemingly values which are common in the data regardless of funding, geography and other 
circumstance. If care here is fundamentally about learning to live life with disease (‘coping’), then ECLOs 
enable care to take place. It is also ‘holistic’ activity, in the sense that they very often ‘complete’ the 
service of caring for the patient, when clinical options for the effective treatment of patients have come 
to an end.  
To an extent, the core activities have been explored quite thoroughly in the preceding sections of this 
report, but we would reiterate that they would seem to revolve around the main categories of capacity 
building, relationships, patient-centred practice and a skills and knowledge base which encompasses the 
awareness raising role(s), which often fosters resilience through emotional support, as well as other 
types of practical help. Although nominally both the health and social care systems are about helping 
the patient/citizen to thrive in the face of disease, ‘care’ involves a range of people: the patients 
themselves/family, professionals, and because it is integral to daily life it is necessarily complex, 
sometimes hard to identify and measure. 
The following descriptions are of aspects of ECLO practice that came to the fore in our interviews, and 
which individual ECLOs might display a particular tendency towards – or else, might display a 
combination of these approaches as part of their palette of skills. 
Pastoral 
In the pastoral aspects of practice, ECLOs use expertise in guiding the patient/citizen through the various 
clinical and non-clinical systems which might be needed to provide care for the citizen and that 
potentially might help them adjust to sight loss, by providing the best possible care. It would seem from 
our interviews that some ECLOs were particularly adept at this, and even though it could be argued that 
this is in effect a key characteristic, it is a domain which some seemed to emphasise more as part of 
their professional practice. This includes advocating in the benefits system, making sure that people are 
getting all entitlements – beyond just signposting to outside agencies. There is a sense in which ECLOs 
act as pastoral ‘shepherds’ – one ECLO calls her patients her ‘flock’ – actively guiding them through with 
a calm and expert hand. ECLOs also operate as quasi-religious ‘pastors’, offering time and a listening ear 
to the troubles and challenges of those in difficulties. They can further act in a ‘confessional’ mode, 
hearing people talk in confidence   - many patients are more comfortable talking about their lives to 
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non-medical staff. Pastoral ECLOs tend to make time for long-term engagement with patients where 
needed, so that help and support is given at the point at which the patient/citizen is ready to accept it 
(as much as needing it). 
Advocate 
By advocate ECLO practice, we would draw attention to those who are concerned with making sure that 
patient/citizen’s right and entitlements are fully met, and are able to advocate for these not only within 
the clinical system, but also with employers or aspects of the welfare system. Superficially, there are 
similarities here with the pastoral domain, but we would emphasise the ability to go beyond referral or 
signposting to agencies outside of the clinical environment. Equally important is the ability to advocate 
on behalf of the patient/citizen within the clinical system or pathway. 
Experiential 
The experiential or lived experience ECLOs are those who bring to the ECLO role relevant lived 
experience of sight loss, or their professional experience in a closely related caring profession such as 
nursing. In some of our interviews, there was a sense that there were insights offered by those who had 
trodden the same path which gave a greater sense of passion and empathy. There are some nurses who 
are ECLOs, and they can bring a more specialised clinical knowledge to offer the patient, as well as 
already being more integrated into the NHS system locally. Others’ experiences are different and will 
have different strengths to bring. It is also important to state that some ECLOs’ personal experience of 
sight loss is a crucial part of their professional practice and their skills of empathy are highly valued by 
patients. 
Awareness-raiser 
We have already examined the awareness raising aspect of ECLO practice, but we would suggest that 
some ECLOs have a particular interest in making sure that colleagues within the clinical environment 
especially are kept up to speed with the ECLO role, and with making sure that information from outside 
of the clinical sphere e.g. about changes in benefits which might affect the patient/citizen, are widely 
disseminated, or that any new members of a clinical team are made aware of the ECLO role. This 
domain also covers those who have an outreach role or are able to offer courses in the community, for 
instance. 
In-betweener 
The description of ECLOs being an ‘in-betweener’ service came from an interview with a ROVI, and we 
thought that it effectively described how some ECLOs are very adept at linking to all kinds of services 
and agencies. As a key part of the local eye health network, the ECLO is that node of information that 
enables networked power, and is able to connect the services necessary for the care of the 
patient/citizen. They navigate people successfully through the complex and challenging pathways that 
face them. Some ECLOs literally place themselves in-between clinics, and tend to be more peripatetic – 
often travelling to other clinics. They are also increasingly concerned with other outreach activities 
which might be giving talks with outside groups and agencies.  Where clinical judgments will necessarily 
involve a ‘scientific’ assessment of the individual’s health (and further options accordingly), the ECLO’s 
 Evaluation the role and impact of ECLOs · for RNIB – March 2017     Page 133 
options (for the patient/citizen) are more networked and dependent on multiple relationships and 
systems into which the individual might integrate in the world outside the clinic. 
Harm-reduction 
The harm-reduction approach is an aspect of ECLO practice which emphasises taking a belt-and-braces 
approach in terms of processes such as CVI registration, so preventative action is prioritised with a view 
to preventing further more serious harms later on. ‘Harm reduction’ ECLOs are proactive in the sense 
that they will be interested in seeking out those who might end up with significant sight loss before they 
get to that stage e.g. by targeting work around glaucoma and diabetes pathways, and in-patients 
admitted for stroke, for example. They might also be more open to early engagement with the 
certification/registration process, reasoning that the sooner that a person is entitled to the maximum 
amount of help, and that these benefits are in place, then there will be less harm later on, thus 
potentially saving the health and social care system money in the long run.  
Entrepreneur 
The entrepreneur ECLO recognises the need to create awareness and value for their role as an 
important part of the clinical pathway, and uses a range of skills to identify or create opportunities to 
‘sell’ the value of the service to those who have influence. This behaviour is often centred on ensuring 
the maximum number of patients are made aware of their service, and can then be supported by them. 
It is also the case however, that entrepreneur ECLOs are adept at identifying the key ‘levers’ of power 
and aligning themselves with decision-makers to raise the profile of their service. Their system 
knowledge is excellent and they are able to grow their service successfully, to the benefit of patients. 
6.3 WHAT IS THE OVERALL IMPACT ON SERVICES? 
6.3.1 WHAT IS THE IMPACT OF THE ECLO SERVICE ON UK NHS COSTS? 
The qualitative research reported here gives clear evidence as to how the ECLO is valued as part of the 
team.  What is their impact on patient outcomes?  Any data on the contribution the ECLO makes to 
outcomes through giving emotional as well as practical support and how that impacts mental health and 
well-being for a person with sight loss, is relevant. Given the disturbing findings of the DEPVIT study162 
the impact of the ECLO in providing emotional support to people with low vision is timely.   
Another important area of ECLO activity within the clinic is intervening for the patient to reduce the risk 
of falls though facilitating advice, contact with services and building patient confidence in getting out 
and about safely.  As we see from the analyses reported in the chapters above, falls and their 
consequences are not only an unwelcome and potentially catastrophic event for the patient: the impact 
on NHS services and funds is very high.  Any action the ECLO takes to help a person avoid a fall must 
therefore be important. However, the ECLO data reports very limited activity in referrals to falls 
services.  Informally, through the RNIB project team, we understand that these data are not reported 
well by the ECLOs, potentially because falls services are few and far between.  We understand that 
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ECLOs take action in other ways to achieve intervention on behalf of the patient, for example suggesting 
the patient sees their GP to ask for a referral to falls services.   
Whilst falls services may be in short supply, under-reporting this ECLO activity in the ECLO activity data 
seems a missed opportunity.  Additionally, any ‘brief intervention’ that ECLOs can be trained to give 
regarding falls avoidance/building confidence over and above what they do at present and capturing this 
activity may further build the case for the ECLO not only as a ‘value added’ service for patients but also 
pay back through reductions in falls in the low vision population. 
Research undertaken in Northern Ireland, reported by Robinson et al suggests that the ECLO is well 
placed to give advice to the patient on falls prevention and suggests that ECLOs be trained in falls risks, 
falls prevention and post fall management techniques.163  Our estimates reported in section 4.5 suggest 
that any evidenced link to impact of ECLOs in this area could reduce NHS costs. For example, if ECLOs 
could take on the additional training suggested in the report and evidence an active role - perhaps 
delivering a ‘brief intervention’ to patients they anticipate to be at risk or who explicitly express a fear of 
falling - the link between the ECLO activity and a decrease in fall rates gains. The value to the patient, 
confidence in engaging with life and the reassurance this intervention might give them may also play 
through to HRQoL gains.  Equally as we have such strong evidence that the ECLOs are connected to 
services in the community they may have a role, as Robinson et al suggest,164 in educating staff working 
in falls services about the strong link between low vision and falls.  The College of Optometrists report 
gives guidelines as to how this can be done.165 
Similarly, there may be an opportunity for the ECLO to be trained further in recognising the signs of 
depression and proactively facilitating and enabling the patient to access support.  The speculative 
estimations in section 4.5 show how a small reduction in rate of depression in people with low vision - 
through an ECLO facilitated action – can reduce the burden on services and NHS funding, releasing it for 
other services.  Research undertaken by Pybis et al166 suggested that there is a clear need for both 
emotional support and counselling to be available at both the point of diagnosis as well as when needed 
and “embedded into the sight loss care pathway”. Given that there is evidence that the ECLO is 
providing emotional support, there is a case for care pathways to recognise this explicitly and measure 
the impact. It is therefore difficult to establish evidence for a causal link between ECLO interventions 
and their impact on either rates or levels of depression, or the incidence of falls. These links are highly 
plausible, given the evidence marshalled here from a variety of sources about what ECLOs do and how it 
is received, but further data is needed of the types described above. 
6.3.2 WHAT ARE THE SERVICE BENEFITS FOR HAVING AN ECLO? 
Our research shows how, from diverse modes of action, that ECLOs can have a positive impact on 
patients, ease the pressure on ophthalmology clinics and broaden the care which clinical services 
provide, which may play through to patients' longer-term care needs.  
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Although it is clear that the ECLO cannot completely substitute for the consultant in the CVI process, 
there is evidence that the ECLO’s involvement can speed the process, and improve the quality of 
information collected.  Their involvement therefore enables a more useful CVI for the downstream users 
and potentially allows a better uptake and deployment of social services for the patient, and an 
opportunity to engage with the patient and focus on their individual needs. 
We looked for other service benefits that were economically important when an ECLO is present.  
However, the ECLO does not appear to be directly cost saving for the provider (the organization that 
would pay the salary).  In the few cases where an ECLO (at band 4 or 5) takes on a specific role that a 
band 6 nurse may otherwise deliver (such as training in the administration of eye drops), there may be 
some potential to release capacity.  Where this happens the ECLO has to release a meaningful and 
‘releasable’ amount of time reliably and regularly for the nurse and his/her salary budget to be 
redeployed in another capacity - probably a ‘clinic session’ of time on a regular basis.  We don’t have 
any evidence of this happening, but recognition that this task ‘eases pressure’ on the clinic staff.  
In addition to their obvious within, the role and impact of the ECLO is felt outside of the world of the 
clinic; ECLOs are a link between health services, social services, and wider community and voluntary 
sector groups. They enable more integrated services and systems support the overall care of those who 
are sight impaired.  
6.3.3 WHAT WOULD HAPPEN IF ECLO SERVICES WERE EXPANDED? 
ECLO services optimise the capacity of clinical teams by streamlining the work of those teams, ensuring 
that patient pathways and other processes can work more in a more timely manner for the patient. The 
question is, is more (ECLO) better? 
Thinking about patients, the patient survey revealed a significant proportion of patients at ECLO 
supported clinics feel they need support but don’t receive it.  There are signs in the data that these 
patients are at risk of diminishing HRQoL.  This is a signal to us that there may be a case for provision of 
more ECLO support in some centres.  The data are not strong enough given the limitations of sample 
size in this sub grouping, and lack of knowledge of the level of ECLO service at that specific clinic, to be 
concrete evidence of cause (not enough ECLO) and effect (patients whose HRQoL diminishes) but it is 
perhaps the case, locally, that services know where patients are not having their needs met and 
repeating the patient outcome questionnaire in the clinic might be enlightening for service managers.  
6.4 STUDY LIMITATIONS 
An intervention or service that is cost effective is delivering more benefit for more cost, compared with 
the status quo.  We have some tentative evidence, based on our QALY estimates, of cost effectiveness – 
but the sample sizes of the patient groups are small and confidence intervals wide.  Further data 
collection may strengthen this evidence.  In a wider setting we can see that where the additional cost of 
the ECLO is invested, a host of benefits that are not easily measured, are realised.  However the links 
between ‘cause’ – the ECLO – and reduced falls, fewer cases of depression – ‘effect’ – are very weak.  
Again a thoughtful, targeted data collection may strengthen the case for ECLOs not only to be cost 
effective but potentially contribute to a reduction in rates and costs overall to the NHS.  This study 
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confirmed that from a commissioner’s perspective, it is ‘all about the evidence’ and that evidence should 
relate to the local health economy, patient health outcomes, well-being and experience rather than just 
a more general ‘reduction in costs to the NHS’.  
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7 CONCLUSIONS 
This project has provided a breadth and depth of evidence at ‘grass roots’ level to add to what is 
currently known about the role of the ECLO. It now concludes by reflecting on three areas. Firstly, we 
conclude an overview of the findings. Secondly, we consider how the study builds on what is already 
known about information and support provision in eye clinics, and finally, we offer a series of different 
perspectives on the commissioning and implementation of ECLO services.  
7.1 SUMMARY OF FINDINGS AND CONCLUDING POINTS 
In this final part of the report, we provide a concise summary of the key findings across all of the 
different sources of data – summarising the impact on patients, clinics and services. 
7.1.1 IMPACT ON PATIENTS 
ECLOs help those patients experiencing sight loss with the greatest needs. Evidence shows they 
appear to maintain their health-related quality of life over time. They provide a wide range of well-
targeted, well-appreciated services. In particular: 
 The ECLO ‘adds value’ for the patient by recognising the critical issues for them and providing the 
appropriate support and signposting/referring. 
 Contact with the ECLO may impact positively on health-related quality of life for patients in a 
number of ways. 
 ECLOs target the right people but some people may be ‘missing out’, either due to lack of an 
available ECLO, or because they do not access and ECLO where one is present. 
 ECLOs integrate services, securing immediate clinical needs for patients, and also long-lasting 
rights and entitlements; the needs of people are well served by ECLOs integrating health, social 
services and others. 
 ECLOs are proactive patient-centred advocates, reducing stigma, and ensuring people aren’t 
ignored as they move through a complex system; in part through developing relationships, 
networks and trust, and standing up for patients, as constants at a time of change. 
 ECLOs help people to deal with their worries and concerns, demystifying challenging situations, 
and reducing stigma and anxiety and allowing people to benefit from the offer of support that 
exists. 
 ECLOs develop relationships, networks and trust, instigating and inculcating local eye heath 
networks, bringing together professionals in two-way information flows. 
 ECLOs thrive on relationships of trust, becoming key members of the clinic ‘staff’ which is crucial 
to them being able to work effectively, whether or not they have a clinical background. Some 
ECLOs believe that being identified as part of the NHS means that they are seen more as a 
‘trusted’ member of the clinic staff: 'When my badge said I worked for a charity, people didn’t 
want to see you. The minute that badge changed my numbers trebled, because they know you’re 
trained, they know you are a trained professional, they know that you’ll be telling them the proper 
stuff. The NHS see you as a professional' [ECLO]. 
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7.1.2 IMPACT ON CLINICS 
Across the UK, we can describe seven broad types of valued service and support provided by ECLOs, 
working in ways which reflect the individual circumstances of different clinics and hospitals. ECLOs are 
effective in doing this as follows: 
 ECLOs improve and streamline the processes which operate within clinics, helping others provide 
quality services by aiding the smooth running of the clinic, and making administrative processes 
more efficient. 
 ECLOs develop quality services, catalysing and expediting change; they are experts in joining the 
dots and raising the profile of patients’ needs and their ‘soft power’ effects are significant; they 
work with staff to make clinics better places for patients through raising awareness of what they 
need with staff and what represents good practice. 
 ECLOs enhance the profile of services through their added-value; by turning the routine into the 
efficient, and the regular into the effective; they stimulate change that improves the offer of 
clinics bringing up the overall quality of the clinic by looking beyond the vision and the visual. 
 ECLOs are proactive catalysers of change though developing effective relationships both within 
and without the clinic. 
 Whilst many ECLOs are working in the earlier stages of the patient journey to good effect, they 
also provide safe and meaningful ‘departure points’, taking the pressure off the system by offering 
a positive place for patients to reside towards the end of the treatment and clinical care pathway; 
they are an alternative to the binary choices of clinicians (continue treatment or stop treatment). 
 ECLOs provide continuous specialist expertise in how to emotionally support people during 
medical treatment and once that treatment ends, ensuring that people make meaningful contact 
between different services, within and without the hospital. 
 Training and continuing professional development for ECLOs could take account of these domains 
of practice. 
7.1.3 IMPACT ON SERVICES 
ECLOs enhance and broaden the care which clinical services provide, thereby potentially reducing 
patients’ longer-term care needs, and release NHS staff to perform their clinical roles. They add 
capacity and contribute to the increasing quality of the service offered in clinics; and they make a 
contribution to various other NHS objectives relevant to all four nations:  
 The principal benefit for having an ECLO present in clinic is in providing support that others do 
not/cannot provide.  ECLOs have a specific role; they provide a valued added service and they do 
not substitute for other clinic staff.  
 Hence there are no evident cost-savings within the clinic when an ECLO is part of the care team 
but there may be to the wider NHS in terms of reduced burden of falls, depression and anxiety.  
 If ECLO services were expanded, expressed needs may be met for more patients and through the 
ECLO referrals, negative impacts on health and social functioning may be addressed. 
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7.2 HOW DOES OUR WORK BUILD ON EXISTING KNOWLEDGE? 
An RNIB Campaigns report recently summarised the evidence available at that time in relation to the 
range of contributions which ECLOs can make to the totality of service provision.167 These were grouped 
under seven headings: 
 Enhancing the patient experience  
 Improving service efficiency  
 Ensuring positive patient outcomes  
 Providing a cost-effective service  
 Streamlining the CVI process  
 Bridging the gap between health and social care  
 Improving staff satisfaction 
This report confirms that ECLOs do indeed contribute to most if not all of these seven areas, and the 
evidence presented herein adds to that previously summarised by the RNIB.  The one exception relates 
to the extent to which provision is ‘cost effective’. Here the evidence is more nuanced and requires 
more careful consideration, as explained above. 
7.3 PERSPECTIVES ON IMPLEMENTING ECLO SERVICES 
Finally, we feel that it would be useful to add into these conclusion some observations that have been 
made during the course of the study on the ways in which ECLO services have been implemented in a 
number of different contexts. 
ECLO provision offers a variety of different benefits, which potentially have more or less relevance to 
different stakeholders – including NHS and social services commissioners, NHS providers, clinicians and 
patients.  They can perhaps be summarised under five headings: 
1. Meeting quality standards 
Some specific national clinical quality standards are mandated within the four UK nations, but 
this arrangement is unusual, and often resisted by services anxious to ensure that they have local 
discretion to meet local need.  More commonly, national ‘guidance’ on services is issued, and a 
number of national quality standards documents already reference ECLOs (see Appendix 6 for 
details), although their influence is more one of persuasion rather than mandate. 
2. Ensuring equity from a commissioning perspective 
Commissioners will share a concern to minimise variation in provision, and will wish to ensure 
that all eye clinics enjoy a similar level of evidence-based provision in relation to need. 
                                                     
167
 RNIB (2015) See the need: Sight loss advisers, improving patient outcomes through cost-effective care – accessed from: 
https://www.rnib.org.uk/sites/default/files/See%20the%20need,%20Sight%20loss%20advisers%20improving%20patient%20
outcomes%20through%20cost-effective%20care.pdf 
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3. Ensuring equity from a provider perspective 
Most NHS provider organisations will themselves wish to ensure that the service they provide 
their patients is the best possible within the resource made available to them (irrespective of the 
specific requirements of their commissioners).  They will therefore wish to include ECLOs 
alongside other evidence-based provision, and often have sufficient discretion within 
commissioning arrangements to ensure this.  Outside England, of course, there is no formal 
purchaser-provider split, and this considerably simplifies arrangements. 
4. Clinical aspiration 
Individual clinicians, especially those with clinical leadership roles within ophthalmology, have 
the ability to influence business plans and the direction of services within their clinics. 
Aspirational clinicians who see their peers enjoying the benefits of working with ECLOs 
elsewhere can be effective champions of the need to implement such services. 
5. Cost effectiveness 
Commissioners, providers and clinicians usually share a desire to maximise the benefit derived 
from the available resources, and are receptive to services which can demonstrate a greater 
benefit from the same resource, or similar/greater benefit from less resource.  This can be 
derived in the form of cash-releasing savings, or (perhaps more commonly) by enabling services 
to cope with rising demand.  The evidence on the cost-effectiveness of ECLO services has been 
presented and discussed at length. 
 
 
 
There is much evidence in these pages. We trust that this will allow RNIB and a range of other 
stakeholders to gather new insights into the ECLO service and the impact that it has. This study has 
covered much new and existing territory through its primary research. It has confirmed much of the 
evidence that previously existed about ECLOs, and it has expanded our knowledge about the impact that 
ECLOs make into new areas. 
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APPENDIX 1 · PATIENT OUTCOMES QUESTIONNAIRE 
An evaluation of patient information and support services in UK eye clinics  
Welsh Institute for Health and Social Care, University of South Wales and Swansea Centre for Health 
Economics, Swansea University  
Questionnaire for patients 
Study site: 
Thank you for taking the time to consider participating in our survey.   
We would like to know if you have been given information and support in the eye clinic to help you cope 
with poor vision in your daily life and how you feel about your quality of life.  We would also like to 
know if any information and support you have received has made any difference over a period of time 
and would like to contact you again in three months time. If convenient we will arrange a telephone call 
to go through similar questions we will ask you today. 
ABOUT YOU 
Study participant number: 
 Gender:  Male    Female   
 Date of birth: (dd/mm/yy): 
 Postcode: 
 Marital status: 
  
 
 
 
 Who do you live with: 
  Partner/spouse 
  Other family members 
  Live on own 
  Residential/ nursing care  
  Sheltered accommodation 
  Other ____________________________________ 
 Main eye condition:  
  Age-related macular degeneration (AMD) (if known  wet  dry) 
  Diabetic Retinopathy 
  Glaucoma  
 Single  Divorced 
 Married  Civil Partnership 
 Widowed  Co-habiting 
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  Other (please specify) _________________________ 
 When was your eye condition was first diagnosed in the eye clinic? 
  In the last 3 months 
 4 to 6 months ago  
 7 to 12 months ago 
 13 to 18 months ago 
  More than 18 months ago 
  Don’t know 
 Do you have a Certificate of Visual Impairment (CVI)? 
  Yes, sight impaired (partially sighted) 
  Yes, severely sight impaired (blind) 
  No  
  Don’t know  
 Do you have any long-standing illness or disability in addition to your visual impairment? 
  Yes (details) ____________________________________ 
  No  
 Have you received any of the following? 
Further information on your 
eye condition  
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from 
 
Who referred/signposted  
 
Emotional support to talk 
through worries or concern  
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
Informed about or given 
visuals aids such as 
magnifiers 
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
In the following section, we would like to know about your experience of the eye clinic support 
services (either through an ECLO or other person) that you have received. These services will have 
been the kinds of things to help you adapt to your sight condition and maintain your quality of 
life. 
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Information about welfare 
benefits 
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
Information about the 
certification (CVI) 
/registration process 
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
Support for any employment 
issues 
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
Support for a family member 
or carer 
 Yes   
 No, I don’t need it  
 No, but I do need it 
If yes who from  
 
Who referred/signposted  
 
If yes to any of the above continue. If no to all go to Q17. 
Record who Q 11-16 refers to………………………………….. 
 When did you first have contact with the support services? 
  In the last 3 months   
  4 to 6 months ago 
  7 to 12 months ago 
  More than a year ago  
  Don’t know  
 How did you have contact with the support services?  
  Telephone   
  Face to face   
  Written correspondence (e.g. letter or email)   
 After contact with the support services, do you feel more informed about the support available 
to help you live with sight loss? 
  A lot more informed 
  A bit more informed 
  No difference  
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 After contact with the support services do you think you have a better understanding of the 
following:  
 Your eye condition:  
  Yes 
  No 
  Don’t know 
  Not applicable 
 How you care for and treat your eye condition: 
  Yes 
  No 
  Don’t know 
  Not applicable 
 The range of support that is available to you outside the hospital: 
  Yes 
  No 
  Don’t know 
  Not applicable 
 
Thinking about the support that you received from the support services, can you tell us:  
 Did the support services give you the practical support you needed? For example: supporting you 
on how to use aids and adaptations, or telling you about services or support available outside of 
the eye clinic.  
  Yes, all the support I needed 
  Yes, most of the support I needed 
  Neither enough nor too little support 
  No, I would have liked more support 
  No, I would have liked considerably more support 
 
 How helpful was the support and/or information you received from the support services? 
  Very helpful 
  Helpful 
  Neither helpful nor unhelpful 
  Unhelpful 
  Very unhelpful 
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 As a result of speaking to the support services, do you feel more or less able to seek further 
support yourself? 
  Much more able  
  More able 
  No different 
  Less able 
  Much less able  
 
 Have you had any problems with mobility (e.g. experiencing falls) or accidents (e.g. burns or other 
harms) as a result of your vision loss? 
  No (go to Q18) 
  Yes 
 
 If yes, were these: 
  Falls  
  Burns 
  Other (please describe)______________________________ 
 
 How many times in the past 12 months have you needed medical treatment as a result of a fall or 
other accident due to your sight loss? 
_________________________________________________________ 
 
 Do you feel more at risk of falling today than you did 6 months ago? 
Yes, agree 
No, disagree 
 
 Have you had any adaptations to your home or training (as a result of your contact with support 
services)? 
No 
Yes (please describe, include provider) _________________________________ 
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In this section, we would like to know about the impact that the service you received had on your 
quality of life. When answering, please think about the service you were offered and the 
difference that made to you. Please place a tick in ONE box for each of the five groups below. 
Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about     
I have slight problems in walking about     
I have moderate problems in walking about     
I have severe problems in walking about     
I am unable to walk about       
 
SELF-CARE 
I have no problems washing or dressing myself    
I have slight problems washing or dressing myself    
I have moderate problems washing or dressing myself   
I have severe problems washing or dressing myself    
I am unable to wash or dress myself      
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities    
I have slight problems doing my usual activities    
I have moderate problems doing my usual activities   
I have severe problems doing my usual activities    
I am unable to do my usual activities     
 
PAIN / DISCOMFORT 
I have no pain or discomfort       
I have slight pain or discomfort      
I have moderate pain or discomfort      
I have severe pain or discomfort      
I have extreme pain or discomfort      
 
ANXIETY / DEPRESSION 
I am not anxious or depressed      
I am slightly anxious or depressed      
I am moderately anxious or depressed     
I am severely anxious or depressed      
I am extremely anxious or depressed     
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The worst health        
 you can imagine 
We would like to know how good or bad your health is 
TODAY.This scale is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Mark an X on the scale to indicate how your health is 
TODAY.  
 Now, please write the number you marked on the scale 
in the box below.  
             YOUR HEALTH TODAY   = 
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APPENDIX 2 · NON-CLINICAL SUPPORT FOR PATIENTS IN EYE CLINICS – STAFF PRO FORMA 
An evaluation of patient information and support services in UK eye clinics  
NON-CLINICAL SUPPORT FOR PATIENTS IN EYE CLINICS 
As part of the evaluation of patient information and support services in UK eye clinics, we are interested in how much time you spend providing non-medical 
support to patients, such as referring patients to other services.  Please complete the table below as far as possible by estimating for how many patients and 
how much time you spend on the various tasks below in an average week. 
Job title:         Employment band/grade:     WTE:______________________________ 
 
Task Description 
No. of patients to 
whom you provide this 
service in an average 
week 
Average time 
spent per 
patient 
Emotional support I have spent time listening to patients/carers, talking through their worries or concerns.   
Information-giving / 
signposting  
I have provided information about further, non-clinical support, local and/or national.   
I have provided eye health information to patients, family members and others.   
Advocacy 
I have helped people to have their voices heard; to secure their rights and to obtain the 
support they need. 
  
Professional 
networks / 
relationships 
I have made contact with referrers on behalf of patients.   
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Certification and 
registration 
I have informed and advised patients about Certification and Registration and its 
benefits. 
  
I have helped patients in a practical way by helping to fill in forms, for example.   
Monitoring and 
follow up of patient 
progress   
I have followed up with patients that I’ve referred on to other services to check that 
satisfactory progress has been made. 
  
Evaluation / impact 
measurement 
I have engaged and consulted with patients to evaluate our services and to support 
continuous service improvement 
  
Other non-medical 
support 
(Please list, continuing overleaf if needed)   
 
Do you refer patients to the ECLO (or other services)? 
How many per week? 
What type of patients do you refer? 
Does the ECLO save you time in clinic? 
 If yes how much time? 
What would be the impact of there not being an ECLO in clinic? 
 -On patients? 
 - On clinic? 
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APPENDIX 3 · STUDY PROTOCOL 
 
An evaluation of patient information and support services in UK eye clinics 
Data collection protocol 
 
Evaluation team 
Professor Marcus Longley, Dr Mark Llewellyn, Rhys Evans, Jennifer Hilgart 
 Welsh Institute for Health and Social Care, University of South Wales   
Pippa Anderson, Dr Sam Groves  
Swansea Centre for Health Economics, Swansea University 
Contact email: marcus.longley@southwales.ac.uk 
Phone: 01443 483070 
 
STUDY SPONSOR AND ETHICAL CONSIDERATIONS 
The University of South Wales is the sponsor for this evaluation in line with the Research Governance 
Framework for Health and Social Care (2005).  All documentation, including consent forms, information 
sheets, patient surveys and interview schedules have been approved by the University Research Ethics 
Committee.  Although this is considered to be a service evaluation using the NHS Health Research 
Authority criteria (see below), the evaluation is being conducted with full consideration of ethical issues 
in line with good clinical practice.  We are contacting all R&D departments at each site to gain the 
appropriate approvals. 
This study is considered to be solely service evaluation as the participants will not be randomised to 
different groups. We are examining how standard care is delivered and the evaluation protocol does not 
demand changing treatment/ patient care from accepted standards for any of the patients involved.  
Also the findings are not going to be generalisable - we will produce outcomes that are only of interest 
to the specific clinical area being considered. 
BACKGROUND 
RNIB has funded a service evaluation to explore the effectiveness and cost-benefit of Eye Clinic Liaison 
Officers (ECLOs) – also known as Sight Loss Advisers or Vision Support Officers.  The study is being 
undertaken by the Welsh Institute of Health and Social Care, University of South Wales (WIHSC) and the 
Swansea University Centre for Health Economics (SCHE).   The ECLO role was established to provide 
person-centred emotional and practical support tailored to the needs of patients with sight loss, and to 
act as a bridge between health and social care services. The ECLO works directly with people with sight 
loss to provide information and advice, emotional support and assistance in achieving an appropriate 
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referral to community based services. This study is attempting to answer questions relating to the role 
of ECLOs in hospital eye clinics, such as: 
 What is the impact of an ECLO on clinic activity?  
 Are there cost-savings to a department/wider NHS when an ECLO is part of the care team? For 
example, does the support of an ECLO reduce falls and other hospital admissions? 
 What are the patient benefits of having an ECLO present in an eye clinic? 
The evaluation team from WIHSC and SCHE will collect data from hospital sites where a RNIB qualified 
ECLO is present in the eye clinic and, as a comparison, from sites where there is no ECLO present.   At 
these comparison sites, a range of other third sector information and support services may be provided, 
or no such provision maybe available for patients.  This evaluation aims to provide much needed 
information as to the cost-effectiveness and impact on patients of having a trained ECLO available in 
hospital eye clinics.   Information will be collected at a patient and service-wide level. 
METHOD 
The evaluation team intends to conduct site visits to around 30 ophthalmology departments across the 
UK to gather data from a range of clinics where trained ECLOs are present, where other voluntary 
support is available, and where no formal support is provided.  Data collection at each site will compose 
of: 
 Patient survey to evaluate the impact of the service on patient outcomes such as quality of life.  
With informed consent (all patients will be given time to read the information sheet and consent 
form) patients will be asked if they are willing to complete a brief survey about any support 
services they have received.  As patients may have visual impairments, patients will be able to 
complete the survey with a member of the evaluation team in the clinic.  The evaluation team 
member will also go through the information sheet with the patient if they are unable to read it 
themselves.  Patients can also simply consent to take part in the evaluation and will be contacted 
at a later date to complete the survey over the telephone.  Eligible patients include those with an 
eye condition or who have a certificate of visual impairment, who would be eligible for support 
from an ECLO (such as those with AMD, glaucoma, diabetic retinopathy etc).  The evaluation team 
aim to recruit around 10-20 patients from each site. Patients will be asked to consent to a follow-
up phone call in 3 months time, where the survey will be repeated.  Patients will be informed that 
their participation is entirely voluntary and that they are able to withdraw from the evaluation at 
any time without giving a reason.  The care and treatment they receive from the NHS will not be 
affected whether they choose to take part or not.  All consent forms will be kept in a locked 
cupboard in the evaluation team office which is only accessible to the team.  All participants will 
remain anonymous and no identifiable information will be published in study reports or 
publications. 
 Interviews with key staff.  In order to qualitatively gauge the impact of the ECLO or equivalent on 
the clinic, we will conduct semi-structured interviews with key staff such as ophthalmic 
consultants, ophthalmic nurses, administrative staff, and ECLOs.  Interviews will be conducted 
with fully informed consent and will take place on the day of the site visit by the evaluation team 
or over the telephone at a convenient time.  Interviews are expected to last no more than 20 
minutes. Clinical staff can also complete a proforma which aims to assess how much of their time 
is spent providing various forms of support to patients, so that this can be compared between 
sites. Interviews will be transcribed and analysed by the researchers.  All interviewees will remain 
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anonymous and any identifying information will not be provided in any reports or publications.  
Participation by staff is entirely voluntary and they will be free to withdraw their contribution at 
anytime without giving a reason.  
These results will feed into a cost-consequence analysis of the ECLO role and an analysis of the impact of 
the ECLO on patient outcomes and the eye clinic.  The outcomes and impact of the ECLO model will be 
compared with other forms of information and support provision.   
IMPACT AND DISSEMINATION 
The evaluation of the ECLO role is crucial because ECLOs are funded either by RNIB, the NHS, social 
services, other third sector organisations, or a mixture of these.  From a national perspective, the unique 
nature of the ECLO role and substantial funding makes it obligatory that learning from the programme is 
maximised so that we know what models of working are most effective for patients and which are most 
cost-effective.  From a local perspective, the local health community and commissioners require robust 
evaluation to inform decisions on funding these services and their long-term sustainability.   
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APPENDIX 4 · ECLO ACTIVITY DATA 
In addition to the data collected by survey, two sources of routinely collected data were utilised. The 
first is a dataset relating to the daily activities of each RNIB ECLO throughout the UK. This dataset 
contains records from one calendar year split by the constituent countries in the UK. The ECLOs are 
responsible for collecting information on patients’ demographic background, personal information such 
as living arrangements, fear of falling, eye conditions, disabilities and etc. Interaction types and meeting 
durations are also recorded into the data by the ECLOs.  
Unfortunately, each country in the UK collects data in a different way but every effort will be made to 
attain consistency. All patients in each country will be firstly located an ID number and identified as new 
or returning patients by the ECLOs. The difference is, only patients in England can be tracked with the 
uniquely located ID. Nevertheless, some data are not collected in England as they do in Wales, Scotland 
and Northern Ireland, for example, patients’ history of falls, main issue, emotional support and practical 
support. Usually patients have multiple concerns regarding their eye condition, life issues such as 
reading and driving, registration of certificate of vision impairment (CVI), anxiety and emotional distress, 
welfare etc., three main concerns are recorded by the ECLOs followed by support from the ECLOs, 
emotional and practical. 
A second source of data relates to England alone and contains information relating to the time spent on 
completing CVI and information on the patients who are given them. These data inform the cost-
consequence analysis of the ECLO role and an analysis of the impact of the ECLO on patient outcomes 
and the eye clinic. Actual time that the ECLOs spend with patients are recorded in English data rather 
than time intervals in the rest three countries, and ‘CVI completed’ is an outcome option in the outcome 
category so that we can track the patients who have their CVI completed. Although ECLOs’ time spent 
with patients and appointment outcomes are recorded in different files, they can be matched using 
patients’ uniquely allocated IDs.   
The following table lists variables in the data set of four countries.  
Table A4.1. List of variables in ECLO activity data 
Variable name Variable description 
said Patients' ID 
DOC Date of contact 
year Year of collecting 
quarter Quarter of collecting  
neworreturning New or returning patients 
interactiontype Interaction type (face to face, phone, text, email, etc.) 
locationofmeeting Location of meeting (ECLOs office, waiting room, etc.) 
referralsource Referral source (Doctor, eye clinic, self, etc.) 
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gender Gender 
agerange Patients' age range 
localauthority Local authority 
educationstatus Education status 
additionaldisability1,2,3 Patients' other disabilities 
ethnicity Patients' ethnics 
fearoffalling Patients' fear of falling 
historyoffalls Patients' history of falls 
livingstatus Patients' living status 
caringstatus Patients' caring status 
employmentstatus Patients' employment status 
maineyecondition Patients' main eye condition 
othereyecondition Patients' other eye conditions 
firstdiagnosedwitheyecondition Date of patients' eye condition first diagnosed 
certificatestatus Patients' CVI status 
clientissue1,2,3 Patients' main concern (three recorded) 
timespendwithclients ECLOs' time spend with patients 
timespendonbehalfofclients ECLOs' time spend on behalf of patients 
informedabout1,2,3,4,5 Patients' outcome,  informed about from the ECLOs (up to five are recorded) 
signpostedto1,2,3,4,5 Patients' outcome, signposted to other source (up to five are recorded) 
referredto1,2,3,4,5 Patients' outcome, referred to other source (up to five are recorded) 
emotionalsupportgiven Emotional support given to patients (not in English data) 
practicalsupportgiven Practical support given to patients (not in English data) 
familysupportgiven Family support given to patients (not in English data) 
outcometype Outcome type for England patients 
outcomecategory Specific outcome for England patients, including CVI completion 
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APPENDIX 5 · STAFF SURVEY RESULTS FOR OTHER OPHTHALMOLOGY STAFF 
TABLE A5.1 · Support provided by Senior Optometrist / Optometrist 
Type of support provided by Senior Optometrist / 
Optometrist 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, talking 
through their worries or concerns. 
Site with ECLO 7 5.50 3.93 2 12 7 7.5 3.08 4 12.5 
Site without ECLO 3 4.00 3.61 1 8 3 6.67 2.89 5 10 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 7 2.43 2.15 0 5 6 2.17 1.47 1 5 
Site without ECLO 3 2.00 1.00 1 3 3 1.67 0.58 1 2 
I have provided eye health information to patients, 
family members and others. 
Site with ECLO 6 0.83 1.60 0 4 2 3.50 2.12 2 5 
Site without ECLO 0 - - - - 0 - - - - 
I have helped people to have their voices heard; to 
secure their rights and to obtain the support they 
need. 
Site with ECLO 6 0 0 0 0 0 - - - - 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 6 0.50 1.23 0 3 1 1.0 - 1 1 
Site without ECLO 3 0.67 0.58 0 1 2 10.0 7.07 5 15 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 7 0.71 0.76 0 2 4 7.50 6.14 2 15 
Site without ECLO 3 0.67 0.58 0 1 2 3.50 2.12 2 5 
I have helped patients in a practical way by helping to 
fill in forms, for example. 
Site with ECLO 7 0 0 0 0 0 - - - - 
Site without ECLO 3 0.33 0.58 0 1 1 1 - 1 1 
I have followed up with patients that I’ve referred on 
to other services to check that satisfactory progress 
has been made. 
Site with ECLO 7 0 0 0 0 0 - - - - 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 7 0.14 0.38 0 1 1 5.0 - 5 5 
Site without ECLO 3 0 0 0 0 0 - - - - 
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TABLE A5.2 · Support provided by Senior Orthoptist / Orthoptist  
Type of support provided by Senior Orthoptist / Orthoptist 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, 
talking through their worries or concerns. 
Site with ECLO 4 5.75 4.03 1 10 4 10.0 4.08 5 15 
Site without ECLO 3 4.00 3.61 1 8 3 6.67 2.89 5 10 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 4 1.50 1.92 0 4 2 10.0 7.07 5 15 
Site without ECLO 3 2.00 1.00 1 3 3 1.67 0.58 1 2 
I have provided eye health information to 
patients, family members and others. 
Site with ECLO 3 4.67 5.03 0 10 2 10.0 7.07 5 15 
Site without ECLO 0 0 0 0 0 0 - - - - 
I have helped people to have their voices heard; 
to secure their rights and to obtain the support 
they need. 
Site with ECLO 3 0 0 0 0 0 - - - - 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 2 0 0 0 0 1 10.0 - 10 10 
Site without ECLO 3 0.67 0.58 0 1 2 10.0 7.07 5 15 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 4 1.50 1.73 0 4 3 5.67 4.04 2 10 
Site without ECLO 3 0.67 0.58 0 1 2 3.50 2.12 2 5 
I have helped patients in a practical way by 
helping to fill in forms, for example. 
Site with ECLO 4 0 0 0 0 0 - - - - 
Site without ECLO 3 0.33 0.58 0 1 1 1.0 - 1 1 
I have followed up with patients that I’ve 
referred on to other services to check that 
satisfactory progress has been made. 
Site with ECLO 4 0 0 0 0 0 - - - - 
Site without ECLO 3 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 4 0 0 0 0 0 - - - - 
Site without ECLO 3 0 0 0 0 0 - - - - 
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TABLE A5.3 · Support provided by Specialist Doctor / Registrar (non consultant) – ECLO sites only 
 
Type of support provided by Specialist Doctor / Registrar 
(non consultant) – ECLO sites only 
No. of patients to whom you’ve provide this 
service in the last week 
Average time spent per patient (minutes) 
N Mean SD Min Max N Mean SD Min Max 
I have spent time listening to patients/carers, 
talking through their worries or concerns. 
Site with ECLO 6 1.75 2.36 0 5 4 26.75 42.30 2 90 
I have provided information about further, non-
clinical support, local and/or national. 
Site with ECLO 6 4.92 9.88 0 25 4 5.75 4.92 1 10 
I have provided eye health information to 
patients, family members and others. 
Site with ECLO 6 4.17 6.83 0 18 4 8.00 4.49 2 12.5 
I have helped people to have their voices heard; 
to secure their rights and to obtain the support 
they need. 
Site with ECLO 6 0 0 0 0 6 - - - - 
I have made contact with referrers on behalf of 
patients. 
Site with ECLO 6 0.33 0.52 0 1 2 5.50 6.36 1 10 
I have informed and advised patients about 
Certification and Registration and its benefits. 
Site with ECLO 7 0.86 0.85 0 2 4 8.63 7.91 2 20 
I have helped patients in a practical way by 
helping to fill in forms, for example. 
Site with ECLO 6 0.17 0.41 0 1 1 5.0 - 5 5 
I have followed up with patients that I’ve 
referred on to other services to check that 
satisfactory progress has been made. 
Site with ECLO 6 0 0 0 0 0 - - - - 
I have engaged and consulted with patients to 
evaluate our services and to support continuous 
service improvement 
Site with ECLO 6 0 0 0 0 0 - - - - 
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APPENDIX 6 · DETERMINISTIC ECONOMIC MODELLING OUTPUT - FALLS 
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APPENDIX 7 · DETERMINISTIC ECONOMIC MODELLING OUTPUT - DEPRESSION 
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APPENDIX 8 · CLINICAL GUIDELINES RELEVANT TO THE ECLO SERVICE 
The table below provides information about guidelines and recommendations that are relevant to the ECLO service.  These include the NICE Clinical 
Guideline for Glaucoma; guidelines published by the Royal College of Ophthalmologists; and the UK Vision Strategy. 
The first column contains the reference to the guideline.  The second column contains the section of the guidance that is relevant to the ECLO service.  
Comments about the relevance of the guideline to the ECLO service are in the third column.  
Guideline Recommendation 
Relevance to ECLO 
service 
NICE guidelines 
[CG85] Glaucoma: 
diagnosis and 
management168 
1.6 Provision of information 
1.6.1 Offer people the opportunity to discuss their diagnosis, prognosis and treatment, and provide them with 
relevant information in an accessible format at initial and subsequent visits. This may include information on 
the following: 
 their specific condition (OHT, suspected COAG and COAG), its life-long implications and their 
prognosis for retention of sight 
 that COAG in the early stages and OHT and suspected COAG are symptomless 
 that most people treated for COAG will not go blind 
 that once lost, sight cannot be recovered 
 that glaucoma can run in families and that family members may wish to be tested for the 
disease 
 the importance of the person's role in their own treatment – for example, the ongoing regular 
application of eye drops to preserve sight 
 the different types of treatment options, including mode of action, frequency and severity of 
side effects, and risks and benefits of treatment, so that people are able to be active in the 
 
 
 
 
 
 
 
 
 Some ECLOs 
educate patients in 
the importance 
and technique of 
applying eye drops  
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 https://www.nice.org.uk/guidance/cg85 
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decision-making process 
 how to apply eye drops, including technique (punctal occlusion and devices) and hygiene 
(storage) 
 the need for regular monitoring as specified by the healthcare professional 
 methods of investigation during assessment 
 how long each appointment is likely to take and whether the person will need any help to 
attend (for example, driving soon after pupil dilatation would be inadvisable) 
 support groups 
 compliance aids (such as dispensers) available from their GP or community pharmacist 
 Letter of Vision Impairment (LVI), Referral of Vision Impairment (RVI) and Certificate of Vision 
Impairment (CVI) registration 
 Driver and Vehicle Licensing Agency (DVLA) regulations. 
 
 ECLOs are well 
placed to provide 
information about 
local and national 
support groups 
 ECLOs can provide 
information about 
CVIs and referrals 
to social services 
sensory 
rehabilitation 
teams 
The Royal College of 
Ophthalmologists 
Age-Related Macular 
Degeneration: 
Guidelines for 
Management 
September 2013169 
12.1 The diagnosis session in clinic – general remarks 
a. Breaking bad news. Patients report that after receiving news that their eye condition is not treatable, they 
tend not to hear further information during the consultation. It is therefore important that patients are given 
written information at the end of the consultation concerning their eye condition, available rehabilitation 
services and useful contact numbers. 
b. Avoid ‘diagnose and immediate discharge’. Patients with macular disease who have lesions which are not 
treatable with current therapies are often seen only once in the eye clinic and then discharged. They can be 
unaware of what to expect in the future or where they can obtain relevant information or how to find their 
way through the maze of services and organisations. Although there may seem little advantage in seeing the 
patient a second time, because most are not able to take in information after receiving bad news, a follow up 
visit is of benefit to receive further information and ask questions. They must be given contact details of 
someone they can come back and talk to. This may be an Eye Clinic Liaison Officer (ECLO) who may be 
available at the time of diagnosis also. 
 
 Patients whose eye 
condition is not 
treatable can be 
referred to an ECLO 
to access support 
and information. 
Potentially saving a 
follow-up visit with 
the clinician 
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c. The clinic experience at time of diagnosis has an impact on the way patients deal with their diagnosis and 
visual impairment. Patients frequently report that the diagnosis was given in an uncaring manner. A good 
initial experience at the hospital will almost certainly help the patient’s future outlook, expectations and 
achievements. A satisfactory patient experience can only be achieved by good training. 
d. Importance of signposting.  Receiving a diagnosis without the follow up information leaves patients feeling 
lost and isolated. They should be given appropriate information about support services such as visual 
rehabilitation officers and low vision services. Charities such as local societies, the RNIB, and the Macular 
Society offer wide range of services such as telephone advice and counselling services and local support 
groups. 
e. Provide literature in the clinic. Patients appreciate being given information regarding their condition that can 
be read at leisure. It should be the responsibility of staff in the clinic to make information leaflets available and 
ensure that patients are offered them before leaving. The Macular Society and others have a wide range of 
materials in large print and audio. 
 
Smoking is a recognised risk factor for both dry and wet AMD. All patients with macular degeneration/ 
dystrophy should be advised to stop smoking.  
 
Interventions which can help the individual come to terms with their sight loss, retain their independence, and 
improve their function and quality life include information about the condition and prognosis, emotional 
support, counselling, a low vision assessment and practical input such as rehabilitation covering daily living 
skills, mobility and the benefits of lighting, colour and contrast in maximising the use of residual sight. Some 
awareness of the research in the area of retinal repair is helpful as many patients will wish to discuss the 
current research strategies; two examples are stem cells and electronic eye research. 
12.3 Referral to rehabilitation and low vision services 
a. If an individual has sight loss then it is vital that they be offered the opportunity of accessing low vision 
support and advice at an early stage.  Advice and use of task lighting and magnifiers reduce the early impact of 
sight loss and the risk of falls. Do not wait until all treatment options have been explored or until an 
individual’s vision deteriorates to a level that registration as blind/ severely sight impaired or as partially 
sighted/ sight impaired becomes appropriate; before considering referring an individual to low vision and 
rehabilitation services. 
b. Early advice and support means that an individual can learn how to use their remaining vision more 
 
 ECLOs can improve 
patient satisfaction  
 
 
 ECLOs play a role in 
signposting 
patients to support 
services and local 
societies 
 
 ECLOs are often 
instrumental in 
keeping literature 
and leaflets up-to-
date in the eye 
clinic. 
 
 
 
 ECLOs can refer 
patients to 
appropriate 
interventions 
including 
rehabilitation and 
low vision 
assessments 
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effectively, retaining independence and confidence. It is also far easier to learn the principles of using optical 
low vision aids with the lower powers and the skills can be transferred to the higher powers later if needed. 
The longer it is left the more difficult it is to help a person overcome any loss of confidence in their abilities and 
the more likely that depression will occur. General information from the NHS on living with low vision can be 
found at: 
http://www.nhs.uk/Livewell/Eyehealth/Pages/Livingwithlowvision.aspx 
c. Find out where and what low vision services are available locally and refer your patients with low vision as 
soon as possible. Some may well be hospital based and others may be community based. 
d. It should no longer be the case that access to a low vision service is certification/ registration led. 
e. The NHS Eyecare Services Programme sets out what should be expected from a Low Vision Services, and is 
available online. 
The principles: 
· Access to rehab and low vision support will vary according to local arrangements. Clinicians should be present 
or represented on their local low vision committee. All local systems should adhere to these principles: 
· Low vision services must reflect a multi-disciplinary, multi-agency approach that co-ordinates with other 
health and social care providers in the area, including services provided at the client’s residence at the time. 
This methodology ensures efficient and professional delivery of services. 
· The services delivered must be based upon needs identified by clients and be sufficiently flexible to meet the 
disparate needs of its client group. There should be evidence of user participation in agreements on the setting 
up and implementation of pathways and protocols. 
· Registration as sight impaired or severely sight impaired should not be a pre-requisite to accessing low vision 
services. 
· Locally designed guidelines, pathways and protocols should be underpinned, whenever possible, by evidence 
based knowledge and accepted guidance. This must conform with and contribute to local clinical governance 
arrangements. 
· Assessment. There should be a tailored needs-based assessment for each client following referral to the low 
vision service. A low vision assessment should always offer: 
o An eye health examination or evidence of recent examination or referral for examination according to local 
 
 ECLOs can refer 
patients to 
rehabilitation 
services before the 
point of 
registration 
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protocols. 
o A functional visual assessment 
· After assessment the following should be offered, as appropriate, to the user: 
o Prescription/provision of appropriate optical/non-optical aids. The sale of some low vision aids is restricted 
to certain professionals or requires appropriate supervision. The supply/loan of aids should be governed by 
local 
protocol. 
o Advice on lighting, contrast and size, filters, tactile aids, electronic aids and other non-optical aids. 
o Training and/or therapy to enable optical and non-optical aids and other techniques to be used effectively. 
o Links to broader rehabilitation services, such as home assessment and mobility as well as possible referral to 
structured therapy programmes and counselling. 
o A review of benefits, welfare rights, concessions, support groups, (both local and national) 
o Advice on access to the full range of low vision equipment available for purchase through local society 
resource centres or the RNIB or direct from retailers. If an individual is experiencing difficulties because of 
problems with their sight they are entitled to an assessment of need by social services – they do not need to 
be registered as severely sight impaired or sight impaired. The level of support offered once an assessment of 
need has taken place will depend on locally decided criteria, but social services will be able to provide the 
client information as to the advice and support that is available in an area for people with sight loss and on any 
services for which they may be eligible. In some areas social services will contact patients via the sensory 
impairment team rehabilitation officers for the visually impaired. Rehabilitation officers can provide training 
and support to a person with sight loss in their homes and local environment to cover daily living and mobility 
skills. The aim is to help an individual to retain their independence. They can also provide practical advice on 
how to use remaining vision effectively including the use of lighting, colour and contrast, which can be 
extremely beneficial even when there is minimal reduction to visual quality. It does not take long for people to 
lose confidence in their abilities as their sight deteriorates and for many this can lead to depression. 
12.4 Registration 
a. What is registration? 
Practices may vary in different devolved administrations in the UK: region specific information will be available 
from the local macular unit. In England each local council keeps a register of sight impaired and severely sight 
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impaired people living in its area. The register is held by the social services or social work department, or by a 
local voluntary agency. The Certificate of Visual Impairment (CVI) was introduced in 2003 and is used to certify 
people as sight impaired or severely sight impaired. Concessions are calculated from the date of examination. 
Hospital eye services can download the Word version of the CVI form for tailoring with their own contact 
details from the NHS web, or by emailing OPDEnquiries@dh.gsi.gov.uk. This form formally certifies someone as 
sight impaired or severely sight impaired so that the local council can register him or her. Its second purpose is 
to record a standard range of diagnostic and other data that may be used for epidemiological analysis. 
b. Why register somebody as severely sight impaired or sight impaired? 
· Recent figures for the numbers of people registered as severely sight impaired or sight impaired have 
dropped significantly since the introduction of the (CVI). There may be many reasons for this, but it certainly 
does not reflect a drop in the numbers of people experiencing sight loss.  
· If anything evidence based on the aging population predicts a sharp increase in the numbers of visually 
impaired individuals in the coming years. The services for people with sight loss are decreasing in some areas 
because of this drop in the numbers of people being registered. 
· Epidemiology and prevalence data in the UK is based on the information contained within processed CVIs. If 
they are not completed for whatever reason then the future planning of health and social care services will be 
flawed. 
· Social Services still base their budget allocations for support to people with sight loss on the number of CVIs 
that they receive. A reduction in registrations means that funding is allocated elsewhere. Many visually 
impaired people may not choose to be or are never offered the opportunity to become registered 
· Certification is also the trigger for a review of benefits that an individual may receive, though these may vary 
in different devolved administrations in the UK.  
12.5 Signposts to others who will provide support 
a. “Signposting” to others who can provide information, support and advice is vital. Not knowing how to access 
information or what help is available is cited by people with sight loss as the biggest barrier to coming to terms 
with their sight loss. 
b. Signposting may be the provision of contact details so the individual can find out further information for 
themselves. Useful details to pass on would include: 
· contact number for local sensory impairment teams – most councils have a single entry point duty telephone 
number 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ECLOs can signpost 
patients to local 
support, 
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· Local VI society contact details 
· Knowledge of local low vision services referral mechanisms and access criteria 
· The Macular Society: – the national charity providing support for people with macular degeneration 
information and 
advice services. 
 
The Royal College of 
Ophthalmologists 
Diabetic Retinopathy 
Guidelines 
December 2012170 
SECTION 14: COMMISSIONING FOR DIABETIC RETINOPATHY 
 
14.3 RESOURCE REQUIREMENTS IN CONTEMPORARY DIABETIC EYE DISEASE SERVICE DELIVERY 
14.3.1 Personnel 
The contemporary management of diabetic eye disease requires teamwork with the retinal specialist leading 
each team. The most important aspect of diabetic eye disease management is the prompt and correct 
diagnosis of the condition, especially regarding the retinal involvement due to diabetes. This means that there 
should be an effective retinopathy screening service to detect retinopathy in the community, and trained 
personnel who would decide which patients need referral to the eye hospital for further management., It is 
crucial that there be well defined pathways for patients to access care services in the hospital after being 
referred by screening for retinopathy in the community. The ENSPDR has refined the referral pathway recently 
introducing virtual triage set up for hospital referrals. Furthermore, the management of particular patients 
may change from time to time, including switching from one treatment to another, or multi-modality 
treatment. To provide the service, greater personnel resources are required. (Level B) 
 Ideally, a maximum of ten to twelve patients should be seen per clinic, i.e. not more than 20-24 
patients for a 2-session day. There should be appropriate adjustment in clinic booKing’s for 
trainees and their supervising ophthalmologists. 
 The following minimum service team would be required (for each clinical session) for a 
population of 300,000: 
 2x doctors (one consultant with retinal expertise and one non-consultant) 
 2x trained nurses 
 1 x ophthalmic photographer/technician 
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 1 x healthcare assistant 
 1 x administrative coordinator 
 1 x data collection and management support staff 
 1x eye clinic liaison officer (ECLO) 
 
14.3.9 ECLO 
The eye clinic liaison officer will provide the vital link between diabetic retinopathy treatment, and 
rehabilitation (LVA) and support (social) services and allow better integration of care. Patients who do not 
respond to treatment need direction to appropriate low vision services. The ECLO, where available, should 
ensure smooth transition from healthcare to social care. In hospitals without an ECLO, effective measures need 
to be in place to ensure that patients are directed to available support at a time of their choice. Specialists 
need to ensure that they offer patients the option of registration as visually impaired or severely visually 
impaired as soon as patients reach the thresholds for registration. Whilst registration remains a crucial 
gateway to support (low vision rehabilitation, provision vision devices, counselling, benefits etc.), it is 
important to encourage eye health professionals to raise awareness of available support services even before 
patients reach the level of registration in order to maximize the chances of patients adjusting to their sight loss 
with minimal trauma. 
 
 
 
 
 
 Guidelines 
specifically refer to 
the provision of an 
ECLO within the 
diabetic 
retinopathy service 
Adult Community 
Optical Low 
Vision Community 
Service 
Pathway171 
Issued by 
Local Optical 
Committee Support 
Unit 
Appendix 2 
Information to be provided as part of the low vision assessment: 
• ECLO – contact details (Eye Clinic Liaison Officer) 
• ILCO – contact details (Independent Living Coordinator) 
• Rehabilitation Officer for Visual Impairment – contact details 
• Other local social services, what they can offer and contact details 
• Local Blind Society(s), what they can offer and contact details 
• Local Visionary (if different), what they can offer and contact details 
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April 2011 • Action for Blind People team (part of the RNIB group), what they can offer and contact details 
• Local Citizen’s Advice Bureau - contact details 
• Local tax office – contact details 
• Local benefits office – contact details 
• Local housing office – contact details 
This information should be supplied to low vision practices by the service commissioners, CCGs and local 
authority social service. The information should be checked at least annually for currency and accuracy 
Commissioning 
better eye care: 
clinical 
commissioning guide 
from The College of 
Optometrists and 
The Royal College of 
Ophthalmologists172 
 
Adults with low 
vision  
 
November 2013 
Recommendations 
 Every part of the country should have access to a low vision service. 
 Low vision services should not only be open to people who meet visual acuity thresholds or 
who register as sight impaired. Low vision services can mitigate the practical, emotional and 
occupational or educational impacts of sight loss for people who do not meet the criteria to 
register as sight impaired. 
 Access to low vision services should be prompt and flexible. Early intervention is key to getting 
the best outcomes. Flexibility means service users can access the service from multiple routes 
and should be entitled to reassessments as their vision changes. 
 Integration is particularly important for low vision services. Effective low vision services adapt 
to individual needs and work as seamlessly as possible with other services, including hospital 
eye units, education, social care, voluntary organisations and stroke, rehabilitation and fall 
teams. Serious consideration should be given to the provision of an eye care liaison officer 
(ECLO) in every eye clinic in order to facilitate this. 
 Commissioners should ensure low vision services have dedicated funding in their programme 
budget for eye health and explore the possibility to jointly fund and provide the service with 
health, local authority and voluntary sector resources. 
 Specifies provision 
of an ECLOS in the 
service delivery 
model 
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Commissioning 
better eye care: 
clinical 
commissioning guide 
from The College of 
Optometrists and 
The Royal College of 
Ophthalmologists173 
Age-related macular 
degeneration 
November 2013 
Objectives: Patients have emotional and practical support to cope with their condition 
Services should help AMD patients adapt to their condition and improve visual functioning and well being. 
Examples, include Eye Care Liaison Officers (ECLO) and/or a Low Vision service 
Discharging patients 
Patients with dry AMD should be offered low vision support if visual loss is impacting upon their independence 
and lifestyle. Patients who meet the criteria for a certificate of visual impairment should offered one. Decisions 
on when to discharge patients with wet AMD are more complex but should be at clinicians’ discretion and 
based on how stable the condition is and if treatment will bring any further benefits to the patient. Again, 
patients should be offered low vision support and a certificate of visual impairment if appropriate. 
• Specifies provision of an 
ECLOS in the service 
delivery model 
 
 Low vision support 
and information 
about 
CVIs/registration 
can be provided by 
the ECLO 
UK Vision Strategy 
2013-2018174 
Strategy Outcome 1 
Everyone in the UK looks after their eyes and their sight In the next five years, we will work to: 
• raise awareness and understanding of eye health, particularly focusing on people most at risk of eye disease 
• encourage every individual to develop personal responsibility for their eye health and sight 
• raise awareness of eye health and the impact of sight loss among health and social care practitioners and 
ensure the early detection of sight loss and prevention where possible. 
 
Strategy Outcome 2 
Everyone with an eye condition receives timely treatment and, if permanent sight loss occurs, early and 
appropriate services and support are available and accessible to all 
In the next five years, we will work to: 
• improve the co-ordination, integration, reach and effectiveness of eye health and eye care services 
• ensure that, when permanent sight loss occurs, emotional support, habilitation and/or rehabilitation will be 
 ECLOs can play an 
educational role 
with patients in 
terms of looking 
after their eye 
health.  Also ECLOs 
can work to raise 
awareness of the 
impact of sight loss 
among health and 
social care 
professionals. 
 ECLOs can help to 
ensure patients are 
signposted and 
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provided in a timely fashion, enabling people to retain or regain their independence. 
Strategy Outcome 3 
A society in which people with sight loss can fully participate In the next five years, we will work to: 
• improve attitudes, awareness and actions within education, employment and other services 
• ensure that children and young people with sight impairment can take their place in society 
• achieve improved compliance with equality legislation 
referred to services 
efficiently. 
 ECLOs work with 
patients with sight 
loss to maintain 
and gain 
employment.  
ECLOs also work 
with children and 
young people in 
eye clinics. 
Adult UK Eye Health 
and Sight Loss 
pathway 
Vision 2020175 
This pathway specifies the requirement for Early Intervention (Advice, information & emotional support) e.g. 
Eye 
Clinic Liaison Officer (ECLO), Vision Support Service or similar in the service delivery for adults as they progress 
along the eye health and sight loss pathway. 
 ECLOs are well 
placed within eye 
clinics to provide 
early intervention 
to address 
patients’ needs. 
Eye Health Network 
for London: 
Achieving Better 
Outcomes176 
Recommendation 1 
The important role of the Eye Clinic Liaison Officer (ECLO) should be included as part of the service 
specification. 
Recommendation 3: Age-related Macular Degeneration 
Ensure that all patients who have visual loss have access to an ECLO service and services which provide support 
and visual rehabilitation. 
Recommendation 8: Low Vision 
Integration is particularly important for low vision services. Effective low vision services need to adapt to 
 Specifies provision 
of an ECLO as part 
of the service  
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individual needs and work as seamlessly as possible with other services, including hospital eye units, 
education, social care, voluntary organisations and stroke, learning disability, rehabilitation and falls teams. 
There should be an ECLO service in every eye clinic in order to facilitate this. 
VISION 2020(UK) Ophthalmic Public Health Outcome measures 
Portfolio Eye Specific Indicator 9 
“Eye Care Liaison (ECLO) Service. Every Commissioning Organisation (e.g. CCGs in England) to have 
commissioned an ECLO Service to be provided within HES, community or both” 
Action on AMD177 Key Recommendations  
1. Appropriate funding and resources must be made available now that treatment is possible 
2. There should be no compromise in the standard of service provision, or quality or frequency of intravitreal 
treatment administration 
3. Continued evaluation and adaptation/redesign of local wet AMD NHS service is required 
4. Recruitment 
5. Prioritisation/stratification of patients 
6. Virtual clinics 
7. Use of other community spaces such as mobile units, polyclinics or GP clinics 
8. Multi-disciplinary clinics—staff training / development, flexible role, and appropriate use of staff 
9. Use of community optometrists for monitoring ‘stable' patients (at low risk of needing treatment) 
10. Electronic referrals from community optometrists 
11. Electronic medical records 
12. Employment of an Eye Clinic Liaison Officer to guarantee a holistic service that takes account of the 
emotional support needs of patients and helps secure a smooth transition from health to social care and other 
support services as required 
 Specifies provision 
of an ECLO as part 
of the AMD service 
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